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Abstract 
The study and applications of non-covalent interactions within an assembly of distinct 
molecules have attracted much attention over the past few decades. The energy range of these 
interactions such as hydrogen-bonding (H-bonding) makes them a subtle phenomenon to 
investigate. The aim of this project was to prepare novel ferrocene-based H-bonding receptors 
and to study them in the electrochemical sensing of neutral compounds and in organocatalysed 
transformations. The synthesis and characterisation of 2-ferrocenyl oxazoles via gold chemistry 
to access a new H-bonding motif for electrochemical sensing was successfully achieved. 
However the targeted structure bearing a secondary amine at the 4-position of the oxazole, was 
found to be highly unstable and unsuitable for sensing applications. Further studies on 
ferrocene-based H-bonding systems towards their application in asymmetric organocatalysis 
were also carried out. Different chiral and achiral ferrocene-(thio)ureas were prepared and 
tested in four organic reactions. Their performances in the Henry and in the Morita-Baylis-
Hillman reactions gave acceptable yields but did not show significant enantioselectivities. A 
bi-functional ferrocene-thiourea was found to be effective in the enamine co-catalysed aldol 
reaction of acetone and trans-β-nitrostyrene, and in the double Michael cycloaddition of ω-
nitropentenoate methyl and trans-β-nitrostyrene, leading to a tetrasubstituted cyclopentane. 
The H-bonding properties of the ferrocene-(thio)ureas with carboxylates was also studied by 
1H NMR spectroscopy. Finally, approaches towards the preparation of ferrocene-based 
boronate-ureas were investigated. 
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1. General introduction 
1.1. Supramolecular chemistry / H-bonding 
Supramolecular chemistry is the study of well-defined and highly organised structures formed 
by non-covalently bound molecules. It involves weaker types of bonding arising from 
electrostatic interactions, such as hydrogen bonding (H-bonding), ion pairing (stronger in the 
solid state) or π-stacking, and hydrophobic interactions. Depending on the features of the bound 
molecules (polar groups, aromatic, alkyl chain, polarizability…) all of these interactions can 
play a role, with different intensities, and combine to offer new interactions (for example 
cation- and anion-π interactions, ion-dipole…).1 An important concept of the supramolecular 
field is the specific affinity of a given host (receptor) towards its guest (substrate). The best 
illustration of the potential of these weak interactions is found in the evolution of Nature, which 
gave rise to the very fine utilisation of these dynamic interactions in biological systems. Early 
studies in supramolecular chemistry led Donald Cram (carcerands encaging Cl- anion),2 Jean-
Marie Lehn and Charles Pedersen (polycyclic ethers chelating K+ cation)3 to the Nobel Prize in 
1987 "for their development and use of molecules with structure-specific interactions of high 
selectivity".4  
H-bond interactions (Figure 1) have received much attention for their potential in binding 
strength and substrate recognition, due to their directionality and cooperativity.5  
 
Figure 1: a) Hydrogen-bonding interaction between the electronegative donor D and acceptor A. b) 
Cooperativity of multiple H-bonds, and secondary interactions between adjacent H-bonds (attractive: 
red, repulsive: black) 
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A vast number of synthetic receptors, neutral or charged, have now been designed around 
simpler Hydrogen Bond Donor (HBD) units, among them amides, ureas, hydroxyl, amines and 
N-heterocycles (Figure 2).  
 
Figure 2: simple HBD 
To be specific to a substrate, the different H-bonding sites of a receptor also need to be spatially 
localised, via their backbone, to adopt a complementary shape that optimises the binding 
affinity (lock and key model).6  
1.2. Types of HBD 
An important feature in H-bond assisted catalysis is primarily the type of Hydrogen Bond 
Donor (HBD), in which the number and the directionality of the H-bond(s) as well as the width 
between them can be tuned to ensure the best geometry for a given transformation. The focus 
of this discussion is on the most developed dual HBD, which possesses two anchoring points 
for the substrate(s). The most common strategy to access a polarised D-H bond (D = Donor) is 
the use of nitrogen as D, and to a lesser extend oxygen. Due to its trivalency, the geometry of 
the N-H bond can be more easily controlled than with divalent oxygen (in the case of O-H 
bonds). Among the different types of dual HBD, the earliest examples were made using urea 
or thiourea (Figure 3). 
 
Figure 3: Model of (thio)urea 
The potential for urea to selectively bind to a guest (nitro, phosphine oxide, ketone, aldehyde, 
ether) was discovered through solid-state studies.7 Soon after, this potential was successfully 
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applied in solution-state chemistry in the radical allylation of cyclic α-sulfinyl radicals.8 Since 
then the scope of (thio)urea catalysed transformations has widened immensely and tremendous 
levels of yield and enantio-selectivity have been achieved when used in organocatalysts.9  
 
With a very similar structure, guanidine derivatives have also been investigated by Takemoto’s 
group (Figure 4).10 
 
Figure 4: Guanidine derivatives 
They offer access to more rigid HBD as it is possible to lock the conformation through covalent 
bonds linking the imine with one of the amine moieties. Furthermore, the substitution of the 
imine nitrogen by an electron withdrawing group (CO or SO2) allows for further acidification 
of the hydrogens. These types of guanidine exhibit a slightly longer distance (≈ + 0.2 Å) 
between the two hydrogens.  
From an understanding of the active sites of some enzymes, which exhibit ionic interactions, a 
new type of ionic HBD has emerged based on protonated pyridine.11 Work by Takenaka and 
co-workers led to the preparation of dual HBD based on 2-aminopyridinium (Figure 5).12 
 
Figure 5: Model of 2-aminopyridinium 
They developed a chiral version by merging their 2-aminopyridinium catalytic unit into the 
framework of helicenes.13 
All the afore-mentioned HBD exhibit the same directionality regarding H-bond donation 
(parallel). A new class of dual HBD has been studied during the past decade, namely 
squaramide (Figure 6). Squaramides present a number of differences with thioureas: rigidity 
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(through more delocalisation possible), non-zero polar moment, distance between hydrogens 
(typically 2.7 Å) and a notably different directionality of the two H-bonding sites.  
 
Figure 6: Model of squaramide 
Squaramides have proven to be reliable and powerful dual HBD catalysts in many different 
transformations.14  
As with ureas, sulfamides have been considered as potential HBD in organocatalysis after H-
bonding interaction were first established in the solid state (Figure 7).15  
 
Figure 7: Model of sulfamide 
Their NH protons are more acidic due to the higher electron-withdrawing effect of the sulfonyl 
group. The geometry of the sulfur atom, tetrahedral as opposed to the planar carbone sp2 in 
(thio)ureas, also modifies the directionality of the H-bonds. Sulfamides have been successful 
catalysts in the addition of aldehydes and acetone to β-aryl-nitroethenes and (E)-methyl 2-oxo-
4-phenylbut-3-enoate.16 
1.3. Strategies for activating HBDs 
Besides the geometry of the D-H bonds mainly addressed by the type of HBD (directionality, 
relative position), their strength has to be tuned to match the requirement of a particular 
transformation. Although factors other than pKa are at play, it is generally the case that an 
increased acidity of the protons tends to have a beneficial effect on both selectivity and yield. 
pKa values for simple neutral (thio)urea HBD can vary from 18.7 for diphenyl urea to 13.4 for 
diphenyl thiourea in DMSO.17  Due to the difference in p orbitals (2p in O and N, and 3p in S) 
overlapping with the carbon’s 2p orbital, the character of the CO, CN and CS bonds (simple or 
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double) can be described through the predominance of one of the mesomeric forms (Scheme 
1).  
 
Scheme 1: Mesomeric forms of urea and thiourea. Predominant forms in red 
From this it appears that the carbonyl/amine form of the urea and the iminium/thiolate form of 
the thiourea are the most favoured, explaining the greater acidity of the thiourea over urea. 
 
Many strategies have been developed to enhance and modulate the pKa, the earliest of them 
using electron-withdrawing phenyl substituents. In 2002, Schreiner and co-workers 
successfully used the 3,5-bis(CF3)phenyl substituent (Figure 8),18 which proved to be a 
standard reference due to its reliability and efficiency in many cases.19  
 
Figure 8: Electron-withdrawing 3,5-bis(trifluoromethyl)phenyl substituent 
The electron-withdrawing, hence acidifying, trifluoromethyl groups can also help to maintain 
a stabilised conformation of the catalyst by introducing more H-bonds into the system (Figure 
9).20  
 
Figure 9: Example of substituent assistance, offering higher HBD acidity, planarity, and substrate 
organisation 
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The acidity is increased by the electron-withdrawing character of the CF3 groups which also 
induce intramolecular H-bonding between the meta- hydrogens (acting as a Lewis acid) and 
the sulfur (acting as a Lewis base). The concept of activation by Lewis acid was put forward 
by Smith and co-workers in 1996 with their work on boronate-urea receptors.21 They studied 
the binding to acetate in DMSO and calculated an equilibrium constant of 6×104 M-1 compared 
to 4×102 M-1 for the corresponding phenyl analogue (Scheme 2). 
 
Scheme 2: Difluoroboronate enhancing the H-bonding strength 
This elegant difluoroboronate-urea strategy has been successfully employed in the activation 
of nitrocyclopropane ester and α-nitrodiazo esters, and in the enantioselective addition of 
indoles to nitrostyrene.22 Sulfoxides have also been incorporated into the design of HBD as 
they provide a convenient acidifying effect, decreasing the pKa by 2 – 3 units compared to the 
3,5-bis(CF3)phenyl substituted equivalent, and at the same time, giving the opportunity to add 
a chiral element to the structure (Figure 10).23  
 
Figure 10: Sulfoxide activating substituent bringing chirality  
 
1.4. Chiral Scaffolds 
As discussed above, sulfoxides are a chiral acidifying substituents and offer a good opportunity 
for enantioselectivity.24 Incorporated a decade earlier, the 1,2-trans-substituted cyclohexane 
scaffold gave the highly enantioselective hydrocyanation of N-allyl or N-benzyl aldimines,25 
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ketoimines,26 and Mannich reactions.27 The Takemoto group designed a bi-functional catalyst 
featuring a HBD thiourea moiety and a tertiary amine linked by cyclohexyl (Scheme 3) capable 
of achieving the aza-Henry reaction with good enantiomeric ratios.28  
 
Scheme 3: 1,2-trans-substituted cyclohexane scaffold in the aza-Henry reaction 
Notably, a recent study showed the presence of four different conformers in solution, which 
exhibited deactivating inter- or intra-molecular H-bonding interactions.29 The active 
conformation happened to be the least populated conformation. Smith and co-workers 
addressed this issue with the efficient design of the catalyst depicted in Scheme 4.30 Their work 
on non-peptidic reverse turn linkers allowed them to elaborate a highly populated state of pre-
organised active conformations.31 This bio-mimetic structure gave astonishing results in terms 
of enantio-selectivity (>99% ee) and catalyst-loading (5% down to 0.1%) in the Mannich 
reaction between N-Boc aldimines and silyl ketene acetals. 
 
Scheme 4: Flexible well-defined bi-functional catalyst for the Mannich reaction between N-Boc 
aldimines and silyl ketene acetals 
Nature provides a myriad of available complex chiral molecules; one of them, cinchona, has 
attracted many researchers’ attention. The cinchona-based skeleton (Figure 11) offers many 
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derivatisation options and as a consequence is now widely found in the literature regarding 
multifunctional HBD organocatalysis.32  
 
Figure 11: Model of cinchona 
Cinchona-based catalysts also give an easy access to an array of different weak interactions: 
H-bonding (HBD), ionic interactions (protonated tertiary amine), p-stacking (quinoline) and 
hydrophobic (3-vinylquinuclidine).  
More recently, paracyclophane-based catalysts have emerged as a new unexplored area that 
uses planar chirality (Figure 12).  
 
Figure 12: Model of paracyclophane 
This simple scaffold was used in the thiourea (R1 = thiourea, R2 = OH) catalysed Friedel-Crafts 
alkylation of indole with nitro-styrene and the hydrogenation of nitro-olefins in moderate to 
good yields but low levels of enantioselectivity.33 The aldol reaction of acetone with isatin 
mediated by a proline-thiourea paracyclophane catalyst (R1 = thiourea, R2 = N-Boc-
prolinamido) was achieved with consistently good yields and moderate to good 
enantioselectivity.34 Finally, Kitagaki and co-workers reported in 2013 the efficient bis-thiourea 
paracyclophane-catalysed Henry reaction of nitromethane and nitro-ethane with aromatic 
aldehydes.35 Good enantiomeric excesses were obtained (typically more than 90%), confirming 
the potential of planar chirality in being investigated when designing new chiral HBD catalysts. 
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1.5. Organocatalysis: screened reactions 
1.5.1. The Henry reaction 
Discovered in 1895, the Henry reaction provides an efficient way of forming a C-C bond from 
nitroalkanes and aldehydes or ketones (Scheme 5).  
 
Scheme 5: The Henry reaction catalysed by a base and a HBD 
A sub-stoichiometric amount of base is required to deprotonate the α- proton of the nitroalkane, 
generating nitronate A1 (Scheme 6). Nitronate A1 is stabilised by H-bonding with the 
protonated base, and can also be further stabilised by the HBD (thiourea in Scheme 6). Upon 
approaching of the aldehyde, the weakest H-bond between nitronate A1 and the thiourea breaks 
to allow for the aldehyde to bind to the thiourea.36 If the conformation of the resulting structure 
is constrained (low degree of freedom) then the relative position of the nitronate and the 
aldehyde remains constant, which consequently sets the stereo-outcome of the reaction. 
Subsequent nucleophilic attack of nitronate A1 onto the activated carbonyl leads to β-nitro 
alcoholate A2 which gives the Henry product 43 upon reprotonation. 
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Scheme 6: General mechanism for the HDB catalysed Henry reaction 
Among the most efficient organocatalysts for the Henry reaction, a bi-functional tertiary amine-
thiourea derived from cinchona gave high yields and enantioselectivities (typically 90% ee) 
with a variety of aromatic aldehydes (Figure 13).37 
 
Figure 13: Highly stereoselective organocatalyst for the Henry reaction of aromatic aldehydes and 
nitromethane 
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1.5.2. The Morita-Baylis-Hillman reaction 
The Morita-Baylis-Hillman (MBH) reaction is another powerful C-C bond forming process 
between a Michael acceptor and an aldehyde or ketone, catalysed by a tertiary amine (Scheme 
7). 
 
Scheme 7: The Morita-Baylis-Hillman reaction between benzaldehyde and cyclohexen-1-one 
 The general accepted mechanism of the HBD assisted MBH reaction between cyclohexenone 
and benzaldehyde involves the aza-Michael addition of the tertiary amine onto the enone to 
form zwitterion B1 which can be stabilised by the HBD (Scheme 8).38 The HBD activated 
aldehyde is then attacked by B1 to give the aldol adduct B2. It is still under debate whether the 
proton-transfer conducing to product 44 is initiated by a proton source (HBD in this case, red 
arrow) or involves the O-addition to another molecule of aldehyde (green arrow) followed by 
a six-membered conformation able to ensure the proton-transfer.39 
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Scheme 8: General mechanism for the HDB catalysed MBH reaction 
The stereo-determining step is the attack of B1 onto the aldehyde. Consequently, their approach 
towards each other must be organised to achieve any enantioselectivity. The first example of 
bi-functional (hydroxyl HBD / tertiary amine) cinchona-based catalysts (Figure 14) was 
reported in 1999 for the reaction of various aromatic and aliphatic aldehydes with the very 
reactive 1,1,1,3,3,3-hexafluoroisopropyl-acrylate.40 Enantiomeric excesses as high as 99% 
were observed. 
 
Figure 14: Efficient organocatalyst in the asymmetric MBH reaction 
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1.5.3. HBD / Enamine co-catalysis 
The organocatalysed enamine type reaction of ketones with nitroolefins was described in 2001 
with L-proline.41 Despite the very good yields obtained, the transformation suffered from a lack 
of enantioselectivity, reaching 7% ee for the reaction between acetone and trans-β-nitrostyrene. 
In 2007, Clarke and co-worker reported a new approach for this reaction by creating a multi-
component catalytic system that self-assembles through H-bonding (Scheme 9), giving 67% ee 
with cyclohexanone and trans-β-nitrostyrene.42  
Scheme 9: Enamine/HBD organocatalysis via self-assembled catalysts 
This catalytic system was developed with the desire to improve the enantioselectivity of the 
process by adding a bulky stereo-controlling element to the L-proline.  To create an organised 
chiral environment and at the same time speed up the screening of catalysts, a non-covalent 
bond between the catalytic site and the stereo-controlling part of the catalysts was introduced. 
This non-covalent interaction can be hydrogen-bonding or ionic as reported in the more recent 
study carried out by Xu and co-workers in 2008.43 They combined a phenylalanine (exhibiting 
a carboxylic acid functionality) derived thiourea with a modified proline bearing an imidazole 
thio-ether (exhibiting basic sp2 nitrogen)  in place of the original carboxylic acid moiety (Figure 
15). They reported the efficient asymmetric conjugate addition of acetone to trans-β-
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nitrostyrene (95% yield, 64% ee). The same year another study was published by Zhao and co-
workers using an amino acid and a chiral tertiary amine bearing a thiourea unit (based on 
cinchona) to catalyse the same reaction.44 The self-assembled catalytic system was held 
together by ionic interaction (acid/base) and achieved moderate to good enantio-selectivity, and 
an excellent 95% ee (R enantiomer) when L-phenylglycine was used in place of L-proline 
(Figure 15). The proposed mechanism involves the condensation of the ketone and the amino-
acid catalyst forming the enamine intermediate as a first step. The nitroalkene then binds to the 
HBD enabling it to be attacked by the enamine. The authors suggested the following transition-
state prior to C-C bond formation: 
 
Figure 15: Transition state of nitrostyrene with an assembly of cinchona-based thiourea and L-
phenylglycine 
 
1.5.4. Formation of tetrasubstituted cyclopentane  
The generation of a contiguous multi-stereocenter-containing cyclic product from achiral 
substrates is also possible using organocatalysis.45 While proline derived catalysts have been 
widely employed to prepare optically active poly-substituted cyclohexanes and cyclopentane, 
the use of HBD catalysts remains largely unexplored.46 Very recently Cobb and co-workers 
designed an asymmetric domino Michael-Michael reaction between ω-nitro-hexenoate and 
trans-β-nitrostyrene catalysed by a cinchona-based thiourea (Scheme 10).47  
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Scheme 10: HBD catalysed cycloaddition of ω-nitro-hexenoate and trans-β-nitrostyrene by Cobb and 
co-workers 
The reaction scope was explored by varying the substituent of the nitroalkene, including 
pentafluorophenyl, furan, thiofuran, and para-methyl, -methoxy, -fluoro and -chlorophenyl. All 
of these gave the corresponding cyclohexanes with high enantiomeric excess (from 87% to 
>99% ee). They noted that the enantiomeric excess was time-dependent and that the minor 
diastereoisomers were converted to the major diastereoisomer when subjected to the same 
reaction conditions, so the major diastereoisomer was the thermodynamic product. They 
proposed the mechanism depicted in Scheme 11. 
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Scheme 11: Proposed mechanism for the domino Michael-Michael reaction leading to 
thermodynamic cyclohexane product 
The coordination of ω-nitro-hexenoate to the thiourea catalyst allows for the deprotonation in 
α- of the bound nitro group to form azinate D1. Upon binding of D1 and trans-β-nitrostyrene to 
the catalyst, the stereocontrolled intermolecular nucleophilic attack takes place to give a second 
azinate D2. The subsequent cyclisation of D2 gives four cyclohexane products D3. This is 
thought to be a fast process relative to the protonation of the azinate as no protonated D2 was 
observed. The four diastereoisomers D3 are then equilibrated to the most stable 
diastereoisomer. It is interesting to note that while the formation of cyclohexane was highly 
promoted, the cyclopentane analogue could not be produced with this catalyst.  
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1.6. HBD for recognition purposes: ferrocene-containing sensors 
Due to its reliable redox properties, ferrocene has been incorporated into a number of 
supramolecular receptors that can sense the binding of a guest species due to a change in its 
oxidation potential (Fc/Fc+).48 Some examples of H-bonding systems containing urea and 
related motifs are here described. In 2002, Alonso and co-workers successfully detected the 
presence of submillimolar hydrogenphosphate anion using dendrimers of poly(propylene-
imine) backbones and peripheral ferrocenyl-urea groups.49 Similar work on ferrocenyl-ureas 
showed the selective binding to hydrogenphosphate or chloride (Figure 16).50 
 
Figure 16: Electrochemical detection of H2PO4- (left, K = 1.2 x 103 M-1) and Cl- (right, K = 8.8 x 102 
M-1) 
Molina and co-workers added 18-crown-6 ether to the urea and found that only H2PO4- formed 
a complex, over Cl-, Br-, HSO4- and NO3-.51 A slight change in the redox potential of the 
ferrocene was observed upon chelation of the potassium cation into the crown ether (Figure 
17). 
 
Figure 17: Ferrocenyl-urea crown ether for the electrochemical sensing of KH2PO4 
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A series of calixarene-containing ferrocenyl-ureas have been developed by Beer and co-
workers (Figure 18), showing high affinity for benzoate and hydrogenphosphate anions (K = 
2.1 and 1.1 × 103 M-1 respectively in CD3CN at 293 K and 1.5 mM).52 
 
Figure 18: Calix[4]arene-containing ferrocenyl-urea for privileged hosting of benzoate anion 
Neutral molecules have also been investigated as guests, such as barbital compounds. A 1,3-
disubstituted ferrocene was prepared by Collinson and co-workers to selectively bind to neutral 
di-ethyl barbital, over ethylene urea and trimethylene urea, via six H-bonds (Figure 19).53 The 
binding constant was established as K = 3.2 x 103 M-1 in CDCl3 at 5 mM at 293 K.      
 
Figure 19: 1,3-di-substituted ferrocene receptor for the selective binding to barbital 
In 2008, the Tucker group reported the efficient asymmetric preparation of chiral ferrocene 
ureas (Figure 20) and their electrochemical properties concerning the chiral recognition of 
carboxylate guests (tetrabutylammonium salts of 2-phenyl butyrate, mandelate and N-
benzensulfonyl proline).54 The redox potential of the ferrocene moiety upon guest binding 
moved towards lower values. However the values were the same for each enantiomer of each 
guest used. Nevertheless a degree of enantioselectivity was observed in the recognition of the 
enantiomers of N-benzensulfonyl proline guest (K(S) = 1778 M-1, K(R) = 1071 M-1). 
CHAPTER 1: GENERAL INTRODUCTION  
19 
 
 
Figure 20: Chiral ferrocene-based urea receptor 
Two years later, the same group published their work on the electrochemical determination of 
the enantiomeric excess of a mixture of (R)- and (S)-binol using a chiral ferrocene imine (Figure 
21).55 They found the binding constant with (R)-binol to be 19 times higher than with (S)-binol. 
 
Figure 21: Chiral ferrocene-based boronic acid receptor 
 
1.7. Thesis outline 
This thesis concerns the study of supramolecular ferrocene systems for molecular recognition 
and organocatalysis. 
Chapter 2 explores the feasibility of building new hydrogen bond donor / acceptor sensors 
based on the gold-catalysed formation of ferrocene oxazoles. The preparation of 2-ferrocenyl-
4-N-sulfonamide-5-alkyloxazole via gold chemistry and their electrochemistry (cyclic 
voltammetry) are reported. Further deprotection of the sulfonamide to the corresponding 
secondary amine using a simpler model is also discussed. Finally, a number of X-ray structures 
are analysed. 
 
Chapter 3 focuses on the application of ferrocene systems to the well-studied area of 
asymmetric catalysis using ureas and thioureas. A series of ferrocene-tethered (thio)urea 
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catalysts were prepared, containing either central or planar chirality, or both within a bi-
functional catalyst. An NMR study of their hydrogen bonding properties is presented and their 
performances in selected asymmetric catalytic reactions are assessed. An evolution of their 
design and the resulting preparations are also described and discussed. 
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2. Ferrocenyl amino oxazoles as H-bonding receptors 
2.1.  Introduction 
2.1.1. Oxazoles in weak interaction / coordination chemistry 
Prior to the 1980’s oxazoles were thought to be a type of heterocycle rarely encountered in 
biologically active compounds. Since then, a myriad of oxazole-containing molecules, such as 
Ulapualide A (Figure 22), have been discovered, their pharmaceutical properties have been 
studied (anti-tumour, anti-fungal, anti-bacterial, anti-malaria, anti-viral),56 and synthetic 
methodologies have been developed towards their preparation.57  
 
Figure 22: (-)-Ulapualide A extracted from Hexabranchus sanguineus, a nudibranch from the Indo-
Pacific 
Although the sp2 nitrogen within the ring is a rather weak Lewis base, oxazoles may coordinate 
to a metal and form a complex. Hence, many oxazole-containing ligands have been designed 
and successfully incorporated in metallic complexes, of iridium,58 copper,59 zinc,60 nickel,61 or 
palladium (Figure 23).62  
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Figure 23: Oxazole ligands in palladium and iridium complexes 
Furthermore, chiral polyoxazole macrocycles (tris-, hexa-, septa-oxazole, telomestatin) showed 
the ability to selectively bind to G-quadruplex DNA through weak interactions such as π-
stacking and/or hydrogen bonding.63 
 
2.1.2. Project – Aims 
Previous work in the Tucker group showed that amidopyridine ferrocene (Figure 24) binds to 
carboxylic acids through hydrogen-bonding interactions.64 The electrochemical potential of the 
ferrocene unit was then shifted towards less positive values by ca. 20 mV upon addition of one 
equivalent of the neutral guest, allowing for the detection of aliphatic carboxylic acids.  
 
Figure 24: Amidopyridine ferrocene binding to carboxylic acid (R = alkyl) 
The aim of the work presented here was to create a new oxazole-based motif for recognition of 
neutral guests and incorporate it within the ferrocene sensing unit (Scheme 12). 
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Scheme 12: 2-Ferrocenyl-4-aminooxazole for electrochemical recognition of a matching guest 
This two-point motif was to be generated using gold chemistry developed in the Davies 
group;65 via the addition of a pyridinium-N-aminide onto a nosyl-protected (4-
nitrobenzylsulfonyl) ynamide to form a 4-N-trisubtituted oxazole and subsequent deprotection 
of the sulfonamide (Scheme 13).  
 
Scheme 13: Retro-synthetic analysis of gold-mediated 4-N-substituted oxazole formation ( Fc = 
Ferrocene) 
The resulting motif presents a hydrogen bond donor, as a secondary amine substituted to the 4-
position of the oxazole ring, and a hydrogen bond acceptor, as the sp2 nitrogen belonging to the 
oxazole ring. The tethering of a ferrocenyl unit on the 2-position of the oxazole would allow 
for sensing and reporting the presence (or absence) of a guest binding to the 4-amino oxazole 
moiety by electrochemical methods. This guest should possess a complementary H-bonding 
motif such as carboxylic acid for example. The redox potential of the ferrocenyl unit should 
change upon addition of a guest. Ideally, the change in potential would be dependent of the 
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specific detected guest. In addition, such an organometallic compound might be a candidate 
for drug discovery, as it is composed of the bio-interactive moieties oxazole and ferrocene.66 
2.1.3. Preparation of oxazoles 
Numerous synthetic methods have been developed to build this heterocycle, offering milder 
and milder reaction conditions and increasing flexibility regarding to the substituent scope.67 
Multi-component reactions were designed to yield fully substituted oxazoles from readily 
available starting materials,68 as well as metal free procedures using iodine,69 hypervalent 
iodine,70 brönsted acid catalysis,71 one-pot cyclisation/reduction of β-hydroxy amides.72 
Investigations on metal-catalysed processes also provided many methodologies to achieve the 
formation of highly substituted oxazoles using, among others, propargylic alcohols,73 
propargylic amides,74 α-diazocarbonyl compounds,75 or alkynes.76  
In 1999, Tárraga and co-workers developed an aza-Wittig methodology to prepare the 
disubstituted 2-amino-5-ferrocenyloxazole from β-azido acetylferrocene (Scheme 14). They 
also reported its electrochemistry, which will be discussed later.77  
 
Scheme 14: Tárraga’s synthesis of 2-amino-5-ferrocenyloxazole 
In 2011 the Davies group reported the efficient gold (III) mediated formation of 4-
aminooxazoles from ynamide and pyridinium-N-aminides, through a formal [3+2] dipolar 
cycloaddition (Scheme 15).65  
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Scheme 15: Formal [3+2] cycloaddition of pyridine N-aminide onto ynamides catalysed by gold 
The scope of this reaction allows for a wide variety of substituents at all positions, such as 
alkyl, allyl, aryl, halo-aryl, heterocycles, ethers or silyl alkynyl groups. In addition, the use of 
an ynamide instead of a simple alkyne ensures an exceedingly high level of chemo- and regio-
selectivity, due to the increased electrophilicity centred on the α carbon of the triple bond 
(Scheme 16).78  
 
Scheme 16: Origin of the chemo- and regio-selectivity of nucleophilic attack onto activated ynamide 
The proposed mechanism (Scheme 17) involves the coordination of gold(III) onto the triple 
bond of ynamide 3, enhancing the electrophilic character on the carbon adjacent to the nitrogen. 
The aminide 2 then attacks the alkyne regioselectively forming intermediate A1. The next step 
can be the concerted cyclisation / loss of pyridine (green arrow) or the step-wise loss of pyridine 
then cyclisation (red arrow). Deauration of A2 inducing aromatisation leads to the desired 
oxazole 1 and regeneration of the gold catalyst. 
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Scheme 17: Proposed mechanism for the gold mediated [3+2] dipolar cycloaddition of aminide 2 to 
ynamide 3 
To date, no organometallic oxazoles have been prepared via this route, and 2-ferrocenyl-4-N-
aminoalkyl-5-alkyl or -aryl oxazoles have not been synthesised in general. The challenges here 
are to determine whether this structure 1) can be made via a gold catalysed [3+2] dipolar 
cycloaddition / nosyl deprotection sequence, 2) possesses the ability to engage in hydrogen 
bonding with selected partners, and 3) can report the bound/unbound state of the aminooxazole 
via an electrochemical response of the ferrocene unit. 
2.2. Results and discussion 
2.2.1. Synthesis of N-nosyl-protected ferrocene oxazole  
Ferrocene oxazole 1 was to be prepared via gold-catalysed formal [3+2] dipolar cycloaddition 
of pyridinium ylide 2 and ynamide 3 in a regioselective fashion to offer the 4-N-(4-
nitrobenzene)sulfonylamide ring substitution (Scheme 18). 
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Scheme 18: Gold-mediated formation of oxazole 1 (Fc = Ferrocene) 
To achieve this, ylide 2 and ynamides 3 needed to be prepared. The ferrocene derived ylide 2 
was synthesised from commercially available ferrocenecarboxylic acid, which was subjected 
to oxalyl chloride in dichloromethane to generate the acyl chloride, then to aminopyridinium 
iodide (Scheme 19).  
 
Scheme 19: Preparation of ylide 2 
Unlike its phenyl equivalent, ferrocene ylide 2 could not be successfully prepared in sodium 
hydroxide / water system (Table 1, Entry 1).65 Switching to toluene as solvent, several bases 
were tried, potassium carbonate revealed to be the best choice ahead of cesium carbonate or 
pyridine (Table 1, Entry 2, 3 and 5). Although a good yield was obtained when triethylamine 
was used (Table 1, Entry 4), it could not be removed.  
Entry Solvent Base Temp (°C) Yield 2 Yield 4 
1 Water NaOH rt 12 0 
2 Toluene Pyridine rt 9 50 
3 Toluene Pyridine 90 7 30 
4 Toluene Et3N rt 62 (a) 0 
5 Toluene K2CO3 90 35 28 
6 MeCN K2CO3 80 24 0 
7 CH2Cl2 K2CO3 rt 65 0 
8 CH2Cl2 K2CO3 40 60 0 
9 CH2Cl2 Cs2CO3 rt 50 0 
Table 1: Optimisation of the preparation of ylide 2. Isolated yields (%). (a) NMR yield 
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A solvent study showed that dichloromethane was more suitable than toluene or acetonitrile 
(Table 1, Entry 5, 6 and 7). After 5 days at room temperature, the desired compound was 
obtained in 65% yield (Table 1, Entry 7). Increasing the temperature did not have a beneficial 
effect on the reaction outcome (Table 1, Entry 7 and 8). Up to half of the starting carboxylic 
acid self-condensed to give anhydride 4 when toluene was the solvent (Table 1, Entry 2). 
Conversion of 4 to the desired ylide 2 was achieved by reaction of aminopyridinium iodide in 
presence of pyridine (Scheme 20). 
 
Scheme 20: Conversion of anhydride 4 into ylide 2 
Crystals of ylide 2 suitable for X-ray diffraction were obtained by slow evaporation of 
chloroform. They crystallised in a monoclinic system, along with water in a 1:1 ratio. The Cp 
rings of ferrocene were only 3° away from eclipsed. The dihedral angle between O1, C6, N2 
and N1 was nil, indicating the full conjugation of the π orbital of the carbonyl with the pz of 
the nitrogen. As shown in Figure 25 and 26, both of the hydrogen atoms of the water molecule 
participate in the resulting four member ring structure by H-bonding with the lone pairs of the 
oxygen of the carbonyl with a distance dH-O = 2.00 Å (Table 2).  
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Figure 25: Crystallographic structures of ylide 2, along with a molecule of water. Displacement 
ellipsoids – 50% probability. (Data collection and structure resolution by Dr. Mateusz B. Pitak) 
 
Figure 26: Hydrogen-bonds between water and the carbonyl of ylide 2 within the crystal structure. 
Displacement ellipsoids – 50% probability. (Data collection and structure resolution by Dr. Mateusz 
B. Pitak) 
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      DHA d(DH) d(HA) d(DA) <(DHA) 
O2-H1O...O1i 0.839(15) 1.998(17) 2.8171(16) 165(2) 
O2-H2O...O1 0.816(16) 2.001(16) 2.8174(16) 178(2) 
Table 2: Distances and angles of Hydrogen bonds between ylide 2 and water (Å and °) 
Each molecule of water is also engaged, by the oxygen atom this time, in 3 other hydrogen 
bonds which are almost orthogonal to each other (Figure 27). They involve the para hydrogen 
of the pyridinium moiety of a 2nd aminide molecule (distance dO-H = 2.52 Å, Table 3, Entry 4), 
the ortho and meta hydrogens of the pyridinium moiety of a 3rd aminide molecule (distance dO-
H = 2.31 and 3.21 Å, Table 3, Entry 2 and 3 respectively) and the proton at the 2-position of the 
Cp ring of the 1st aminide bound (distance dO-H = 2.47 Å, Table 3, Entry 5). 
 
Figure 27: Crystallographic structure of ylide 2 exhibiting hydrogen bonds with molecules of water. 
(Some ferrocenoyl units are omitted for clarity). (Data collection and structure resolution by Dr. 
Mateusz B. Pitak) 
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Entry DHA d(DHA) d(HA) d(DH) <(DHA) 
1 O1-H2O-O2 2,817 2,003 0,815 178 
2 C1-H1-O2 3,446 2,309 0,951 147 
3 C2-H2-O2 3,581 3,207 0,95 106 
4 C3-H3-O2 3,458 2,517 0,95 171 
5 C8-H8-O2 3,331 2,469 0,95 151 
Table 3: Hydrogen bonds in the crystal structure of ylide 2 (Å and °, determined from the 
crystallographic data with the software Mercury 2.4)   
In 2008, Stahl and co-workers reported the preparation of ynamides from different types of 
secondary amines: cyclic carbonates or carbamates, indoles and sulfonamides.79 The latter was 
hoped to allow deprotection to give direct access to the desired secondary amine in the target 
oxazoles 1. To offer the mildest deprotection conditions, p-nitrobenzenesulfonamide (nosyl, 
Ns) was chosen as it requires the least aggressive conditions to be removed.80 Consequently 
ynamides 3 were prepared from the corresponding protected amine 5 reacted with the 
appropriate terminal alkyne in the presence of copper (II) chloride catalyst (Scheme 21: 
Copper-mediated oxidative coupling of protected amine 5 and terminal alkyne to form 
ynamides 3a-d). Good to high yields were obtained.  
 
Scheme 21: Copper-mediated oxidative coupling of protected amine 5 and terminal alkyne to form 
ynamides 3a-d 
With the ylide 2 and the ynamides 3 in hand, the formation of ferrocene oxazole 1 was catalysed 
by dichloro(pyridine-2-carboxylato)gold(III) ([Au]) in toluene at 90 °C (Scheme 22).  
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Scheme 22: Gold catalysed formation of oxazoles 1a-d 
Compound 1c was obtained in 15% yield after one day, and in 51% when left for six days 
(Table 4, Entry 4 and 5). The bulkier 2-ferrocenyl-4-N-(N-phenyl)nosylamide-5-phenyloxazole 
1a required two days with 2.5 equivalents of ylide 2 to yield 46% of product (Table 4, Entry 
1), and gave only 10% yield with 1.5 equivalents after 24 hours (Table 4, Entry 2). Compounds 
1b and 1d gave 37% and 10% yields respectively (Table 4, Entry 3 and 6). 
Entry Compound R
1
, R
2 Time (d) Yield
1 1a Ph, Ph 2 46
a
2 1a Ph, Ph 1 10
3 1b Ph, Me 6 37
b
4 1c n -Bu, Ph 1 15
5 1c n -Bu, Ph 6 51
6 1d n -Bu, Me 1 10  
Table 4: Gold catalysed formation of oxazole with various substituents. Isolated yields (%). 
Equivalents of ylide 2 used: 1.5 in all cases, except for a) 2.5 and b) 2  
 2-Phenyl-oxazole 6 was also synthesised (Figure 28) in a much greater yield (80%) from 
ynamide 3b and N-benzoylpyridinium ylide to be used as a model in the deprotection step (see 
section 2.2.3). 
 
Figure 28: Phenyl oxazole 6 
Crystallographic structures of oxazole 1a and 1c were obtained (Figure 29 and Figure 30). The 
Cp rings of ferrocene were only 5° away from eclipsed for both 1a and 1c. The carbon 
substituted on the Cp (C21) ring was not in the Cp ring plane, with a dihedral angle (C21-C22-
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C26-C25 in Figure 29 and C19-C20-C24-C23 in Figure 30) of 9.8° and 10.5° for 1a and 1c 
respectively. The oxazole ring plane and the connected Cp ring plane presented an interplanar 
angle of 15° and 17° for oxazole 1c and 1a respectively, where the oxazole ring tilts towards 
the un-substituted Cp ring.  In both structures, the sulfonamido nitrogen atom was not 
conjugated with the oxazole.  
 
Figure 29: Crystallographic structures of oxazoles 1a. Displacement ellipsoids – 50% probability. 
(Data collection and structure resolution by Dr. Mateusz B. Pitak) 
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Figure 30: Crystallographic structures of oxazoles 1c. Displacement ellipsoids – 50% probability. 
(Data collection and structure resolution by Dr. Mateusz B. Pitak) 
Hydrogen-bonding interactions exist between two para-nitrophenyl units, occurring between 
the oxygen of the first molecule (O1) and the meta hydrogen of the other molecule (C6-H) with 
a distance dCH-O of 3.468 Å and 3.340 Å for oxazole 1a and 1c respectively (Figure 31).  
 
Figure 31: Intermolecular hydrogen bonding between 2 nitrophenyl moieties in 1a (dH-O = 2.53 Å) 
and 1c (dH-O = 2.40 Å). (Determined with the software Mercury 2.4. Data collection and structure 
resolution by Dr. Mateusz B. Pitak) 
CHAPTER 2: FC AMINO OXAZOLES AS H-BONDING RECEPTORS 
39 
 
After the successful synthesis of this series of mono-oxazole ferrocenes, it was decided to 
investigate whether 1,1’-bisoxazole ferrocene could be made using this gold mediated 
procedure (Figure 32).  
 
Figure 32: 1,1’-Bisoxazole ferrocene 7 
Following the described procedure, bis-ylide 8 was prepared from 1,1’-biscarboxylic acid 
ferrocene in an isolated yield of 4% (Scheme 23). 
 
Scheme 23: Synthesis of 1,1’-bis-ylide ferrocene 8 
This compound was extremely polar and mostly remained on the silica phase during column 
chromatography, along with the unreacted deprotonated aminopyridinium, rendering the 
purification process rather difficult. 
Compared to the case of mono-ylide 2, the gold-catalysed cycloaddition of ynamide 3 onto bis-
ylide 8 was a more challenging goal. The presence of two ylide moieties within the same 
molecule may generate a competitive reaction pathway. As shown in Scheme 24, the first 
nucleophilic attack of one aminide (giving B1) would be followed by a second attack from the 
other aminide to form the macrocyclophane B2 (instead of the O-attack as described in section 
2.1.3). Such a pathway may lead to compound 9. 
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Scheme 24: Possible competitive reaction pathway with 1,1’-bis-aminide oxazole 8 
However analysis of the products revealed that the desired 1,1’-bis-oxazole ferrocene 7 could 
be formed during the reaction (Scheme 25). Bis-ylide 8 gave exclusively oxazoles 7b and 7c 
in 14% and 8% yields respectively, leaving most of the bis-ylide 8 unreacted. 
Scheme 25: Gold-mediated formation of 1,1’-bisoxazole ferrocene 7 
 
2.2.2. Electrochemistry  
Ferrocenyl oxazoles 1a-c and ylide 2 (Figure 33) were analysed by cyclic voltammetry (Figure 
34 and Figure 35 respectively) and each gave a reversible one-electron redox process (0.3 mM 
in dry dichloromethane, supporting electrolyte: tetrabutylammonium hexafluorophosphate 0.1 
M, decamethylferrocene (dmfc) as internal reference reference).81 
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Figure 33: Compounds studied by electrochemistry 
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Figure 34: Cyclic voltamograme for 1a, 1b and 1c, potentials vs dmfc at 0.1 V.s-1 
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Figure 35: Cyclic voltamograme for 2. Potentials vs dmfc at 0.1 V.s-1 
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The reversibility of these redox processes can be assessed by considering the Randles-Sevcik 
equation, which expresses the linear dependence between the peak currents and the square root 
of the scan rate for a reversible redox process as: 
Ip = 2.69×10-5n3/2AD1/2Cv1/2 
Ip = peak current (A) 
n = number of electrons transferred per molecule 
A = electrode surface area (cm2) 
D = diffusion coefficient of solution species (cm2.s-1) 
C = bulk concentration (mol.cm-3) 
ν = scan rate (V.s-1) 
By plotting the anodic peak current against the square root of the scan rate, with scan rates 
ranging from 0.1 to 1.1 V.s-1, it can be concluded that oxazoles 1a-c and ylide 2 display a fully 
reversible behaviour under these conditions (Figure 36). 
 
Figure 36: Linear dependence of anodic peak current on the square root of the scan rate for 
compounds 1a-c and 2. 
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As expected, given the electron deficiency of the oxazole moiety, compounds 1a-c exhibited 
higher potential values than ferrocene (ca. 770 mV against 532 mV respectively, Table 5, Entry 
1-3 and 5). Among the different ferrocenyl oxazoles characterised, only a slight variation in the 
E1/2 values was observed, with 5-butyl oxazole 1c exhibiting the lowest value (E1/2 = 752 mV, 
Table 5, Entry 3) compared to 5-phenyl oxazole 1a (E1/2 = 779 mV, Table 5, Entry 1), suggesting 
a stronger electron donation through the oxazole ring by the butyl chain. By comparing 1a and 
1b, it appears that the N-sulfonamido substituent has a very limited effect on the ferrocene 
moiety, as they oxidise at similar potentials (E1/2 = 779 mV and 775 mV respectively, Table 5, 
Entry 1 and 2). Tárraga and co-workers showed that 2-ferrocenyl-5-phenyloxazole oxidises at 
a higher potential than ferrocene by 128 mV in dichloromethane.77 Comparatively, oxazole 1a 
oxidises at 247 mV more than ferrocene. It is then possible to attribute this difference (+119 
mV) to the N-nosyl at the 4-position of the ring. 
Entry Compound Epc E pa E 1/2 ΔE p
1 1a 739 818 779 79
2 1b 736 814 775 78
3 1c 713 794 752 81
4 2 507 581 559 74
5 Ferrocene 502 562 532 60  
Table 5: Potential values (mV) from cyclic voltammetry, vs dmfc at 0.1 V.s-1 
Interestingly ylide 2 has an E1/2 value 27 mV higher than ferrocene (559 mV against 532 mV 
respectively, Table 5, Entry 4). This may suggest that the ylide moiety can nearly compensate 
for the electron-withdrawing effect of the carbonyl group. Such a compensation could arise 
from an electro-donation by the negatively charged nitrogen. A one electron process would be 
characterised by a difference between the anodic and cathodic peak potentials, ΔEp, of 59 mV.82 
At 100 mV.s-1, ΔEp ranges from 74 mV for ylide 2 to 81 mV for oxazole 1c. However in these 
conditions, these values are typical for ferrocene species. The low polarity of the solvent 
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(dichloromethane) implies an uncompensated resistance in the solution, increasing with the 
scan rate; which results in a larger ΔEp.
 83  
2.2.3. Deprotection of 4-N-Nosylamine oxazole 
As mentioned in section 2.1.2, the aim was to prepare oxazoles 10a-d by deprotection of the 
nosyl-protected oxazoles 1a-d (Scheme 26). To date, the preparation of oxazoles bearing a 
secondary amine at the 4-position has not been reported in the literature. 
 
Scheme 26: Nosyl deprotection of oxazole 1a-d 
As described in section 1.2.1, oxazole 6 was prepared as a less expensive though similar model 
to oxazoles 1 and 7 for preliminary studies on the nosyl deprotection (Scheme 27).  
 
Scheme 27: 2-Phenyl-4-N-sulfonamide oxazole 6 to amine 11 
Sulfonamide 6 was subjected to deprotection conditions to access 4-N-amino oxazole 11. 
Nucleophiles such as mercaptoacetic acid, thiophenol, thioethanol were tested, along with 
DBU (diazabicyclo[2.2.2]octane), triethylamine, potassium carbonate or sodium methanolate 
as base. The anticipated general mechanism for the deprotection of para-nitrobenzene 
sulfonylamide is shown in Scheme 28. After deprotonation of the thiol, the nucleophilic thiolate 
attacks the ipso position of the benzene ring to form intermediate C1. Rearomatisation of the 
ring releases intermediate of interest C2 and by-product Cbp. Sulfur dioxide is then extruded 
from C2 and the deprotected amine is produced upon protonation. 
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Scheme 28: Anticipated mechanism for nosyl deprotection 
However it appeared that in our case, a side reaction took place regardless of the solvent (DMF 
or MeCN), or the nature and stoichiometry of the nucleophile (EtSH, PhSH or HSCH2CO2H) 
and the base (DBU), yielding oxidised compound 12 along with its hydrolysed derivative 13. 
In a few instances the desired amine 11 was detected (HRMS: calculated for C16H14N2O: 
250.1106, found 250.1107), but this result could not be reproduced and the purification failed 
to deliver the amine as a pure compound. Nevertheless, the sulfide by-product 14 was isolated 
from the reaction mixture, indicating that the deprotection reaction did occur (Scheme 29). 
Scheme 29: Deprotection products 
Interestingly, sulfides 14 (R = Et, Ph) have been reported to undergo self-induced photo-
oxidation (to sulfoxides) when subjected to oxygen and light (λmax = 340 nm).84 The mechanism 
involves photosensitiser-like behaviour of the sulfide which, upon irradiation, converts triplet 
oxygen into reactive singlet oxygen. When the authors trapped the formed singlet oxygen with 
a diene (1,3-cyclohexadiene), no sulfoxide was detected but only the endoperoxide product 
CHAPTER 2: FC AMINO OXAZOLES AS H-BONDING RECEPTORS 
46 
 
from the Diels-Alder reaction between singlet oxygen and 1,3-cyclohexadiene (Scheme 30). 
This suggests that singlet oxygen reacts faster with a diene-type substrate than with sulfide 14. 
 
Scheme 30: 4-Nitrophenyl phenyl sulfide 14 as photosensitiser (R = Et, Ph)  
Furthermore when substituted by hydrogen(s), methyl(s) and/or phenyl(s), the oxazole ring has 
been reported to be a suitable diene for the cycloaddition of singlet oxygen in acetonitrile.85 
The resulting endoperoxide, which was isolated, thermally collapsed to triacylamine (Scheme 
31).86  
 
Scheme 31: Reaction of oxazoles with singlet oxygen and their thermal decomposition to 
triacylamine 
To a certain extent oxazole 11 may behave in a similar fashion and form an endoperoxide 
intermediate, rearranging in a different way as to provide compound 12. The structure of the 
latter was confirmed by X-ray crystallography (Figure 37). 
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Figure 37: Crystallographic structure of compound 12, presenting an inter-molecular H-bond between 
NH and O (dNH-O = 2.798 Å). (Data collection and structure resolution by Dr. Mateusz B. Pitak) 
To test the hypothesis of the singlet oxygen / sulfide 14 / light-driven transformation of amine 
11 into oxidised compound 12, the deprotection was carried out under the same conditions 
described previously, with the exception of using de-oxygenated dry acetonitrile (dried over 3 
Å molecular sieves overnight then through bubbling argon for 10 minutes) and isolating the 
reaction mixture from light by wrapping with aluminium foil (from the reaction flask to the 
end of the column). Unfortunately this did not stop the oxidation process from taking place and 
both oxidised compounds 12 and 13 were observed. The collected fraction became light-blue 
in colour when exposed to sunlight. A mechanism is therefore proposed for the oxidation of 11 
to 12 (Scheme 32). 
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Scheme 32: Proposed mechanism for the oxidation of oxazole amine 11 by triplet oxygen 
The enamine type reactivity of oxazole 11 allows for a nucleophilic attack on triplet oxygen to 
give intermediate D1 which cyclises by Michael addition forming endoperoxide oxazole D2. 
Opening of the five-membered ring to the stabilised six-membered ring D3 further rearranges 
to give dioxirane D4. The electrophilic character of the dioxirane allows a new molecule of 
amine 11 to attack, forming intermediate D5. Fragmentation of the latter gives oxidised 
compound 12 and D6 which opens to form a second molecule of 8.  
Additionally, when the deprotection of sulfonamide 6 was followed by an acidic work-up (HCl 
1 M), only compound 13 was obtained in a high yield of 90% (Scheme 33). 
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Scheme 33: Oxidative ring opening followed by acidic hydrolysis of oxazole sulfonamide 6 
The ferrocene version was next attempted as it was in hand. Once again, when 2-
ferrocenyloxazole 1b was subjected to the standard deprotection conditions followed by silica 
gel column chromatography, no desired amine was detected and only compound 15 was 
isolated (Scheme 34). Likewise, if an acidic work up was conducted with HCl 1M, then only 
compound 16 was isolated. 
 
Scheme 34: Deprotection conditions applied to ferrocene oxazole 1b 
Hence the most likely explanation for this outcome is that the desired secondary amine is made 
but it then undergoes spontaneous oxidation when in contact with 3O2 from the air and slowly 
hydrolyses with moisture (Scheme 35). 
 
Scheme 35: Spontaneous oxidation and hydrolysis of 4-N-amino substituted oxazole 
Given that protected compound 1 is air stable (as well as in HCl 1 M), it may be reasonable to 
suggest that the nosyl moiety prevents the heterocycle from a spontaneous air-oxidation, 
potentially attributable to its substantial electron-withdrawing effect.  
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2.3. Conclusion and future work 
Novel mono-oxazole ferrocene 1 and 1,1’-bis-oxazole ferrocene 7 were successfully prepared 
via gold catalysis. Cyclic voltammetry studies of mono-oxazole 1 showed the reversible one 
electron redox process expected for a ferrocene species. They also emphasised the strong 
electron-withdrawing character of the oxazole ring, increasing the potential at which the 
ferrocene unit is oxidised (ca. +240 mV vs ferrocene). Almost half of this increase could be 
attributed to the presence of N-sulfonamido (N-Nosyl) at the 4-position of the oxazole (+119 
mV for 2-ferrocenyl-4-N-(N-phenyl)sulfonamide-5-phenyl oxazole 1a vs 2-ferrocenyl-5-
phenyl oxazole). Finally, deprotection of the nosyl group led to the desired secondary amines 
10 and 11, which most likely underwent spontaneous oxidative ring opening with triplet oxygen 
to give compounds 15 and 12, easily hydrolysed to compound 16 and 13 respectively. This 
difficulty with the synthesis precluded the study of 4-N-amino oxazole systems as new H-
bonding receptors. 
In order to stabilise the oxazole ring and avoid spontaneous oxidation, future work on gold-
mediated preparation of 4-NH-substituted oxazole could move towards the replacement of the 
N-alkyl/aryl group with a more electron withdrawing group, such as amide or 3,5-(CF3)-phenyl 
(Figure 38). This would potentially reduce the electron density available in the structure, hence 
improving its resistance towards oxidation. 
 
Figure 38: Potentially more stable modified 4-N-amino oxazoles as H-bonding receptors 
 
 
CHAPTER 2: FC AMINO OXAZOLES AS H-BONDING RECEPTORS 
51 
 
2.4. References 
56 a) D. Davyt, G. Serra, Mar. Drugs, 2010, 8, 2755-2780; b) Z. Jin, Nat. Prod. Rep., 2011, 28, 
1143-1191. 
57 V. S. C. Yeh, Tetrahedron, 2004, 60, 11995-12042. 
58 X. Li, X-T. Yu, H-J. Chi, Y. Dong, G-Y. Xiao, P. Lei, D-Y. Zhang, Z. Cui, Spectrochim. 
Acta, Part A, 2013, 116, 473-477. 
59 P. Comba, N. Dovalil, G. Haberhauer, G. R. Hanson, Y. Kato, T. Taura, J. Biol. Inorg. Chem., 
2010, 15, 1129-1135. 
60 A. Pintér, G. Haberhauer, Eur. J. Org. Chem., 2008, 2375-2387. 
61 A.O. Eseola, M. Zhang, J.-F. Xiang, W. Zuo, Y. Li, J.A.O. Woods, W.-H. Sun, Inorg. Chim. 
Acta, 2010, 1970-1978.  
62 a) J. Mazuela, P. Tolstoy, O. Pamies, P. G. Andersson, M. Dieguez, Org. Biomol. Chem., 
2011, 9, 941-946; b) M. Poyatos, A. Maisse-François, S. Bellemin-Laponnaz, L. H. Gade, 
Organometallics, 2006, 25, 2634-2641; c) A. O. Eseola, W. Li, O. G. Adeyemi, N. O. Obi-
Egbedi, J. A. O. Woods, Polyhedron, 2010, 29, 1891-1901. 
63 a) D. S. Pilch, C. M. Barbieri, S. G. Rzuczek, E. J. LaVoie, J. E. Rice, Biochimie, 2008, 90, 
1233-1249; b) K. Jantos, R. Rodriguez, S. Ladame, P. S. Shirude, S. Balasubramanian, J. Am. 
Chem. Soc., 2006, 128, 13662-13663. 
64 J. D. Carr, L. Lambert, D. E. Hibbs, M. B. Hursthouse, K. M. A. Malik, J. H. R. Tucker, 
Chem. Commun., 1997, 17, 1649-1650. 
65 P. W. Davies, A. Cremonesi, L. Dumitrescu, Angew. Chem. Int. Ed., 2011, 123, 9093-9097. 
66 H. V. Nguyen, A. Sallustrau, J. Balzarini, M. R. Bedford, J. C. Eden, N. Georgousi, N. J. 
Hodges, J. Kedge, Y. Mehellou,?C. Tselepis, J. H. R. Tucker, J. Med. Chem., 2014, 57, 5817-
5822. 
67 A. V. Gulevich, A. S. Dudnik, N. Chernyak, V. Gevorgyan, Chem. Rev., 2013, 113, 3084-
3213. 
68 a) D. A. Black, B. A. Arndtsen, Tetrahedron, 2005, 61, 11317-11321; b) H. v. Wachenfeldt, 
P. Röse, F. Paulsen, N. Loganathan, D. Strand, Chem. Eur. J., 2013, 19, 7982-7988; c) A. Y. 
Shaw, Z Xu, C. Hulme, Tetrahedron Lett., 2012, 53, 1998-2000; d) N. Elders, E. Ruijter, F. J. 
J. de Kanter, M. B. Groen, R. V. A. Orru, Chem. Eur. J., 2008, 14, 4961-4973. 
69 a) C. Wan, L. Gao, Q. Wang, J. Zhang, Z. Wang, Org. Lett., 2010, 12, 3902-3905; b) H. 
Jiang, H. Huang, H. Cao, C. Qi, Org. Lett., 2010, 12, 5561-5563. 
70 A. Saito, A. Taniguchi, Y. Kambara, Y. Hanzawa, Org. Lett., 2013, 15, 2672-2675. 
                                                 
CHAPTER 2: FC AMINO OXAZOLES AS H-BONDING RECEPTORS 
52 
 
                                                                                                                                                        
71 Y-M. Pan, F-J. Zheng, H-X. Lin, Z-P. Zhan, J. Org. Chem., 2009, 74, 3148-3151. 
72 A. J. Phillips, Y. Uto, P. Wipf, M. J. Reno, D. R. Williams, Org. Lett., 2000, 2, 1165-1168. 
73 a) X. Zhang, W. T. Teo, P. W. H. Chan, J. Organomet. Chem., 2011, 696, 331-337; b) M. 
D. Milton, Y. Inada, Y. Nishibayashi, S. Uemura, Chem. Commun., 2004, 2712-2713; c) M. P. 
Kumar, R-S. Liu, J. Org. Chem., 2006, 71, 4951-4955. 
74 a) A. S. K. Hashmi, J. P. Weyrauch, W. Frey, J. W. Bats, Org. Lett., 2004, 6, 4391-4394; b) 
A. Saito, K. Iimura, Y. Hanzawa,?Tetrahedron Lett., 2010, 51, 1471-1474; c) A. Arcadi, S. 
Cacchi, L. Cascia, G. Fabrizi, F. Marinelli, Org. Lett., 2001, 3, 2501-2504. 
75 a) K. J. Doyle, C. J. Moody, Tetrahedron, 1994, 50, 3761-3772; b) M. C. Bagley, R. T. Buck, 
S. L. Hind, C. J. Moody, A. M. Z. Slawin, Synlett, 1996, 825-826; c) M. C. Bagley, R. T. Buck, 
S. L. Hind, C. J. Moody, J. Chem. Soc., Perkin Trans. 1, 1998, 591-601; d) M. Austeri, D. Rix, 
W. Zeghida, J. Lacour, Org. Lett., 2011, 13, 1394-1397; e) J. R. Davies, P. D. Kane, C. J. 
Moody, Tetrahedron, 2004, 60, 3967-3977. 
76 a) W. He, C. Li, L. Zhang, J. Am. Chem. Soc., 2011, 133, 8482-8485; b) X. Li, L. Huang, H. 
Chen, W. Wu, H. Huang, H. Jiang, Chem. Sci., 2012, 3, 3463-3468. 
77 A. Tárraga, P. Molina, D. Curiel, J. L. López, M. Desamparados Velasco, Tetrahedron, 1999, 
55, 14701-14718. 
78 P. W. Davies, A. Cremonesi, N. Martin, Chem. Commun., 2011, 47, 379-381. 
79 T. Hamada, X. Ye, S. S. Stahl, J. Am. Chem. Soc., 2008, 130, 833-835. 
80 T. Kan, T. Fukuyama, Chem. Commun., 2004, 353-359. 
81 I. Noviandri, K. N. Brown, D. S. Fleming, P. T. Gulyas, P. A. Lay, A. F. Masters, L. Phillips, 
J. Phys. Chem. B, 1999, 103, 6713-6722. 
82 C. M. A. Brett, A. M. Oliviera, Voltametric Sensors In Electroanalysis, Oxford University 
Press: 1998. 
83 R. S. Nicholson, Anal. Chem., 1965, 37, 667-671. 
84 a) D. J. Pasto, F. Cottard, S. Horgan, J. Org. Chem., 1993, 55, 4110-4112; b) D. J. Pasto, F. 
Cottard, L. Jumelle, J. Am. Chem. Soc., 1994, 116, 8978-8984. 
85 K. Gollnick, S. Koegler, Tetrahedron Lett., 1988, 29, 1003-1006. 
86 K. Gollnick, S. Koegler, Tetrahedron Lett., 1988, 29, 1007-1010. 
CHAPTER 3: FC (THIO)UREAS AS ORGANOCATALYSTS 
53 
 
3. Ferrocenyl-(thio)ureas as organocatalysts 
3.1. Introduction 
3.1.1. Ferrocene-containing organocatalysts 
Ferrocene has been used widely in supramolecular structures for sensing purposes. Another 
characteristic of ferrocene is its well-defined bulkiness, which allows for the development of 
effective chiral environments. This is of particular interest in the field of asymmetric catalysis, 
where the chiral information must be optimally transferred from the catalyst reaction site to the 
forming product. Although a great number of ferrocene-containing ligands have been designed 
for metal-catalysed transformations, there are relatively few examples in the field of 
organocatalysis. Early research by Fu and co-workers explored the nucleophilicity of N-
heterocycle catalysts with planar chiral ferrocene structures.87 Among them the remarkable Fc-
DMAP (Figure 39) showed high performances in a wide array of asymmetric transformations.88  
 
Figure 39: Fc-DMAP catalysts  
More recently, Cozzi and co-workers reported efficient enamine catalysis using a ferrocenyl 
pyrrolidine,89 in which the steric bulk of ferrocene was used to lock the conformation of the 
enantio-determining step, after the formation of the enamine (Figure 40).90 
 
Figure 40: Ferrocenyl pyrrolidine for enamine catalysis 
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The addition of aldehydes to nitroalkenes was achieved in good yields and up to 95% ee. A 
similar example was published very recently, this time with a structure containing an amide 
bond linking a chiral α-methylferrocene to an L-proline unit (Figure 41).91 
 
Figure 41: Ferrocene-proline organocatalyst 
Finally, Chen and co-workers published promising results regarding their work on ferrocene-
based phosphine-squaramide organocatalysts (Figure 42).92 This catalyst exhibited both central 
and planar chirality and was used in the intramolecular Morita-Baylis-Hillman reaction of 7-
aryl-7-oxo-5-heptenals, forming a variety of 2-aroyl-2-cyclohexenols in up to 96% ee. 
 
Figure 42: Ferrocene-based phosphine-squaramide organocatalyst 
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3.1.2. Project - Design 
Taking advantage of the work done previously in the Tucker group on ferrocenyl (thio)urea,93 
it was decided to investigate the ferrocene scaffold in organocatalysed asymmetric 
transformations. Figure 43 summarises the different ferrocenyl (thio)ureas that have been 
prepared and tested.  
 
Figure 43: Overview of the different (thio)urea to be synthesised and tested 
Compounds 17a-b have the (thio)urea unit directly connected to the electron-rich ferrocene 
unit whereas compounds 18a-d contain a methylene linker between the two units. Thioureas 
19a,b integrate a stereogenic centre at the methylene linker, while compound 20 features planar 
chirality on the ferrocene. Thiourea 21 exhibits a tertiary amine that is expected to have a 
nucleophilic character, similar to Takemoto’s bi-functional catalyst.28 These catalysts have 
been tested in: 1) the Henry reaction of nitromethane and benzaldehyde, 2) the Morita-Baylis-
Hillman reaction between nitromethane and cyclohexenone, 3) the enamine co-catalysed aldol 
reaction of acetone and nitro-styrene, and 4) the double Michael addition to prepare tetra-
substituted cyclopentane. A more detailed background of these reactions is presented in section 
1.5.. 
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3.2. Results and discussion 
3.2.1. Synthesis 
 Preparation of achiral ferrocenyl thiourea 
Ferrocene was deprotonated using tert-butyllithium at 0 ̊C and the lithiated ferrocene was 
trapped with tributyltin chloride in THF overnight to form stannylferrocene species 22, before 
being converted to the 1-iodoferrocene 23 by stirring it with iodide in dichloromethane for one 
day (Scheme 36).94 This two-step procedure has the advantage of relying on ferrocene tin 
species that are more easily purified by column chromatography than their iodo equivalents. 
 
Scheme 36: Two-step procedure for the preparation of iodoferrocene 23 from ferrocene 
Subsequent copper (I) / iron (III) catalysis in the presence of ammonia and sodium hydroxide 
in ethanol at 90 ̊C gave aminoferrocene 24 in good yield.95 The addition of 3,5-
bis(trifluoromethyl)phenyl iso(thio)cyanate in dichloromethane offered the desired 
ferrocenyl(thio)urea 17a-b in excellent yields (Scheme 37). 
 
Scheme 37: Preparation of achiral (thio)ureas 17a-b from iodoferrocene 23 
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 Preparation of achiral ferrocene-methylene thiourea 
Ferrocenecarboxaldehyde was converted to the corresponding aldoxime 25 with 
hydroxylamine hydrochloride under basic conditions,96 followed by a reduction with lithium 
aluminium hydride to yield 95% of ferrocenemethylamine 26 over two steps.97 The latter was 
reacted with the appropriate iso(thio)cyanate to offer the achiral catalysts 18a-d in good yields 
(Scheme38). 
 
Scheme 38: Preparation of achiral (thio)ureas 18a-d from ferrocene carboxaldehyde 
 
 Preparation of central chiral thiourea 
To access enantiopure catalysts, a chiral auxiliary derived from (R)-1-phenyl-1-butanol was 
used. Preparation of the chiral auxiliary was achieved by a Mitsonubu reaction between 
hydroxyphthalimide and (R)-1-phenyl-1-butanol to offer (S)-alkoxyphthalimide 27 (Scheme 
39).98 
 
Scheme 39: Preparation of chiral auxilliary 27 
Ferrocenecarboxaldehyde was reacted with chiral auxiliary (S)-27 in the presence of hydrazine, 
giving the ether aldoxime (S)-28 in 71% yield over 2 steps (Scheme 40).99 Diastereoselective 
alkylation of (S)-28, via activation by boron trifluoride diethyl etherate and addition of the 
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appropriate alkylating agent (RMgCl or RLi), gave the desired enantiopure hydroxylamine 
ether (R, S)-29a,b with the expected order of yields regarding to the bulkiness of the R groups, 
ranging from 60% to 89% for R = t-Bu and Me respectively. The organo-magnesiun alkylating 
agent BnMgCl was reactive enough to generate (R, S)-29a, while the lithium analogue (t-BuLi) 
was required to install the bulkier t-Bu group onto the oxime carbon, giving (R, S)-29b.  
 
Scheme 40: Installation of centrale chirality via hydroxylamine ethers (R, S)-29a,b 
Cleavage of the N-O bond was achieved by reacting (R, S)-29 with zinc powder under acidic 
conditions (Scheme 41). The different amines (R)-30a,b were produced in low to moderate 
yield, and were treated with (trifluoromethyl)phenyl isothiocyanate to form the corresponding 
central chirality-containing thioureas (R)-19a,b. 
 
Scheme 41: Reductive cleavage of hydroxylamines (R, S)-29a,b and coupling to isothiocyanate 
giving chiral thioureas (R)-19a,b 
The (S) enantiomer of 19b was prepared in similar yields following the same procedure starting 
with (R)-27. The preparation of racemic thiourea 19a was undertaken using a similar symmetric 
strategy, starting from ferrocene carboxaldehyde (Scheme 42). It was subjected to 
methoxyamine hydrogen chloride in the presence of sodium acetate in hot ethanol to yield 
oxime 31 almost quantitatively. Subsequent activation by boron trifluoride diethyl etherate at -
78 ˚C and alkylation by BnMgCl led to hydroxylamine ether 32a in moderate yields. Further 
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reduction using zinc powder in an acidic medium and sonication produced the corresponding 
amine 79, which was directly coupled with (3,5-bis(CF3)phenyl)isothiocyanate to give rac-
19a. 
 
Scheme 42: Preparation of racemic thiourea 19a 
Chiral HPLC analysis of 19a and 19b (see Appendix) showed an enantiomeric excess of 96% 
for (R)-19a (AD column, 5% IPA in hexane, 1 mL.min-1, Rt = 18.4 min) and 96% for (R)- and 
(S)-19b (OD column, 10% IPA in hexane, 1 mL.min-1, Rt = 5.1 min and 4.5 min respectively). 
 Preparation of planar chiral thiourea 
The synthesis of enantiopure catalyst (Rp)-20 relies on the diastereoselective ortho-lithiation of 
dioxane 33 (Figure 44) developed by Kagan’s group.100 
 
Figure 44: Diastereoselectively ortho-lithiated key intermediate 33 
Ferrocenecarboxaldehyde was first transformed into the corresponding dimethoxyacetal before 
being trans-acylated to dioxane 34 with (S)-1,2,4-butanetriol. The two possible 
diastereoisomers were present and were carefully separated by column chromatography. Pure 
compound 34 was then subjected to sodium hydride and methyl iodide, giving the ether 35 
with 40% yield over 3 steps (Scheme 43).  
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Scheme 43: Preparation of enantio-pure dioxane 35 
Subsequent deprotonation of 35 by tert-butyllithium at -78 °C was ortho directed by the chiral 
dioxane moiety, and the resulting ortho-lithiated species were quenched with methyl iodide 
(Scheme 44). Planar chiral ferrocene 36 was then obtained in 85% yield and only one 
diastereoisomer was detected by 1H NMR. Deprotection of the aldehyde under acid conditions 
gave compound (Rp)-37 in good yield (66%). 
 
Scheme 44: Installation of planar chirality and deprotection of the dioxane to give aldehyde (Rp)-37 
Further reaction with hydroxylamine hydrochloride gave the aldoxime (Rp)-38 in excellent 
yield (Scheme 45). Reduction to the corresponding amine (Rp)-39 with lithium aluminium 
hydride in refluxing THF and addition to 3,5-bis(trifluoromethyl)phenyl isothiocyanate gave 
the planar chiral containing thiourea (Rp)-20 with a moderate yield of 60% over two steps. 
 
Scheme 45: Preparation of thiourea (Rp)-20 from aldehyde 37 
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The preparation of racemic 20 was achieved via a similar route, with the difference that the 
dioxolane protecting group was not chiral, nor did it exhibit the stabilising methoxy group for 
the lithiation step (Scheme 46). Ferrocenecarboxaldehyde was first condensed with 2,2-
dimethylpropan-1,3-diol by acid catalysis in toluene to generate dioxolane 40 in good yield. 
Subsequent lithiation by t-BuLi and quenching with methyl iodide gave the di-substituted 
ferrocene 41. It is interesting to note that compound 41 was obtained in a similar yield to the 
asymmetric version (compound 36), so the absence of the methoxy group was not detrimental 
to the stabilisation of the ortho-lithiated species prior to quenching. After the efficient 
deprotection of dioxolane 41 by PTSA in the presence of water, the resulting aldehyde rac-37 
was treated with hydroxylamine hydrogen chloride to quantitatively yield oxime rac-38. 
Finally, the reduction of rac-38 was achieved with LiAlH4 in refluxing THF, and the crude 
amine was then coupled to (3,5-bis(CF3)phenyl)isothiocyanate to give rac-20. 
 
Scheme 46: Preparation of racemic thiourea rac-20 
The enantiomeric purity of thiourea (Rp)-20 could not be accurately determined as the optimal 
HPLC conditions with the available chiral columns did not succeed in giving a full peak 
separation of the enantiomers of rac-20 (see Appendix). However some separation was 
observed and the enantiomeric excess was estimated to be above 75%.   
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 Preparation of bi-functional thiourea 
The synthesis of the bi-functional thiourea 21 proceeded via diastereoselective ortho-lithiation 
of enantiopure 1-ferrocenyl-1-(N-N-dimethyl)amine ethyl 42 (Figure 45).101 
 
Figure 45: Diastereoselectively ortho-lithiated key intermediate 42  
The synthesis of bi-functional catalyst 21 started with the enantioselective reduction of 
acetylferrocene by borane di-methyl sulfide in the presence of CBS catalyst, offering the 
enantiopure alcohol 43.102 Acylation of the latter followed by substitution with dimethylamine 
gave the chiral tertiary amine 45 in 84% yield over 3 steps (Scheme 47).  
 
Scheme 47: Preparation of chiral intermediate (S)-45 
In order to functionalise the ortho position of the Cp ring, compound (S)-45 was 
diastereoselectively deprotonated by tert-butyllithium at -78 C̊ (Scheme 48), and the resulting 
ortho-lithiated ferrocene was quenched with dimethylformamide to afford the single 
diastereoisomer (S, Rp)-46 in 78% yield.  
 
Scheme 48: Diastereoselective formylation of (S)-45 to planar chiral ferrocene (S, Rp)-46 
As for previous catalysts, the obtained aldehyde (S, Rp)-46 was then converted to the aldoxime 
(S, Rp)-47 and quantitatively reduced to the amine (S, Sp)-48 by reaction with LiAlH4 in 
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refluxing THF. Finally, treatment with 3,5-bis(trifluoromethyl)phenyl isothiocyanate gave the 
enantiopure bi-functional catalyst (S, Sp)-21 in 79% yield (Scheme 49). 
Scheme 49: Preparation of bi-functional ferrocene (S, Sp)-21 from aldehyde (S, Rp)-46 
The enantiopurity of (S, Sp)-21 was checked by chiral HPLC (OD column, 15% IPA in hexane, 
1 mL.min-1, monitored at 230 nm), with an enantiomeric excess of 99% for the (S, Sp) version 
(see Appendix). The other enantiomer (R, Rp)-21 was also prepared, following the same 
procedure, and also showed an enantiomeric excess of 96%. 
 
3.2.2. NMR studies 
 Achiral and bi-functional Fc-(thio)urea 
For all compounds 17a-b and 18a-d, the presence of sulfur over oxygen increased the 
downfield shift of the (thio)urea protons, which is indicative of a higher acidity. Proton Hb was 
mostly influenced by the identity of the atom X with a difference of 0.8 ppm (δ = 9.4 ppm with 
X = S, and δ = 8.6 ppm with X = O) and to a much lesser extent by the nature of the N-
substitution at the other end of the (thio)urea (Table 6, Entry 2 and 4). Proton Ha was almost 
equally affected by the nature of X (Δδ ≈ 1.4 ppm) than by the number of carbons (n = 0, 1) 
between its nitrogen and the ferrocene (Δδ ≈ 1.4 ppm). It was surprising that Ha was being 
unshielded by that magnitude when connected directly to the electron rich ferrocene (n = 0). 
By comparing 18a-b (Table 6, Entry 3 and 4) and 18c-d (Table 6, Entry 5 and 6), it appears 
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that the substitution of the phenyl ring (3,5-bis(CF3) or 4-NO2 respectively) does not have a 
significant influence on the NH protons. 
 
Entry Compound n X δ Ha δ Hb δ Hc
1 17a 0 S 9.04 9.37 8.34
2 17b 0 O 7.68 8.53 8.18
3 18a 1 S 7.73 9.43 8.31
4 18b 1 O 6.21 8.61 8.16
5 18c 1 S 7.66 9.43 7.95
6 18d 1 O 6.18 8.64 7.73
7 21 1 S 9.14 9.14 8.12  
Table 6: Chemical shift of selected protons in achiral and bi-functional (thio)ureas (1H NMR, ≈ 50 
mM in acetone d6, ppm) 
1H NMR spectra of compound 21 showed both of the NH protons resonating at the same 
chemical shift (c.a. 9 ppm in acetone d6). Hydrogen Ha is connected to a non-electron-
withdrawing moiety (-CH2Fc) and yet resonates +1.4 ppm more downfield than its analogue 
18a. This could indicate a possible H-bonding interaction between Ha and the tertiary amine, 
adding an electron-withdrawing effect to proton Ha and increasing its chemical shift (Figure 
46).103  
 
Figure 46: Proposed equilibrium between an unbound open conformation and the intramolecularly H-
bound closed conformation of thiourea 21 
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A dilution NMR experiment was carried out on 21 and 18a at 30 mM and 3 mM concentration 
in CD3CN. No change was observed in the chemical shift of the NH protons of thiourea 18a. 
Regarding thiourea 21, The chemical shift of proton Ha was the same at both concentrations 
while proton Hb moved by 0.2 ppm upfield upon dilution and may also suggests the existence 
of some aggregate in solution (intermolecular S—Hb interaction). This supports the idea of an 
intramolecular H-bonding interaction in 21. 
 H-bonding study by 1H-NMR spectroscopy 
The binding of (thio)ureas 17b, 18a-b and (S, Sp)-21 with different tetrabutylammonium 
carboxylates (acetate 49, (S)-2-phenylbutyrate 50, (S)- and (R)-mandelate 51) was monitored 
by noting changes to the NH chemical shift in deuterated acetonitrile at 294 K (Scheme 50).104  
 
Scheme 50: 1H NMR binding study of (thio)urea 17b, 18a-b and (S, Sp)-21 with tetrabutylammonium 
carboxylate 49, 50 and 51 
As expected for an H-bonding interaction, the observed NH signal is the average shift between 
the bound and unbound receptor, which is fast on the NMR time scale (Figure 47).  
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Figure 47: Observed 1H NMR signal of proton under the influence of a fast exchange (left) and slow 
exchange (right)  
The concentration of the (thio)urea receptors was set at 5 mM, and the carboxylate guests were 
added from a stock solution prepared at c.a. 0.2 M in CD3CN. The stoichiometry of the 
receptor-guest had been previously established by the Tucker group as 1:1 on similar receptors 
using Job plots.105 
Ø H-bonding with guest acetate 
Acetate 49 was added to receptors 17b, 18a-b and (S, Sp)-21 in CD3CN. The obtained titration 
curves showed that full complexation was reached after one equivalent of carboxylate 49 for 
the mono-functional receptors 17b and 18a-b, indicating strong binding under these conditions 
(Figure 48). The maximal variation in chemical shift for Ha (full lines) and Hb (dashed lines) 
are 4.4 ppm and 5 ppm respectively for receptor 17b (red lines), 4 ppm and 4.7 ppm 
respectively for 18b (green lines), and 4.7 ppm and 5.2 ppm respectively for 18a (orange lines). 
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Figure 48: Chemical shift of protons Ha and Hb of 17b, 18a-b and (S, Sp)-21 (5 mM in CD3CN) upon 
addition of carboxylate 49  
The chemical shift of protons Ha and Hb of receptor (S, Sp)-21 (blue lines) varied by 2 and 4.5 
ppm respectively. The obtained curves showed different behaviours upon addition of guest. For 
both Ha and Hb, at first an unexpected decrease in chemical shift (-0.3 ppm) was observed until 
0.15 equivalent of guest was added. It then quickly increased (+1 ppm), following the same 
curve, until 0.3 equivalents of guest was reached. This suggests that Ha and Hb still had the 
same electronic environment during this part of the titration; hence the intramolecular H-bond 
may have been preserved.  Beyond 0.3 equivalent of guest added, the signal of Ha and Hb splits. 
While the signal of Hb continued to go up field (+3 ppm at full complexation), the signal of Ha 
started to form a plateau (+1 ppm at full complexation). This phenomenon was dependant on 
the concentration of guest, indicating the existence of an equilibrium between two assemblies. 
The first one consisting of a 2:1 complex (host:guest) at low guest concentrations, and the 
second one of a 1:1 complex as more guest was present. The proposed mode of binding is 
depicted in (Scheme 51). 
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Scheme 51: Proposed mode of binding between receptors 17b, 18a-b and (S, Sp)-21 upon addition of 
acetate 49  
As the binding was too strong under these conditions,106  the binding constant with the mono-
functional receptors could not be determined by 1H NMR, nor could be the binding constant 
with (S, Sp)-21, due to its peculiar behaviour. 
Ø H-bonding study with guest (S)-2-phenylbutyrate 
The H-bonding study with guest (S)-2-phenylbutyrate 50 was undertaken with receptors 18a 
and (S, Sp)-21. The chemical shift variation of protons Ha (full lines) and Hb (dashed lines) upon 
addition of carboxylate is shown in Figure 49.  
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Figure 49: Chemical shift of protons Ha and Hb of 18a and 21 (5 mM in CD3CN) upon addition of 
carboxylate 50. The peak of proton Ha of (S, Sp)-21 was very broad 
As with the guest acetate, 18a (green lines) was fully complexed after one equivalent of added 
carboxylate, with again a strong binding observed, and a variation in chemical shift of 2.2 ppm 
and 4.5 ppm for Ha and Hb respectively. Bi-functional receptor (S, Sp)-21 (red lines) showed a 
different behaviour than with acetate, as the signal of protons Ha and Hb split into two distinct 
signals directly after the first addition of carboxylate. The chemical shift of Ha varied very little 
upon addition of guest 50 (+0.6 ppm), suggesting a continuous H-binding with NMe2 
(intramolecular) and / or CO2- (intermolecular). The proposed mode of binding is thought to be 
a 1:1 complex as for the other receptors (Scheme 52).  
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Scheme 52: Proposed mode of binding between receptors 18a and (S, Sp)-21 upon addition of 
carboxylate 50  
The binding constant between (S, Sp)-21 and 50 could be determined by following the signal 
of Hb as KHb 21—75 = 1.2 × 103 ± 0.1 M-1 at room temperature using the program WinEqNMR.107 
Ø H-bonding study with guest mandelate 
Further H-bonding studies were carried out with thiourea 18a and bi-functional thiourea (S, 
Sp)-21 with each of the enantiomers of mandelate 51. The chemical shift variation of protons 
Ha and Hb upon addition of carboxylate is shown in Figure 50. 
 
Figure 50: Chemical shift of protons Ha and Hb of 18a and (S, Sp)-21 (5 mM in CD3CN) upon 
addition of carboxylate (R)- and (S)-51 
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Mono-functional receptor 18a was fully bound after the addition of one equivalent of guest 51, 
with a variation in chemical shift of 3.4 and 4 ppm for Ha and Hb respectively. As in the case 
of the receptor (S, Sp)-21 and acetate guest 49, a similar type of curve was obtained with (S, 
Sp)-21 and butyrate guest 51 (both enantiomers). Protons Ha and Hb had the same variation of 
chemical shift until 0.4 equivalent of guest was reached, then their signal split into two signals. 
The associated binding constant could be determined with the signal of Hb as KHb 21—76 = 1.5 × 
103 ± 0.1 M-1 at room temperature using the program WinEqNMR.107 The proposed mode of 
binding for 18a and (S, Sp)-21 to carboxylate 51 (both enantiomers) is depicted in Scheme 53. 
  
Scheme 53: Proposed mode of binding of receptors 18a and (S, Sp)-21 upon addition of (R)- and (S)-
mandelate 51 
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3.2.3. Application of Fc-(thio)urea in organocatalysis 
A summary of the different (thio)urea catalysts prepared is depicted in Figure 51.  
 
Figure 51: Ferrocenyl (thio)urea prepared to be tested as organocatalysts 
These were examined in standard organocatalysed reactions (the Henry and the MBH reactions 
with every catalysts) and in more complex reactions (enamine co-catalysis and double Michael 
cycloaddition with catalyst 21 exclusively) in order to investigate their performance in different 
reactions. 
 The Henry reaction 
The Henry reaction was carried out on benzaldehyde and nitromethane in THF with 20 mol% 
of HBD catalyst and DABCO (in the case of bi-functional catalyst (S, Sp)-21 DABCO was 
omitted) at room temperature for seven days (Scheme 54). 
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Scheme 54: Organocatalysed Henry reaction between benzaldehyde and nitromethane 
Entry Catalyst Yield 52 Ee (%) 
1 DABCO 84 - 
2 18a + DABCO 55 - 
3 19a + DABCO 96 0 
4 19b + DABCO 78 0 
5 20 + DABCO 92 0 
6 21 63 10 
7 18a + 21 82 0 
8 18a 0 - 
9 45 81 0 
10 18a + 45 66 0 
11 20 + 45 22 0 
Table 7: Henry reaction between nitromethane and benzaldehyde. Each catalyst was loaded at 20 
mol%. Ee determined by chiral HPLC: OD column, 20% IPA in hexane, 1 mL/min, monitored at 220 
nm. Rt = 9.8 min and 12.0 min 
As a base alone can catalyse the Henry reaction, a control reaction was first realised with 
DABCO as the sole catalyst (Table 7, Entry 1). This indicated the level of background reaction 
between the nitronate and the aldehyde without HBD assistance. When DABCO was used in 
combination with achiral thiourea 18a, the reaction was less efficient (Table 7, Entries 1 vs 2). 
Such an outcome might be explained by invoking a strong affinity between the thiourea and 
one of the reaction intermediates, which may prevent the ammonium from transferring its 
proton to the product, hence slowing down the normal course of the reaction.  Central chiral 
containing thiourea 19a and planar chiral containing thiourea 20 effectively promoted the 
Henry reaction although no enantioselectivity was observed (Table 7, Entries 3 and 5). 
Thiourea 19b did not enhance nor decreased the activity of DABCO as a similar yield was 
obtained (Table 7, Entry 4), and again no enantiomeric excess was observed. Tertiary amine 45 
showed similar activity to DABCO (Table 7, Entries 9 and 10), indicating a sufficient basicity 
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for the deprotonation of nitromethane. Comparatively, bi-functional catalyst (S, Sp)-21 was able 
to perform the reaction however in lower yield (Table 7, Entry 6), probably due to the 
unavailability of its basic amine (assumedly already engaged in intramolecular H-bonding).103 
Nevertheless, a small preference for the (S) enantiomer was observed, indicating some level of 
organisation. A model providing the (S) product is shown in Scheme 55. It relies on the steric 
hindrance of the methyl to orient the approaching aldehyde. 
Scheme 55: Proposed mechanism for the Henry reaction catalysed by (S, Sp)-21 giving  (S)-52 
However only 10% ee was obtained, which suggest that the background reaction between the 
nitronate and the aldehyde (without HBD assistance) may happen at a similar rate, so the 
product is not exclusively produced via catalyst assistance. The combination of 18a and (S, Sp)-
21 was more productive than 18a and DABCO or (S, Sp)-21 alone or 18a and tertiary amine 
(S)-45, probably due to the higher amount of HBD (Table 7, Entry 7 vs 2, 6 and 10). However 
it resulted in a complete loss of enantioselectivity compared to (S, Sp)-21 used alone suggesting 
an unorganised structure during the C-C bond formation. In the absence of substantial ee further 
studies were undertaken in reactions where the background reactivity is less competitive. 
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 The MBH reaction 
The Morita-Baylis-Hillman reaction was tested with benzaldehyde and cyclohexenone in 
presence of 20 mol% of HBD catalyst and DABCO (except in the case of bi-functional catalyst 
21) without solvent. The reaction was carried out for 24 h at room temperature (Scheme 56). 
 
Scheme 56: Organocatalysed MBH reaction between benzaldehyde and cyclohexenone 
Entry Catalyst Yield 53 (7d) Ee (%) 
1 DABCO 0 - 
2 18a 0 - 
3 18a + DABCO 49 (79) - 
4 18b + DABCO 37 (56) - 
5 18c + DABCO 48 (72) - 
6 18d + DABCO 34 (58) - 
7 19a + DABCO 16 0 
8 19b + DABCO 20 0 
9 20 + DABCO 35 0 
10 17a + DABCO 11 - 
11 17b + DABCO 18 - 
12 21 0 - 
13 21 + DABCO 0 - 
14 18a + 21 0 - 
15 18a + 45 <5 - 
Table 8: MBH reaction between cyclohexenone and benzaldehyde. Ee determined by chiral HPLC: 
OD column, 10% IPA in hexane, 1mL/min, monitored at 220 nm. Rt = 11.1 min and 12.3 min 
Control reactions with DABCO or HBD 18a alone showed no conversion of the starting 
material (Table 8, Entries 1 and 2), only their combination promoted the transformation (Table 
8, Entry 3), indicating the absence of background reactivity. In contrast with thioureas 18a and 
18c, lower catalytic activities were observed with urea 18b and 18d (Table 8, Entries 3 vs 4 
and 5 vs 6), while the substitution of the aromatic ring (3,5-CF3 or 4-NO2) did not have such a 
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significant effect (Table 8, Entries 3 vs 5 and 4 vs 6). Introducing elements of chirality with 
catalysts 19a,b and 20 led to less efficient transformations and no enantiomeric excess, with 
no obvious correlation between the yield and the steric hindrance brought by the chiral 
elements (Table 8, Entries 7-9).  The lack of enantioselectivity may be attributed to their remote 
location relative to the reaction site. Superior catalytic activity of catalyst 18a was observed 
over catalysts 17a-b (Table 8, Entries 2, 10 and 11), when the HBD moiety is connected to the 
ferrocene by one carbon linker instead of none. Whether used alone or in combination with 
DABCO, bi-functional thiourea 21 was inactive in this reaction (Table 8, Entries 12 and 13), 
suggesting the inability of its HBD unit to provide sufficient level of complexation and 
activation of the substrate. These observations may support the hypothesis of an intramolecular 
H-bond between the thiourea and the tertiary amine, rendering the thiourea less available for 
intermolecular H-bonding. Furthermore, when 18a and 21 or 18a and 45 were used, no 
conversion was observed (Table 8, Entries 14 and 15). This suggests the non-nucleophilicity of 
the tertiary amine, probably due to steric reasons. 
 HBD / Enamine catalysis 
Bi-functional catalyst 21 and L-proline were combined in DMSO, allowing for the two to self-
assemble via acid/base proton exchange, prior to adding acetone and trans-β-nitrostyrene in 
the reaction mixture (Scheme 57).   
 
Scheme 57: Ionic proline-thiourea catalyst for the addition of acetone to trans-β-nitrostyrene 
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After 2 days at room temperature, product 54 was obtained in 48% yield. Comparatively, when 
L-proline was used as the sole catalyst, only a trace amount of the product was detected. 
Scheme 58: Proposed mechanism for the addition of acetone to trans-β-nitrostyrene 
The proposed mode of action (Scheme 58) requires the ionic assembly of L-proline and catalyst 
21 as starting point, followed by condensation of acetone and L-proline to form enamine C2. 
As trans-β-nitrostyrene approaches, the nitro functionality would engage in H-bonding with 
the thiourea part of the assembly and would be presented to the enamine moiety, ideally in a 
stereocontrolled manner. Subsequent attack of the α- carbon of the enamine onto the α,β-
unsaturated nitro and hydrolysis would then deliver the desired γ-nitro ketone 54. 
Unfortunately, it was not possible to determine the enantiomeric excess with the chiral HPLC 
columns available. 
 Formation of tetrasubstituted cyclopentane 
The formation of a tetrasubstituted cyclopentane from trans-β-nitrostyrene and methyl-5-
nitropent-2-enoate catalysed by bi-functional catalyst was investigated. Preparation of methyl-
5-nitropent-2-enoate 56 required nitration of acrolein to 55 followed by a Wittig reaction with 
methyl-2-(triphenylphosphanylidene)acetate (Scheme 59). 
CHAPTER 3: FC (THIO)UREAS AS ORGANOCATALYSTS 
78 
 
 
Scheme 59: Preparation of substrate 56 
The catalysis reaction was carried out in dichloromethane at room temperature for 7 days at a 
concentration of 0.2 M (relative to 56) and with 10 mol% of catalyst 21 (Scheme 60).  
 
Scheme 60: Cycloaddition of trans-β-nitrostyrene and 56 catalysed by 21 
The isolation of the products was difficult by silica gel column chromatography; a single 
fraction containing two new products (57a and 57b) along with unreacted substrate 56 was 
obtained. It is worthwhile to note that the reaction intermediate produced after the first C-C 
bond formation was not observed, similarly to the analogous tetrasubstituted cyclohexane 
formation reported by Cobb and co-workers.47 Taken in a minimal amount of dichloromethane, 
a precipitate appeared upon addition of diethyl ether and was obtained as a white powder in a 
9:1 ratio of diastereoisomers, as determined by HPLC (Figure 52).  
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Figure 52: Analytical HPLC of the precipitated diastereoisomer 57a. C18 column, MeCN/H2O: 0/1 to 
1/0, 1 mL.min-1, monitored at 254 nm 
NOE studies of the precipitate and the filtrate (containing 57a and 57b) resulted in the 
assignment of the relative stereochemistry of 57a and 57b (Figure 53).  
 
 Figure 53: The two diastereoisomers of 57 at C3 
Product 57a was assigned as the major diastereoisomer in the precipitate, and 57b as the other 
diastereoisomer. For both diastereoisomers, protons He and Hf exhibited a strong correlation 
suggesting their cis configuration. While diastereoisomer 57b showed one other strong 
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relationship between protons Hf and Hg, diastereoisomer 57a exhibited a strong NoE effect 
between protons Hc and Hg, and a weak one between Hf and Hg. The precipitated material was 
purified by HPLC and pure 57a was collected to be analysed by chiral HPLC, which revealed 
a racemic mixture of enantiomers (Rt = 43 and 47 min, Figure 54). 
 
Figure 54: Chiral HPLC of 57a. Amylose 2 column, MeCN/H2O: 30/70, 1 mL.min-1, monitored at 
210 nm 
In order to rationalise the stereo-outcome of the catalysis, a mechanism is proposed in Scheme 
61. After deprotonation of nitro compound 56, the resulting methylenazinate D1 (blue in 
Scheme 61) is stabilised by the thiourea unit while nitro-styrene (red in Scheme 61) binds to 
the newly formed ammonium cation in a manner that minimises the steric interactions. This 
favoured conformation leads diastereoselectively to the first nucleophilic attack giving 
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enantiomers (1-S, 2-R)-D2 and (1-R, 2-S)-D2, and setting the cis relationship between He and 
Hf in the future product.  
 
Scheme 61: Proposed mechanism for the Michael addition of 56 onto trans-β-nitrostyrene forming 
intermediates azinate D2 
Upon displacement of the nitro group (blue in Scheme 62), the new azinate group in D2 (red in 
Scheme 62) can be stabilised by three H-bonds, allowing for the free rotation of the rest of the 
molecule in order to bring the carbonyl of the enone ester (green in Scheme 62) towards the 
activating ammonium, initiating the nucleophilic cyclisation.  
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Scheme 62: Proposed mechanism for the cyclo-addition of (R, S)-D2 forming cyclopentane (R, R, R, 
S)-57a and (R, R, S, S)-57b. The same proposed mechanism is assumed for the transformation of the 
other enantiomer of D2 (not depicted)  
As there was no trace of protonated D2 in the reaction mixture, the cyclisation seems to be a 
relatively fast process. Both cis and trans conformations, relative to the azinate and enone ester 
prior to cyclisation, were favoured. Proton transfer from the ammonium to the produced 
enolates cis- and trans-D3 led to products 57a and 57b. It was noteworthy the reaction did not 
take place when 3,3-dimethylprop-2-enal was used instead of trans-β-nitrostyrene. 
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3.2.4. Boron-containing Fc thiourea 
From the analysis of the Henry and MBH reactions, it appeared that the stereogenic elements 
in catalysts 19a-c (Me, Bn and t-Bu) and 20 (Me) had no control over the enantioselectivity, 
presumably due to their distance from the reactive centre. In order to improve this, a new 
catalyst design was required. As a new strategy it was decided to act on the flexibility of the 
thiourea moiety by locking it in a well-defined position, coplanar with the connected Cp ring, 
utilizing the work of Smith21 and Mattson22 on boron activated ureas (Figure 55). 
 
Figure 55: Boronate-urea HBD by Smith (left) and Matson (right) 
Boronate-urea ferrocenes 58-61 and 62 (Figure 56) were to be synthesised, hoping that this 
new structure would bring more enantioselectivity in the test reactions. 
 
Figure 56: Structure of the different boronate-urea to be prepared 
This design relies on the O-B interaction between the urea and the boronate, with the 
preparation of difluoroboronate species to greatly enhance this interaction compared with the 
pinacolboronate ester analogue. Along with the asymmetric preparations of these catalysts, 
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shorter racemic preparations were undertaken to assess their catalytic activity. Difficulties 
encountered during the synthesis prevented the completion of this study. 
 Preparation of 1-urea-2-boronate ferrocene 
Ø Racemic synthesis 
The racemic synthesis of catalysts 58 and 59 was based on the ortho-lithiation of N-Boc-
ferroceneamine 63 (Scheme 63).108 Compound 63 was quantitatively prepared from 
ferroceneamine 24 and Boc2O in water.109 The results of the lithiation of 63 with t-BuLi and 
quenching with boron pinacol to form 64 are summarised in Table 9.  
 
Scheme 63: Preparation of disubstituted ferrocene 64 
Entry Solvent i) T (°C) Boron ii) T (°C) Product 
1 THF -78 to -20 B(OiPr)3 -20 to rt 18% 
2 THF -78 to -20 B2pin2 -20 to rt SM 
3 THF -78 B(OiPr)3 -78 to rt SM 
4 THF/Et2O -78 to -20 B(OiPr)3 -20 to rt Complex mixture 
5 THF/Et2O -78 to -20 B2pin2 -20 to rt Complex mixture 
Table 9: Study of the ortho-lithiation of 63 leading to di-substituted ferrocene 64 
Product 64 was obtained in 18% yield when the lithiation was conducted in THF at -20 ˚C for 
2 h and boron triisopropoxide was the electrophile (Table 9, Entry 1). The use of bis(pinacolato) 
diboron as electrophile was unsuccessful (Table 9, Entry 2) and deprotonation of ferrocene 63 
at -78 ˚C did not occur (Table 9, Entry 3). When the solvent system was THF/Et2O, a complex 
mixture of di- (64) and 1,1’-substituted ferrocene was obtained (Table 9, Entry 4 and 5). 13C 
NMR of 64 (and of other boronate ferrocene) did not show the carbon connected to the boron, 
due to the magnetic interaction with the boron nuclei provoking the fast relaxation of the 
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carbon.54b 11B NMR (δ = 15.1 ppm, broad signal, ref: B(Oi-Pr)3 in CDCl3) indicated the trigonal 
nature of the boronate; hence an absence of interaction between the boron and the oxygen of 
the carbamate.110 Subsequent deprotection of Boc-protected amine 64 with TFA led 
unexpectedly to 1,1’-substituted ferrocene 65 and amine 24 (Scheme 64).  
 
Scheme 64: TFA deprotection of Boc-protected amine 64. NMR yield estimation 
An important change in colour just after the addition of TFA, from orange to dark green then 
orange again after 10 minutes, happened during the reaction. An attempt to explain this 
surprising outcome is depicted in Scheme 65.  
 
Scheme 65: Suggested mechanism for the transformation of 64 to 65 
The proposed mechanism involves the expected first steps of a TFA N-Boc deprotection, 
leading to carbamic acid E2 by loss of t-butyl cation. Subsequent nucleophilic attack of the 
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oxygen onto the boron may give spiro-boronate E3. Protonation of the Cp ring can form 
intermediate E4, which rearomatises to compound E5 by cleavage of the C-B bond. The 
unsubstituted Cp ring, being more electron rich and at better distance than the substituted Cp 
ring, can then react in a Friedel-Crafts fashion on the electron-poor boron to produce the 1,1’-
bis-substituted ferrocene E6. Decarboxylation of E6 generates product 65. 
 
Scheme 66: Formation of bis substituted ferrocene 56. Relevant NMR chemical shifts (ppm) of 1H, 
13C and 11B are indicated 
Subjecting amine 65 to 3,5-bis(trifluoromethane)phenyl-isocyanate in dichloromethane 
afforded urea 66 in 63% yield (Scheme 66) from the protected amine 63. Analysis of 66 (1H, 
13C and 11B NMR) showed no evidence of interaction between the urea and the pinacol boron 
ester.21a The chemical shift of the NH protons and C=O carbon were similar to those of the 
non-borated analogue ferrocene thiourea 17b (δ = 7.68 and 8.53 ppm for Ha and Hb 
respectively, and 153.5 ppm for the carbonyl). The boron NMR of 66 confirmed the trigonal 
geometry of the boron atom (δ = 15.1 ppm, ref: B(Oi-Pr)3 in CDCl3). 
Ø Asymmetric synthesis 
Until very recently, no chiral auxiliary for aminoferrocene had been reported. Metallinos and 
co-workers developed in 2012 the first example of chiral directing group for N-substituted 
ferrocene.111 Following their procedure, the straightforward preparation of L-proline hydantoin 
67 was carried out by heating L-proline and potassium cyanide in 6 N HCl (Scheme 67).  
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Scheme 67: Preparation of L-proline hydantoin 67 
The copper catalysed reaction of 67 with iodoferrocene 23 afforded compound 68 in 56% yield 
(Scheme 68). Relying on the selective reduction of amide before urea type carbonyls, 
compound 68 was subjected to Schwartz’s reagent (Cp2Zr(H)Cl), followed by treatment with 
triethylsilylchloride. The chiral environment provided by the hydantoin moiety afforded only 
one diastereoisomer of the key compound 69. 
 
Scheme 68: Preparation of key intermediate 69 
Diastereoselective ortho-lithiation of 69 with t-BuLi at -78 ˚C and quenching with boron tri-
isopropoxide led to boronic isopropyl ester 70, which was directly esterified with pinacol to 
compound 71 in high yield (Scheme 69).  
 
Scheme 69: Diastereoselective ortho-lithiation of 69 leading to di-substituted ferrocene 71 
Unfortunately, the synthesis towards the preparation of urea 59 stopped at that point as the 
required deprotection conditions were not efficient in the case of compound 71 (Scheme 70). 
Starting material was mostly recovered along with some degradation product. 
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Scheme 70: Unsuccessful cleavage of the chiral auxilliary in the preparation of urea 59 
 
 Preparation of 1-methyleneurea-2-boronate ferrocene 
Ø Racemic preparation 
The preparation of di-substituted boronate-urea ferrocene 60 was attempted via the lithiation 
of ferrocenyl dioxolane 40 (Scheme 71). 
 
Scheme 71: Retro-synthesis of boronate-urea 60 
Lithiation of dioxolane 40 by t-BuLi in Et2O and quenching with B(Oi-Pr)3 resulted in a poor 
yield of ortho- and meta-lithiated species leading to compounds 72a and 72b respectively 
(Scheme 72). 
 
Scheme 72: Lithiation of dioxolane 40 
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Reactions in THF or at lower temperature failed to improve this yield. Addition of pinacol to 
72a in THF gave the desired boron pinacol ester analogue, which was deprotected with PTSA 
to yield aldehyde rac-73 (Scheme 73). Subjection to hydroxylamine hydrogen chloride in hot 
ethanol/water mix and in the presence of sodium acetate did not offer the expected ferrocene 
oxime rac-74. 
 
Scheme 73: Unsuccessful synthesis towards di-substituted boronate-urea ferrocene rac-60 
 
Ø Asymmetric synthesis 
As for compound 20 the planar chirality was introduced via compound 35, quenching the 
resulting ortho-lithiated ferrocene with tri-isopropoxide boron, thus obtaining the non-racemic 
boronic acid which was almost quantitatively converted to boronic pinacol ester 76 by reacting 
it with pinacol in hot toluene for 2 h (Scheme 74).  
 
Scheme 74: Ortho-lithiation of dioxolane 35 to form (Rp)-76 
The chiral auxiliary was removed using trimethylsilyltriflate and 2,4,6-collidine followed by 
aqueous quenching to offer the aldehyde (Rp)-73 in 89% yield (Scheme 75).112 Another 
deprotection method was attempted with PTSA but the yields were generally lower with some 
degradation occurring. The aldehyde was then transformed into aldoxime (Rp)-74 in 76% yield 
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by a modified procedure using 2,4,6-collidine instead of potassium carbonate and keeping the 
reaction at room temperature. The reduction of aldoxime (Rp)-74 to primary amine (Rp)-75 was 
tried unsuccessfully with lithium aluminium hydride. Different temperature, concentration, 
stoichiometry and reaction time were investigated but none of them produced the desired 
amine, although the starting aldoxime was fully consumed and more polar product(s) appeared 
(TLC).  
 
Scheme 75: Unsuccessful synthesis towards di-substituted boronate-urea ferrocene (Rp)-60 
 
 Synthesis of 1-methyleneurea-1’-boronate ferrocene 
The preparation of 1,1’-heterobis-substituted ferrocene 78 relied on the selective 1’-lithiation 
of NH-Boc protected ferrocene 77 (Scheme 76).113 The latter was easily prepared from amine 
26 and Boc2O in water.114 Subsequent 1’-lithiation by t-BuLi and quenching by triisopropoxide 
boron gave the resulting boronic acid which was directly esterified by pinacol to offer 
compound 78 in good yield. 
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Scheme 76: Preparation of 1,1’-heterobis-substituted ferrocene 78 from amine 26 
Unfortunately, in the presence of TFA compound 78 did not yield the desired amine 79 but only 
the starting material (Scheme 77). 
 
Scheme 77: Unsuccessful attempt to prepare 1,1’-bis-substituted boronate-urea ferrocene 62 
 
3.3. Conclusions and future work 
New ferrocene (thio)ureas have been synthesised, with a number of structural differences 
including 1) no linker between Fc and the (thio)urea (17a,b) or with a methylene linker (18a-
d), 2) with central chirality on the methylene linker (19a,b) or with planar chirality on the 
ferrocene (20), and 3) both chiralities within bi-functional structure 21. The latter is suspected 
of developing an intramolecular H-bond between NH of the thiourea and the tertiary amine 
forming a seven-membered ring. A study of the H-bonding complexation properties between 
(thio)urea receptors (17b, 18a,b and 21) and tetrabutylammonium carboxylates (49, 50, 51) in 
acetonitrile was carried out by 1H NMR spectroscopy. Simple achiral receptors 17b and 18a,b 
exhibited full complexation after the addition of one equivalent of guest, indicative of a large 
binding constant (K > 103 M-1). Bi-functional receptor 21 had slightly lower levels of H-
bonding to carboxylates (K ≈ 103 M-1), and showed further signs of an intramolecular H-
bonding interaction. The binding curves between host 21 and mandelate guests (R)- and (S)-76 
were identical, indicative of no enantioselectivity. Studies regarding the organocatalytic 
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properties of ferrocene (thio)ureas 17-21, in the Henry and the Morita-Baylis-Hillman 
reactions, showed varying degrees of success in these transformations. The transfer of chirality 
from the catalyst to the product was mostly inefficient, with only catalyst 21 showing any sign 
of enantioselectivity in the Henry reaction. The proline-catalysed addition of acetone onto 
nitrostyrene, co-catalysed by thiourea 21, was achieved with a moderate yield. The formation 
of tetrasubstituted cyclopentane via double Michael addition was undertaken with thiourea 21 
in a moderate yield but with no enantioselectivity. Finally, the synthesis towards the preparation 
of planar chiral ferrocene boronate-ureas was presented. Future work would involve the 
completion of the ferrocene boronate-ureas synthesis, to ultimately assess whether this design 
would allow for an increased activity and more importantly, an increased enantioselectivity. 
Further design could lead to more constrained structures, in which the catalytic site is closer to 
the chiral elements (Figure 57 and Scheme 78). 
 
Figure 57: Modification of bi-functional catalyst with higher enantio-control 
 
Scheme 78: Modification of bis-functional receptor for enantio-recognition of α-hydroxy-ketone 
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4. Experimental section 
4.1. General 
Commercially available reagents and solvents were used without further purification, except 
toluene, Et2O, THF, MeCN and CH2Cl2, which were dried in Pure Solv™ Solvent Purification 
Systems. Flash chromatography was carried out using silica 60, with the eluent specified. 1H NMR 
spectra were recorded at 300 MHz on a Bruker AVIII300 NMR spectrometer, 13C NMR spectra at 
100 MHz on a Bruker AVIII400 NMR spectrometer, at room temperature. Chemical shifts (δ) are 
in ppm and coupling constants (J) are in Hz. Analytical HPLC was performed using a reversed 
phase C18 column with a water/MeCN method (0-40 mins 0% MeCN – 100% MeCN) with a flow 
rate of 1.0 mL/min and monitoring at 220 and 254 nm. The enantiomeric excess of the receptors 
was calculated from the area of the peaks obtained in the chiral HPLC, performed with an AD, OD 
(eluent IPA in hexane) or Amylose 2 column (eluent MeCN/water) with a flow rate of 1 mL/min 
and monitoring at 210, 220 and 254 nm.  MS were recorded with a Waters/Micromass spectrometer 
using the ES+ method unless otherwise stated. IR spectrum were recorded on Perkin-Elmer 
Spectrum 100 (FTIR spectrometer). 
4.2. Synthesis 
4.2.1.  Ferrocene Oxazoles 
4.2.1.1. Synthesis of Fc-oxazoles  
General procedure for the formation of oxazoles 1a-d and 6: To a solution of the appropriate 
ynamide 3 (1 eq, 0,1 M) and  N-pyridinium ylide in toluene at 90 °C was added dichloro(2-
pyridinecarboxylato)gold (5 mol%). After the time indicated, the mixture was filtered through 
a pad of silica to collect the crude oxazole (EtOAc) and the unreacted ylide (EtOAc:MeOH 
4:1). The crude oxazole was purified by silica gel column chromatography (Hexane:EtOAc 
9:1) to yield an orange solid. 
CHAPTER 4 : EXPERIMENTAL SECTION 
96 
 
 
2-Ferrocenyl-4-N-(N-phenyl)nosylamide-5-phenyloxazole 1a: Using 
ynamide 3a (70 mg, 0.18 mmol), ylide 2 (145 mg, 0.47 mmol) and gold 
catalyst (3.6 mg, 0.009 mmol). Reacted for 48 hours. Orange crystals (51 
mg, yield 46%). 1H-NMR (300 MHz, CDCl3) δ = 8.34-8.28 (m, 2 H), 8.03-7.99 (m, 4 H), 7.53-
7.47 (m, 4 H), 7.41-7.24 (m, 4 H), 4.90 (t, J = 1,9 Hz, 2 H), 4.39 (t, J = 1,9 Hz, 2 H), 4.20 (s, 5 
H); 13C-NMR (101 MHz, CDCl3) δ = 161.0, 150.3, 145.5, 144.0, 139.3, 133.2, 130.5, 129.3, 
128.9 (2C), 128.1, 127.1, 126.9, 125.1, 123.5, 70.9, 70.3, 70.0, 67.8; IR (neat) ν (cm-1) = 3099, 
3065, 3038, 2924, 2859, 1595, 1524, 1366, 1346, 1169; mp = 203-205 °C (decomposition); 
m/z = 605.1 [M+] (100%), 606.1 [M+H+] (67%), 628.1 [M+Na+] (78%); HR-MS: calc. for 
C31H24N3O5SFe: 606.0786, found 606.0785 . 
 
2-Ferrocenyl-4-N-(N-methyl)nosylamide-5-phenyloxazole 1b: Using 
ynamide 3b (57 mg, 0.18 mmol), ylide 2 (110 mg, 0.36 mmol) and gold 
catalyst (3.6 mg, 0.009 mmol). Reacted for 6 days. Orange crystals (36 mg, 
yield 37%). 1H-NMR (300 MHz, CDCl3) δ =  8.41 (m, 2 H), 8.14 (m, 2 H), 7.98 (d, J = 7.3 Hz, 
2 H), 7.50 (t, J = 7.5 Hz, 2 H), 7.39 (m, 1 H), 4.84 (s, 2 H), 4.46 (s, 2 H), 4.19 (s, 5 H), 3.22 (s, 
3 H); 13C-NMR (101 MHz, CDCl3) δ = 161.1, 150.4, 144.8, 143.6, 133.6, 130.1, 128.9 (2C), 
127.0, 125.1, 123.9, 70.8, 70.3, 69.9, 67.7, 37.7; IR (neat) ν (cm-1) = 3692, 3667, 3117, 2990, 
2971, 2903, 1742, 1597, 1525, 1365, 1066; mp = 202-204 °C  (decomposition); m/z = 566.3 
[M+Na+] (100%); HR-MS: calc. for C26H21N3O5NaSFe: 566.0436, found 566.0449. 
 
2-Ferrocenyl-4-N-(N-phenyl)nosylamide-5-butyloxazole 1c: Using 
ynamide 3c (100 mg, 0.28 mmol), ylide 2 (128 mg, 0.42 mmol) and gold 
catalyst (5.5 mg, 0.014 mmol). Reacted for 6 days. Orange crystals (54 mg, 
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yield 51%). 1H-NMR (300 MHz, CDCl3) δ = 8.36-8.31 (m, 2 H), 7.99-7.93 (m, 2 H), 7.43-7.39 
(m, 2 H), 7.35-7.28 (m, 3 H), 4.79 (t, J = 1,9 Hz, 2 H), 4.39 (t, J = 1,9 Hz, 2 H), 4.14 (s, 5 H), 
2.79 (t, J = 7.5 Hz, 2 H), 1.65 (dt, J = 15.2 Hz, 7.5 Hz, 2 H), 1.33 (qd, J = 14.5, 5.3 Hz, 2 H), 
0.91 (t, J = 7.3 Hz, 3 H); 13C-NMR (101 MHz, CDCl3) δ = 160.3, 150.2, 149.3, 144.4, 139.9, 
130.2, 129.2, 128.0, 127.5, 123.5, 70.9, 70.3, 69.7, 67.4, 29.5, 22.4, 13.7; IR (neat) ν (cm-1) = 
3270, 3105, 2961, 1606, 1526, 1346, 1162; mp = 167-169 °C; m/z = 585.2 [M+] (50%), 586.2 
[M+H+] (100%), 608.2 [M+Na+] (87%); HR-MS: calc. for C29H28N3O5SFe: 586.1071, found 
586.1099. 
 
2-Ferrocenyl-4-N-(N-methyl)nosylamide-5-butyloxazole 1d: Using 
ynamide 3d (53 mg, 0.18 mmol), ylide 2 (82 mg, 0.27 mmol) and gold 
catalyst (3.6 mg, 0.009 mmol). Reacted for 24 hours. Orange crystals (54 
mg, yield 10%). 1H-NMR (300 MHz, CDCl3) δ = 8.37 (d, J = 7.3 Hz, 2 H), 7.99 (d, J = 7.3 Hz, 
2 H), 4.90 (s, 2 H), 4.52 (s, 2 H), 4.28 (s, 5 H), 3.12 (s, 3 H), 2.80 (t, J = 7.0 Hz, 2 H), 1.71 (m, 
2 H), 1.42 (m, 2 H), 0.98 (t, J = 7.2 Hz, 3 H);  m/z = 524.1 [M+H+] (100%); HR-MS: calc. for 
C29H28N3O5SFe: 523.0864, found 523.0859.  
 
2-Phenyl-4-N-(N-methyl)nosylamide-5-phenyloxazole 6: Using ynamide 
3b (200 mg, 0.63 mmol), N-benzoylpyridinium ylide (188 mg, 0.95 mmol) 
and gold catalyst (12 mg, 0.03 mmol). Reacted for 24 hours. White solid (218 
mg, yield 80%). 1H-NMR (300 MHz, CDCl3) δ = 8.43-8.37 (m, 2 H), 8.18-8.13 (m, 2 H), 8.06-
8.01 (m, 2 H), 7.97-7.90 (m, 2 H), 7.56-7.38 (m, 6 H), 3.23 (s, 3 H); 13C-NMR (101 MHz, 
CDCl3) δ = 157.9, 150.4, 145.9, 143.3, 131.0, 129.3, 129.0, 126.7, 126.2, 125.4, 123.9, 37.8; 
IR (neat) ν (cm-1) = 3088, 3058, 2937, 1527, 1449, 1351, 1302, 1160; mp = 164-166 °C; m/z = 
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458.1 [M+Na+] (100%), 436.1 [M+H+] (56%); HR-MS: calc. for C22H18N3O5S: 436.0967, 
found 436.0978. 
 
1,1'-Bis(4-N-(N-phenyl)nosylamide-5-butyloxazole)ferrocene 7c: Using 
ynamide 3c (69 mg, 0.2 mmol), ylide 13 (43 mg, 0.1 mmol) and gold catalyst 
(3.9 mg, 0.01 mmol). Reacted for 2 hours. Orange crystals (8 mg, yield 8%). 
1H-NMR (300 MHz, CDCl3) δ = 8.30 (d, J = 9 Hz, 2 H), 7.95 (d, J = 9 Hz, 2 H), 7.43-7.38 (m, 
2 H), 7.33-7.27 (m, 2 H), 4.79 (t, J = 1.8 Hz, 2 H), 4.30 (t, J = 1.8 Hz, 2 H), 2.71 (t, J = 7.5 Hz, 
2 H), 1.67-1.56 (m, 2 H), 1.37-1.28 (m, 2 H), 0.90 (t, J = 7.3 Hz, 3 H); mp = 97-99 °C; m/z = 
1007.5 [M+Na+] (100%). 
 
1,1'-Bis(4-N-(N-methyl)nosylamide-5-phenyloxazole)ferrocene 7b: 
Using ynamide 3d (121 mg, 0.38 mmol), ylide 13 (65 mg, 0.15 mmol) and 
gold catalyst (7.4 mg, 0.019 mmol). Reacted for 24 hours. Orange crystals 
(10 mg, yield 11%). 1H-NMR (300 MHz, CDCl3) δ = 8.35 (d, J = 8.4 Hz, 2 H), 8.08 (d, J = 8.4 
Hz, 2 H), 7.85 (d, J = 7.2 Hz, 2 H), 7.42-7.32 (m, 3 H), 4.82 (s, 2 H), 4.44 (s, 2 H), 3.10 (s, 3 
H); 13C NMR (101 MHz, CDCl3) δ = 150.9, 141.8, 131.7, 129.2, 128.6, 124.6, 122.0, 82.6, 
76.8, 69.9, 39.7; IR (neat) ν  (cm-1) = 3106, 2924, 2854, 1683, 1593, 1524, 1346, 1159, 844, 
737; mp = 124-126 °C. 
4.2.1.2. Synthesis of ylides 
Ferrocenyl N-pyridinium aminide 2: Oxalyl chloride (111 μL, 1.3 mmol) and 
DMF (2 drops) were added to ferrocenecarboxylic acid (150 mg, 0.652 mmol) 
in dry dichloromethane (10 mL) and stirred for 6 hours under Ar. The mixture was then 
evaporated to dryness by means of vacuum (50 mbar) for 1 hour. To the dark red solid, still 
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under Ar, were added aminopyridinium iodide (159 mg, 0.717 mmol), potassium carbonate 
(197 mg, 1.43 mmol) and dry dichloromethane (10 mL). After being stirred for 5 days at room 
temperature, the mixture was passed through a pad of silica gel, eluted with EtOAc followed 
by EtOAc:MeOH (4:1) to collect 2. The ylide was further purified by silica gel column 
chromatography (EtOAc:MeOH 9:1) to afford ylide 2 as an orange solid (259 mg, yield 65%). 
1H NMR (CDCl3, 300 MHz) δ = 8.80 (dd, J = 6.9, 1.2 Hz, 2 H ), 7.88 (tt, J = 7.2, 1.2 Hz, 1 H), 
7.64 (dd, J = 7.7, 6.8 Hz, 2 H), 4.77 (t, J = 1.9 Hz, 2 H), 4.29 (t, J = 1.9 Hz, 2 H), 4.242 (s, 5 
H); 13C NMR (CDCl3, 100 MHz) δ = 174.2, 143.3, 136.3, 125.8, 80.1, 69.5, 69.3, 69.0; IR 
(neat) v (cm-1)  = 3341, 3027, 2923, 1613, 1550, 1460, 1367, 1301; m/z  = 329.1 [M+Na+] 
(100%), 307.2 [M+H+] (13%); HR-MS: calc. for C16H14N2ONaFe: 329.0339, found: 329.0353; 
mp = 155 -157 °C (decomposition). 
 
Ferrocenecarboxylic anhydride 4: 1H NMR (CDCl3, 300 MHz) δ = 4.90 
(s, 4 H), 4.56 (s, 4 H), 4.37 (s, 10 H); m/z = 465 [M+Na+] (100%). Data 
in agreement with that previously reported.115 
 
Bis ferrocenyl N-pyridinium aminide 8: Obtained from 1,1'-
bisferrocene carboxylic acid (1.13 g, 4.1 mmol) reacted first with oxalyl 
chloride (2 mL, 24.6 mmol), DMF (0.3 mL, 0.02mmol) in dry CH2Cl2 
(30 mL), then with aminopyridinium iodide (2.00 g, 9 mmol), potassium 
carbonate (2.83 g, 20.1 mmol) in dry CH2Cl2 (20 mL) as an orange solid (65 mg, yield 4%). 
1H-NMR (300 MHz, CDCl3) δ = 8.97 (d, J = 6.0 Hz, 2 H), 7.85 (t, J = 7.5 Hz, 1 H), 7.56 (t, J 
= 6.9 Hz, 2 H), 4.95 (t, J = 1.8 Hz, 2 H), 4.35 (t, J = 1.8 Hz, 2 H); 13C NMR (CDCl3, 100 MHz) 
δ = 173.6, 144.7, 136.5, 125.8, 80.9, 72.0, 70.6, 70.5; IR (neat) v (cm-1) = 3395, 3105, 3064, 
3064, 3042, 1642, 1541, 1491, 1325, 1193, 1038, 766; m/z = 449.0 [M+Na+] (48%), 427.1 
CHAPTER 4 : EXPERIMENTAL SECTION 
100 
 
[M+H+] (100%); HR-MS: calc. for C22H19N4O2Fe: 427.0857 , found 427.0870 ; mp = 173-175 
°C (decomposition). 
 Synthesis of ynamides 
General procedure for the formation of ynamides 3: Following the method of Stahl, copper 
(II) chloride (27 mg, 0.2 mmol), the appropriate sulfonamide (5 mmol) and potassium 
carbonate (212 mg, 2 mmol) were added to a flame-dried 250 mL three-necked round-bottomed 
flask. The flask was purged with oxygen for 15 minutes and toluene (5 mL) followed by dry 
pyridine (1.6 mL, 2 mmol) were added. A balloon filled with oxygen was connected to the flask 
and the stirred mixture was heated at 70 °C. After 15 minutes, a solution of the appropriate 
alkyne (1 mmol) in toluene (5 mL) was added by syringe pump over a period of 4 hours. The 
mixture was allowed to stir at 70 °C for another 4 hours and was then cooled to room 
temperature. After filtration over a pad of silica, the reaction mixture was dry loaded on silica 
and purified by silica gel column chromatography (Hexane:EtOAc 9:1) to yield the desired 
ynamide as a white solid. 
 
4-Nitro-N-phenyl-N-(phenylethynyl)benzenesulfonamide 3a: 298 mg, yield 
79%. 1H-NMR (300 MHz, CDCl3) δ = 8.40-8.32 (m, 2 H), 7.96-7.88 (m, 2 H), 
7.42-7.35 (m, 5 H), 7.35-7.28 (m, 5 H); 13C-NMR (101 MHz, CDCl3) δ = 141.2, 138.3, 131.8, 
129.6, 129.0, 128.7, 128.6, 126.3, 124.3, 121.9, 81.8, 71.3; m/z = 401.1 [M+Na+] (100%). Data 
in agreement with that previously reported.79 
 
4-Nitro-N-methyl-N-(phenylethynyl)benzenesulfonamide 3b: 290 mg, yield 
92%. 1H-NMR (300 MHz, CDCl3) δ = 8.48-8.40 (m, 2 H), 8.18-8.11 (m, 2 H), 
7.40-7.28 (m, 5 H), 3.23 (s, 3 H); 13C-NMR (101 MHz, CDCl3) δ = 150.8, 141.6, 131.6, 129.0, 
128.4, 124.5, 121.9, 82.5, 69.8, 39.6. Data in agreement with that previously reported.115 
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4-Nitro-N-phenyl-N-(butylethynyl)benzenesulfonamide 3c: 288 mg, yield 
80%. 1H-NMR (300 MHz, CDCl3) δ = 8.35 (m, 2 H), 7.85 (m, 2 H), 7.39-7.33 
(m, 3 H), 7.29-7.22 (m, 2 H), 2.32 (t, J = 7.0 Hz, 2 H), 1.51 (m, 2 H), 1.41 (m, 2 H), 0.92 (t, J 
= 7.2 Hz, 3 H); m/z = 399.2 [M+K+]. Data in agreement with that previously reported.115 
 
4-Nitro-N-methyl-N-(butylethynyl)benzenesulfonamide 3d: 238 mg, yield 
80%. 1H-NMR (300 MHz, CDCl3) δ = 8.44-8.38 (m, 2 H), 8.11-8.05 (m, 2 H), 
3.08 (s, 3 H), 2.24 (t, J = 6.9 Hz, 2 H), 1.51-1.40 (m, 2 H), 1.40-1.29 (m, 2 H), 0.90 (t, J = 7.2 
Hz, 3 H); m/z =  319.3 [M+Na+] (100%). Data in agreement with that previously reported.115 
 
4.2.1.4. Deprotection of nosyl 
To a solution of the appropriate protected amine (0.5 mmol) in acetonitrile (8 ml) at 50° C was 
added mercaptoacetic acid (1 mmol) followed by DBU (2.5 mmol). After full conversion of 
starting material (TLC monitoring), either HCl (1M) was added followed by silica gel column 
chromatography to give the hydroxy derivative 12, or the reaction mixture was directly 
chromatographied to yield compound 13. Compound 14 was eluted first. 
(E)-N-(1-(methylamino)-2-oxo-2-phenylethylidene)benzamide 12: 1H-NMR 
(300 MHz, CDCl3) δ = 8.15 (d, J = 7.4 Hz, 2 H), 8.07 (d, J = 8.5 Hz, 2 H), 7.67 
(t, J = 7.5 Hz, 1 H), 7.54-7.49 (m, 1 H), 7.41-7.35 (m, 4 H), 6.01 (br s, 1 H), 3.03 (s, 3 H); 13C-
NMR (101 MHz, CDCl3) δ = 133.8 (C, Ph ipsos), 132.5 (C, Ph ipsos), 130.0 (CH, Ph), 129.2 
(CH, Ph), 128.9 (CH, Ph), 128.8 (CH, Ph), 128.3 (CH, Ph), 29.3 (CH3); IR (neat) ν (cm-1) = 
3352, 3204, 3064, 2924, 1662, 1336; m/z (TOF-EI)  = 267.1 [M+H+] (100%), 289.1 [M+Na+] 
(53%). 
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N-(2-oxo-2-phenylacetyl)benzamide 13: 1H-NMR (300 MHz, CDCl3): δ = 
9.81 (s, 1 H), 8.14 (d, J = 8 Hz, 2 H), 7.92 (d, J = 8.5 Hz, 2 H), 7.70-7.61 (m, 
2 H), 7.58-7.49 (m, 4 H); IR (neat) ν (cm-1) = 3400-2800 (bs), 3061, 1648, 1595, 1536, 1375, 
1227; m/z (TOF-EI) = 276.1 [M+Na+] (100%); mp = 135-137 °C. Data in agreement with that 
previously reported.116 
 
(4-nitrophenyl)(phenyl)sulfane 14: 1H-NMR (300 MHz, CDCl3) δ = 8.06 
(d, J = 9.0 Hz, 2 H), 7.57-7.52 (m, 2 H), 7.49-7.44 (m, 3 H), 7.17 (d, J = 
9.0 Hz, 2 H); m/z = 231.0 [M]+. Data in agreement with that previously reported.117 
 
(E)-N-(1-(methylamino)-2-oxo-2-phenylethylidene)ferroceneamide 
15: 1H-NMR (300 MHz, CDCl3) δ = 8.07 (d, J = 7.8 Hz, 2 H), 7.67 (t, J = 
7.8 Hz, 1 H), 7.55 (t, J = 7.8 Hz, 2 H), 5.71 (br s, 1 H), 4.42 (s, 2 H), 4.39 
(s, 1 H), 4.20 (s, 5 H), 3.00 (s, 3 H); 13C-NMR (101 MHz, CDCl3) δ = 133.9 (C, Ph ipsos), 
129.2 (CH, Ph), 128.9 (CH, Ph), 128.8 (CH, Ph), 71.6 (CH, Cp ring), 70.4 (CH, Cp ring), 70.1 
(CH, unsubstituted Cp ring), 29.3 (CH3); m/z (TOF-EI) = 375 [M+H
+] (100%), 397 [M+Na+] 
(90%). 
N-(2-oxo-2-phenylacetyl)ferroceneamide 16: 1H-NMR (300 MHz, 
CDCl3) δ = 9.05 (br s, 1 H), 8.08 (d, J = 6.7 Hz, 2 H), 7.66 (t, J = 7.2 Hz, 
1 H), 7.54 (t, J = 7.2 Hz, 2 H), 4.86 (s, 2 H), 4.62 (s, 2 H), 4.37 (s, 5 H); 13C-NMR (101 MHz, 
CDCl3) δ = 207.3 (CO), 173.9 (CO), 134.7 (CH, Ph), 130.1 (CH, Ph), 129.1 (CH, Ph), 73.1 
(CH, Cp ring), 70.7 (CH, Cp ring), 69.4 (CH, Cp ring); m/z = 384.0 [M+Na+]; m/z (TOF-ES-) 
= 359.9 [M-H+]. 
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4.2.2. Ferrocene (thio)ureas 
 General procedure for preparation of (thio)urea 
The appropriate amine (1 eq) was dissolved in dry CH2Cl2 (0.1 M) and the appropriate 
iso(thio)cyanate (1.1 eq) was added at room temperature. The mixture was stirred until 
completion (TLC monitoring), and the solvent removed under reduced pressure. The residue 
was purified by silica gel column chromatography (Hexane:EtOAc 9:1) to yield the desired 
compound. Chiral HPLC traces and conditions are in the appendix. 
N-Ferrocenyl-N'-(3,5-bis(trifluoromethyl)phenyl)thiourea 17a: 
Using amine 24 (50 mg, 0.25 mmol) and 3,5-
bis(trifluoromethyl)phenyl isothiocyanate (49 µL, 0.27 mmol). 
Obtained as an yellow-orange powder (107 mg, yield 90%). 1H NMR (Acetone d6, 300 MHz) 
δ = 9.37 (br s, 0.7 H), 9.04 (s, 0.7 H), 8.34 (s, 2 H), 7.75 (s, 1 H), 4.63 (s, 2 H), 4.31 (s, 5 H), 
4.17 (s, 2 H); 13C NMR (Acetone d6, 300 MHz) δ = 180.7 (C, CS), 142.8 (C, Ph ipsos), 131.8 
(C, q, J = 33.2 Hz, Ph meta), 124.8 (CH, Ph ortho), 124.4 (C, q, J = 272.1 Hz, CF3), 118.2 (CH, 
Ph para), 94.6 (C, Cp ring), 70.2 (CH, unsubstituted Cp ring), 66.7 (CH, Cp ring), 65.7 (CH, 
Cp ring); IR (neat): ν (cm-1) = 3233, 3093, 1698, 1535, 1378, 1274, 1170, 1126, 885, 700, 681; 
m/z = 494.8 [M+Na+] (100%); HR-MS: calc for C19H14N2F6SFeNa: 495.0029, found 495.0035; 
mp = 57-59 °C. 
 
N-Ferrocenyl-N'-(3,5-bis(trifluoromethyl)phenyl)urea 17b: Using 
amine 24 (50 mg, 0.25 mmol) and 3,5-bis(trifluoromethyl)phenyl 
isocyanate (47 µL, 0.27 mmol). Obtained as an orange powder (166 
mg, yield 97%). 1H NMR (Acetone d6, 300 MHz) δ = 8.58 (s, 0.7 H), 8.18 (s, 2 H), 7.66 9s, 
CHAPTER 4 : EXPERIMENTAL SECTION 
104 
 
0.7 H), 7.57 (s, 1 H), 4.64 (s, 2 H), 4.18 (s, 5 H), 4.02 (s, 2 H); 13C NMR (Acetone d6, 300 
MHz) δ = 153.5 (C, CO), 143.2 (C, Ph ipsos), 132.5 (C, q, J = 32.8 Hz, CF3), 124.6 (C, q, J = 
271.7 Hz, Ph meta), 118.9 (CH, Ph ortho), 115.3 (CH, Ph para), 97.4 (C, Cp ring), 70.0 (CH, 
unsubstituted Cp), 65.1 (CH, Cp ring), 62.1 (CH, Cp ring);IR (neat): ν (cm-1) = 3291, 3099, 
1647, 1569, 1384, 1274, 1173, 1120, 883, 701, 680; m/z (TOF – ES+) = 478.9 [M+Na+] 
(100%), 455.9 [M+] (80%); HR-MS: calc. for C19H14N2F6OFe: 456.0360, found 456.0349;  mp 
= 178-180 °C (decomposition). 
 
N-(methylferrocene)-N'-(3,5-bis(trifluoromethyl)phenyl)thiourea 
18a: Using amine 26 (200 mg, 0.9 mmol) and 3,5-
bis(trifluoromethyl)phenyl isothiocyanate (202 µL, 1.1 mmol). 
Obtained as a yellow powder (384 mg, yield 86%). 1H NMR (Acetone d6, 300 MHz) δ = 9.43 
(s, 1H), 8.31 (s, 2H), 7.75 (s, 1H), 7.73 (s, 1H), 4.59 (d, J = 5.0 Hz, 2H), 4.33 (d, J = 1.8 Hz, 
2H), 4.21 (s, 5H), 4.15 (t, J = 1.8 Hz, 2H); 13C NMR (Acetone d6, 100 MHz): δ = 181.6 (C, 
CS), 143.0 (C, Ph ipsos), 131.6 (C, q, J = 33.0 Hz, Ph meta), 124.4 (C, q, J = 272.1 Hz, CF3), 
123.4 (CH, Ph ortho), 117.4 (CH, Ph para), 85.3 (C, Cp ring), 69.4 (CH, unsubstituted Cp 
ring), 69.3 (CH, Cp ring), 68.8 (CH, Cp ring), 44.5 (CH2); IR (neat) ν (cm-1) = 3247, 3083, 
3048, 2920, 1556, 1536, 1463, 1380, 1276, 1172, 1122, 948, 884, 678; mp = 127-129 ˚C; m/z 
= 486.0 [M+] (100%); HR-MS: calc. for C20H16N2SF6Fe: 486.0228, found 486.0284. 
 
N-(methylferrocene)-N'-(3,5-bis(trifluoromethyl)phenyl)urea 
18b: Using amine 26 (129 mg, 0.60 mmol) and 3,5-
bis(trifluoromethyl)phenyl isocyanate (114 µL, 0.66 mmol). 
Obtained as a yellow powder (223 mg, yield 79%). 1H NMR (Acetone d6, 300 MHz) δ = 8.61 
(s, 1 H), 8.16 (s, 2 H), 7.53 (s, 1 H), 6.21 (t, J = 5.1 Hz, 1 H), 4.24 (t, J = 1.8 Hz, 2 H), 4.19 (s, 
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5 H), 4.17 (d, J = 5.2 Hz, 2 H), 4.11 (t, J = 1.8 Hz, 2 H); 13C NMR (Acetone d6, 100 MHz)  δ 
= 155.4 (C, CO), 143.7 (C, Ph ipsos), 132.4 (C, q, J = 33.0 Hz, Ph meta), 124.6 (C, q, J = 272.2 
Hz, CF3), 118.5 (CH, Ph ortho), 114.8 (CH, Ph para), 87.3 (C, Cp ring), 69.3 (CH, 
unsubstituted Cp ring), 68.9 (CH, Cp ring), 68.6 (CH, Cp ring), 39.7 (CH2); IR (neat) ν (cm-1) 
= 3327, 3088, 2911, 1640, 1552, 1472, 1384, 1273, 1169, 1118, 1106, 881, 815, 676, 647; mp 
= 201-203 ˚C; m/z = 470.0 [M+] (100%); HR-MS: calcd for C20H16N2OF6Fe: 470.0516, found 
470.0515. 
 
N-(methylferrocene)-N'-(4-nitrophenyl)thiourea 18c: Using amine 
26 (251 mg, 1.1 mmol) and 4-nitrophenyl isothiocyanate (231 mg, 1.3 
mmol). Obtained as a brown solid (383 mg, yield 83%). 1H NMR 
(Acetone d6, 300 MHz) δ = 9.43 (s, 1 H), 8.20 (d, J = 9.3 Hz, 2 H), 7.95 (d, J = 9.3 Hz, 2 H), 
7.66 (t, J = 5.1 Hz, 1 H), 4.58 (d, J = 5.2 Hz, 2 H), 4.32 (t, J = 1.8 Hz, 2 H), 4.20 (s, 5 H), 4.15 
(t, J = 1.8 Hz, 2 H); IR (neat) ν (cm-1) = 3373, 3328, 3162, 3075, 2994, 1593, 1525, 1500, 1321, 
1299, 1242, 1163, 1106, 1034, 821, 740, 644. Data in agreement with that previously 
reported.118 
 
N-(methylferrocene)-N'-(4-nitrophenyl)urea 18d: Using amine 
26 (224 mg, 1.0 mmol) and 4-nitrophenyl isocyanate (188 mg, 1.1 
mmol). Obtained as a yellow-brown powder (258 mg, yield 65%). 
1H NMR (Acetone d6, 300 MHz) δ = 8.64 (s, 1 H), 8.15 (d, J = 8.3 Hz, 2 H), 7.73 (d, J = 8.3 
Hz, 2 H), 6.18 (t, J = 5.1 Hz, 1 H), 4.23 (t, J = 1.7 Hz, 2 H), 4.19 (s, 5 H), 4.17 (d, J = 5.2 Hz, 
2 H), 4.11 (t, J = 1.7 Hz, 2 H); IR (neat) ν (cm-1) = 3377, 3239, 2993, 1641, 1510, 1340, 1223, 
1104, 1040, 829, 829, 676. Data in agreement with that previously reported.118 
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(R)-N-(3,5-bis(trifluoromethyl)phenyl)-N'-(1-ferrocene-2-
phenylethyl)thiourea 19a: Using the general procedure for the 
formation of thiourea with amine 30a (80 mg, 0.26 mmol) and 
3,5-bis(trifluoromethyl)phenyl isothiocyanate (51 µL, 0.3 mmol). Obtained as a yellow powder 
(149 mg, yield 98%). 1H-NMR (300 MHz, CDCl3) δ = 9.53 (1 H, s), 8.40 (2 H, s), 7.82 (1 H, 
d, J = 8.7 Hz), 7.80 (1 H, s), 7.36 – 7.25 (5 H, m), 5.94 (1 H, s),  4.36 (1 H, s), 4.28 (5 H, s), 
4.23 (1H, dd, J = 3.5, 2.2 Hz), 4.20 (2 H, dd, J = 2.4, 1 Hz), 3.29 (2 H, d, J = 6.8 Hz); 13C-
NMR (101 MHz, CDCl3) δ = 181.0 (C, CS), 142.7 (C, Ph ipsos), 139.0 (C, Bn ypsos), 131.9 
(C, q, J = 33.1 Hz, Ph meta), 130.4 (CH, Bn meta), 128.8 (CH, Bn ortho), 127.0 (CH, Bn para), 
124.3 (C, q, J = 272.1 Hz, CF3), 123.5 (CH, Ph ortho), 117.5 (CH, Ph para), 90.5 (C, Cp ring), 
69.4 (CH, unsubstituted Cp ring), 68.5 (CH, Cp ring), 68.1 (2 CH, Cp ring), 66.9 (CH, Cp ring), 
55.3 (CH2), 42.7 (CH, CpCH); IR (neat) ν (cm-1) = 3249, 3211, 3030, 2971, 2939, 1538, 1469, 
1382, 1274, 1171, 1127, 897, 825, 682; m/z = 599.0 [M+Na+] (45%), 576.1 [M+] (100%); HR-
MS calc. for C27H22N2F6SFe: 576.0757, found 576.0754;  mp = 55-57 °C. 
 
N-(3,5-bis(trifluoromethyl)phenyl)-N’-(1-ferrocenyl-2-
phenylethyl)thiourea 19a: To methoxyamine 32 (151 mg, 0.45 
mmol) dissolved in THF (2 mL) was added 2 M HCl (10 mL) 
followed by zinc powder (883 mg, 13.5 mmol). The mixture was stirred at room temperature 
for 30 minutes, then water (5 mL) and Et2O (10 mL) were added and the phases were separated. 
The aqueous phase was basified with sodium hydroxide to pH ≈ 12 and extracted with Et2O 
(6×10 mL). The organic phases were gathered and dried over sodium sulfate, filtered and 
concentrated under reduced pressure. The residue was passed through a short column of silica 
(EtOAc then EtOAc:MeOH:NEt3 90:5:5) to give the racemic amine 30a (64 mg, yield 46%) 
which was directly treated with 3,5-bis(trifluoromethyl)phenyl isothiocyanate (36 µL, 0.2 
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mmol) in CH2Cl2 (1.3 mL) at room temperature for 16 hours. Evaporation of the solvent and 
purification by silica gel column chromatography yielded the racemic thiourea 19a (87 mg, 
72%). 1H-NMR (300 MHz, CDCl3) δ = 9.42 (s, 1 H), 8.30 (s, 1 H), 7.72 (s, 1 H), 7.29-7.14 
(m, 5 H), 5.84 (s, 1 H), 4.28 (s, 1 H), 4.20 (s, 5 H), 4.15 (s, 1 H), 4.11 (s, 2 H), 3.20 (d, J = 6.8 
Hz, 2 H). 
 
(R)-N-(3,5-bis(trifluoromethyl)phenyl)-N'-(1-ferrocene-2-ter-
butyl)thiourea 19b: Using the general procedure for the 
formation of thiourea with amine 30b (43 mg, 0.16 mmol) and 
3,5-bis(trifluoromethyl)phenyl isothiocyanate (32 µL, 0.19 mmol). Obtained as a yellow 
powder (81 mg, yield 97%). 1H-NMR (300 MHz, Acetone d6) δ = 9.54 (1 H, s), 8.48 (2 H, s),  
8.04 (1 H, d, J = 10.0 Hz), 7.71 (1 H, s), 5.40 (1 H, d, J = 10.1 Hz),  4.29 (1 H, dt, J = 2.4 Hz, 
1.3 Hz), 4.24 (5 H, s), 4.19 – 4.15 (2 H, m), 4.15 – 4.12 (1 H, dd, J = 2.4, 1 Hz), 0.88 (9 H, s); 
13C-NMR (101 MHz, Acetone d6) δ  = 182.1 (C, CS), 143.4 (C, Ph ipsos), 132.0 (C, q, J = 33.2 
Hz, Ph meta), 124.5 (C, q, J = 272.0 Hz, CF3), 123.4 (CH, q, J = 3.8 Hz, Ph para), 117.4 (CH, 
dq, J = 7.6, 3.8 Hz, Ph ortho), 89.6 (C, Cp ring), 71.1 (CH, Cp  ring), 69.6 (CH, unsubstituted 
Cp ring), 68.4 (CH, Cp ring), 67.4 (CH, Cp ring), 66.3 (CH, Cp ring), 62.1 (CH, CpCH), 37.6 
(C, t-Bu), 27.2 (CH3); IR (neat) ν (cm-1) = 3253, 3204, 3060, 2965, 1741, 1542, 1467, 1379, 
1272, 1175, 1134, 1106, 954, 891, 817; m/z = 542.1 [M]+ (28%); HR-MS: calc. for 
C24H24N2F6SFe: 542.0914, found 542.0911; mp = 176-178 °C. 
 
(Rp)-1-Thiourea-2-methyl ferrocene 20: (Rp)-1-carboxaldoxime-2-
methylferrocene 37 (164 mg, 0.67 mmol) was dissolved in dry THF (20 
mL) and LiAlH4 (256 mg, 6.7 mmol) was added portion-wise. The 
mixture was stirred at 80 °C for 2 hours and quenched at room temperature with NH4Cl(sat). 
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Amine 39 was extracted with Et2O, dried over sodium sulfate, filtered and evaporated under 
reduced pressure. It was then dissolved in CH2Cl2 (5 mL) and 3,5-(trifluoromethyl)phenyl 
isothiocyanate (96 μL, 0.52 mmol) was added. The solution was stirred for 15 hours and the 
solvent was then removed under reduced pressure. The residue was purified by silica gel 
column chromatography (Hexane:EtOAc 9:1) to give the title compound as a brown powder 
(165 mg, yield 49%). 1H NMR (CDCl3, 300 MHz) δ = 9.43 (s, 1 H), 8.43 (s, 2 H), 7.78 (s, 1 
H), 7.69 (s, 1 H), 4.78 (d, J = 14.0 Hz, 1 H), 4.66 (d, J = 14.0 Hz, 1 H), 4.33 (app s, 2 H), 4.20 
(s, 5 H), 4.10 (app s, 1 H), 2.12 (s, 3 H); 13C NMR (CDCl3, 100 MHz) δ = 181.4 (C, CS), 143.0 
(C, Ph ipsos), 131.9 (C, q, J = 33.0 Hz, Ph meta), 124.2 (C, q, J = 272.9 Hz, CF3), 123.2 (CH, 
Ph ortho), 117.4 (CH, Ph para), 84.2 (C, Cp ring), 83.5 (C, Cp ring), 70.6 (CH, Cp ring), 70.0 
(CH, unsubstituted Cp ring), 69.1 (CH, Cp ring), 66.7 (CH, Cp ring), 43.4 (CH2), 13.3 (CH3); 
IR (neat) ν (cm-1) = 3253, 3071, 2918, 1639, 1551, 1384, 1277, 1126, 887, 700, 681; m/z = 
523.0 [M+Na+] (69%), 500.0 [M+] (100%); HR-MS: calc. for C21H24N2F6SFe: 500.0444, found 
500.0445; mp = 149-151 °C. 
 
Rac-1-Thiourea-2-methyl ferrocene 20: 1H NMR (Acetone d6, 
300 MHz) δ = 9.33 (s, 1 H), 8.34 (s, 2 H), 7.70 (s, 1 H), 7.60 (t, J = 
4.9 Hz, 1 H), 4.69 (dd, J = 14.4, 5.1 Hz, 1 H), 4.57 (dd, J = 14.4, 4.7 
Hz, 1 H), 4.24 (dd, J = 2.3, 1.5 Hz, 1 H), 4.14-4.12 (m, 1 H), 4.12 (s, 5 H), 4.01 (t, J = 2.4 Hz, 
1 H), 2.03 (s, 3 H). 
 
(S,Sp)-1-[N-(N'-(3,5-(trifluoromethyl)phenyl)thiourea)] 
methylene-2-(α-N-dimethylamine)ethylferrocene 21: To a solution 
of (S)-(Rp)-1-aminomethyl-2-(α-N-dimethylamine)ethylferrocene 48 
(171 mg, 0.60 mmol) in dry CH2Cl2 (10 mL) was added drop-wise 
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3,5-(trifluoromethyl)phenylisothiocyanate (115 μL, 0.63 mmol). The mixture was stirred at 
room temperature for 16 hours. The crude mixture was then dry loaded on silica and purified 
by silica gel column chromatography (EtOAc:Hexane:NEt3 45:50:5) to yield a yellow powder 
(266 mg, yield 79%). 1H-NMR (300 MHz, Acetone d6) δ = 9.14 (br s, 2 H), 8.12 (s, 2 H), 7.67 
(s, 1 H), 4.97 (d, J = 12.7 Hz, 1 H), 4.43 (d, J = 14.2 Hz, 1 H), 4.36 (dd, J = 2.2, 1.5 Hz, 1 H), 
4.21 (dd, J = 2.3, 1.4 Hz, 1 H), 4.14 (s, 5 H), 4.10 (t, J = 2.4 Hz, 1 H), 4.05 (q, J = 7.2 Hz, 1 
H), 1.97 (s, 6 H), 1.29 (s, 3 H), 1.27 (s, 3 H);  13C-NMR (101 MHz, Acetone d6) δ (ppm) = 
181.2 (C, CS), 143.0 (C, Ph ipsos), 132.1 (C, q, J = 33.0 Hz, Ph meta), 124.4 (C, q, J = 272.2 
Hz, CF3), 123.7 (CH, Ph para), 117.5 (CH, Ph ortho), 91.0 (C, Cp ring), 83.8 (C, Cp ring), 71.1 
(CH, Cp ring), 70.2 (CH, unsubstituted Cp ring), 68.2 (CH, Cp ring), 66.5 (CH, Cp ring), 57.6 
(CH, CpCHCH3), 44.7 (CH2), 39.1 (CH3, NCH3), 7.6 (CH3, CpCHCH3); IR (neat): ν (cm-1) = 
3096, 2977, 2941, 2867, 2830, 2786, 1529, 1375, 1274, 1126; m/z = 579.9 [M+Na+] (25%), 
557.9 [M+H+] (100%), 512.9 [M+-NMe2] (95%); HR-MS: calc. for C24H26N3F6SFe: 558.1101, 
found 558.1093; mp = 72-74°C. 
 
(R,Rp)-1-[N-(N'-(3,5-(trifluoromethyl)phenyl)thiourea)] 
methylene-2-(α-N-dimethylamine)ethylferrocene 21: 1H-NMR 
(300 MHz, Acetone d6) δ = 9.15 (br s, 2 H), 8.12 (s, 2 H), 7.67 (s, 1 
H), 4.97 (d, J = 12.7 Hz, 1 H), 4.42 (dd, J = 13.4, 7.2 Hz, 1 H), 4.36 (dd, J = 2.3, 1.4 Hz, 1 H), 
4.21 (dd, J = 2.3, 1.3 Hz, 1 H), 4.13 (s, 5 H), 4.10 (t, J = 2.4 Hz, 1 H), 4.05 (q, J = 7.2 Hz, 1 
H), 1.97 (s, 6 H), 1.29 (s, 3 H), 1.27 (s, 3 H). 
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4.2.2.2. Precursors for achiral ferrocene (thio)ureas  
(Tri-n-butylstannyl)ferrocene 22: to ferrocene (8.0 g, 43 mmol) in THF (40 
mL) at 0 °C was added t-BuLi (38.0 mL, 64 mmol) over a period of 20 minutes. 
After 30 minutes, tetrabutyltin chloride (17.4 mL, 64 mmol) was added to the mixture and 
allowed to warm up to room temperature for 2 hours. A solution of sodium hydroxide (30 mL, 
1M) was then added carefully, followed by Et2O (40 mL). The organic phase was separated, 
washed with water (3×40 mL), dried over sodium sulfate and filtered. The solvents were 
removed by evaporation under reduced pressure and the residue was purified by silica gel flash 
chromatography (Hexane) to yield the title compound (10 g, yield 49%).1H NMR (300 MHz, 
CDCl3) δ = 4.36 (t, J = 1.7 Hz, 2 H), 4.13 (s, 5 H), 4.04 (t, J = 1.7 Hz, 2 H), 1.66-1.54 (m, 6 
H), 1.44-1.32 (m, 6 H), 1.07-1.01 (m, 6 H), 0.94 (t, J = 7.3 Hz, 9 H);  13C NMR (101 MHz, 
CDCl3) δ = 74.6, 70.2, 68.6, 67.9, 29.2, 27.4, 13.7, 10.2.  Data in agreement with that previously 
reported.119 
Iodoferrocene 23: Diiode (5.9 g, 23.2 mmol) and tributylstannylferrocene 22 were 
stirred for 24 hours in CH2Cl2 (100 mL) at room temperature. The reaction mixture 
was then washed with sodium meta-bisulfite (4×40 mL), the organic phase was dried over 
sodium sulfate and the solvent was removed under reduced pressure. The residue was purified 
by silica gel column chromatography (Hexane) to give compound 23 (5.4 g, yield 82%). 1H 
NMR (300 MHz, CDCl3) δ = 4.43 (s, 2 H), 4.21 (s, 5 H), 4.17 (s, 2 H); 
13C NMR (101 MHz, 
CDCl3) δ = 74.6 (CH, Cp ring), 71.2 (CH, unsubstituted Cp ring), 68.9 (CH, Cp ring). Data in 
agreement with that previously reported.119 
 
 Ferrocene amine 24: iodoferrocene 23 (400 mg, 1.28 mmol), copper(I) iodide 
(25 mg, 0.13 mmol), iron(III) oxide (20 mg, 0.13 mmol) and sodium hydroxide 
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(120 mg, 2.94 mmol) were mixed in EtOH (12 mL). Aqueous ammonia (6 mL, 13.5 M) was 
added and the solution was heated in a pressure-proof vessel at 90 °C for 8 h. After cooling 
down to room temperature, Et2O (150 mL) were added. The organic phase was washed with 
NaOH 1M (3x80 mL), dried over sodium sulfate, filtered and evaporated under reduced 
pressure. The residue was purified by silica gel column chromatography (Hexane:EtOAc 9:1 
then 1:1) to yield compound 24 as an orange solid (166 mg, 65%). 1H NMR (300 MHz, CDCl3) 
δ = 4.11 (s, 5 H), 4.01 (s, 2 H), 3.86 (s, 2 H), 2.57 (s, 2 H); m/z = 224.1 [M+Na+]. Data in 
agreement with that previously reported.120 
1-Ferrocenyl methenoxime 25: Hydroxylamine hydrogen chloride (323 mg, 4.7 
mmol) in water (2.5 mL) and sodium acetate (573 mg, 7.0 mmol) were added to 
a solution of ferrocene carboxaldehyde (498 mg, 2.3 mmol) in ethanol (10 mL). 
After 3 hours at reflux, the reaction mixture was allowed to cool down and was concentrated 
under reduced pressure. Chloroform was poured onto the residue and the mixture was stirred 
for 20 minutes, filtered and dried over sodium sulfate. The solvent was removed under reduced 
pressure to yield oxime 25 (635 mg, quantitative). 1H NMR (300 MHz, CDCl3) δ = 7.98 (s, 1 
H), 4.54 (t, J = 1.9 Hz, 2 H), 4.36 (t, J = 1.9 Hz, 2 H), 4.22 (s, 5 H); m/z (TOF-ES-) = 228.0 
[M-H+] (100%). Data in agreement with that previously reported.121 
 
1-Ferrocenyl methanamine 26: A solution of oxime 25 (635 mg, 2.3 mmol) and 
lithium aluminium hydride (436 mg, 11.5 mmol) in THF (15 mL) was put at 
reflux for 2 hours. After cooling down to room temperature, sodium hydroxide 1 M was added 
dropwise until all the inorganics precipitated leaving a clear yellow solution, followed by Et2O. 
The organic phase was separated and the precipitate washed with Et2O (3×20 mL), dried over 
sodium sulfate, filtered and evaporated under reduced pressure. The residue was purified by 
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silica gel chromatography (EtOAc:Hexane:MeOH 1:1:0 to 9:0:1 with 5% NEt3) to yield the 
desired product (470 mg, yield 95%). 1H NMR (300 MHz, CDCl3) δ = 4.33 (s, 2 H), 4.23 (s, 2 
H), 4.16 (s, 5 H), 3.77 (s, 2 H), 2.13 (br s, 2 H); 13C NMR (101 MHz, CDCl3) δ = 86.5, 68.4, 
67.8, 48.2. Data in agreement with that previously reported.122 
 
4.2.2.3. Precursors central chiral ferrocene (thio)ureas  
 (S)-N-(1-phenylbutoxy)phthalimide 27: (R)-1-phenylbutan-1-ol 
(1.215 g, 8 mmol), hydroxyphthalimide (1.320 g, 8 mmol) and 
triphenylphosphine (2.121 g, 8 mmol) were dissolved in dry THF (43 
mL) and cooled to 0 °C. Diethyl azodicarboxylate (1.4 mL, 8.9 mmol) was added and the 
solution was stirred at 0 °C for 20 minutes and at 50 °C for another four days. The reaction 
mixture was then concentrated under reduced pressure and the residue was purified by silica 
gel column chromatography (Hexane:EtOAc 9:1) to give the title compound as a white solid 
(2.3 g, yield 95%). 1H NMR (CDCl3, 300 MHz)  δ = 7.74-7.63 (m, 4 H), 7.48-7.43 (m, 2 H), 
7.36-7.28 (m 3 H), 5.33 (t, J = 7.1 Hz, 1 H), 2.17 (dddd, J = 13.5, 9.9, 6.8, 5.7 Hz, 1 H), 1.89 
(dddd, J = 13.5, 9.8, 7.3, 5.9 Hz, 1 H), 1.55 – 1.27 (m, 2 H), 0.97 (t, J = 7.4 Hz, 3 H);  m/z = 
318.1 [M+Na+] (100%) . Data in agreement with that previously reported.98 
 
 (E)-(S)-(+)-O-(1-phenylbutyl)ferrocene-1-carboxaloxime 28: 
Compound 27 was dissolved in EtOH at 50 °C and the solution was left 
to cool down until precipitation started to occur, hydrazine hydrate (0.21 
mL, 4.3 mmol) was added as followed by ferrocene carboxaldehyde (840 mg, 3.9 mmol). The 
mixture was stirred for 15 h at room temperature. The solvent was then evaporated under 
reduced pressure and the residue was taken with CH2Cl2 and filtered. The filtrate was 
concentrated under reduced pressure and purified by silica gel column chromatography 
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(Hexane:EtOAc 95:5) to give the title compound as a red solid (1.207 g, yield 85%). 1H NMR 
(CDCl3, 300 MHz)  δ =  7.89 (s,  1 H), 7.27-7.18 (m,  5 H), 5.03 (t,  J = 6.7,  1 H), 4.40 (d,  J 
= 15.6,  2 H), 4.21 (s,  2 H), 4.00 (s,  5 H), 1.89 (m,  1 H), 1.68 (m,  1 H), 1.32 (m,  2 H), 0.87 
(t,  J = 7.3,  3 H); 13C NMR (CDCl3, 100 MHz)  δ = 149.0 (CH), 143.0 ( C), 128.3 (CH), 127.4 
(CH), 126.9 (CH), 84.8 (CH), 76.8 ( C), 70.2 (CH), 70.0 (CH), 69.5 (CH), 68.3 (CH), 67.4 
(CH), 38.4 ( C), 19.0 ( C), 14.2 (CH3); m/z (TOF-EI) = 384.1 (M+Na+, 100%). Data in 
agreement with that previously reported.98 
 
General procedure for alkylation of (E)-(S)-(+)-O-(1-phenylbutyl)ferrocene-1-
carboxaloxime: The oxime (1 eq) was dissolved in dry toluene (0.36 M), cooled to -78 °C and 
BF3.OEt2 (3 eq) was added. After 15 minutes the alkylating agent (excess) was added drop-
wise and the mixture was stirred for 3 h. Saturated ammonium chloride was then added drop-
wise to quench the solution which was extracted with EtOAc (until no coloration). The organic 
phase was dried over sodium sulfate, filtered and evaporated under reduced pressure. The 
residue was purified by silica gel column chromatography (Hexane:EtOAc 9:1). 
 
N-(1R)-(1’S)-1-Ferrocenyl-2-phenyl-N-(1-phenylbutoxy)-1-ethylamine 
29a: Obtained from the oxime (215 mg, 0.6 mmol), BF3.OEt2 (0.22 mL, 1.8 
mmol) and BnMgCl (2 mL, 1.9 mmol) as an orange solid (211 mg, yield 
78%). 1H NMR (CDCl3, 300 MHz)  δ = 7.55-7.20 (m, 10 H), 5.90 (s, 1 H), 4.72 (dd, J = 7.8, 
5.9 Hz, 1 H), 4.20-4.14 (m, 3 H), 4.09 (s, 5 H), 4.01-3.94 (m, 2 H), 3.44 (dd, J = 13.1, 6.0 Hz, 
1 H), 2.99 (dd, J = 13.1, 7.3 Hz, 1 H), 2.04-1.90 (m, 1 H), 1.77-1.57 (m, 2 H), 1.54-1.42 (m, 1 
H), 1.09 (t, J = 7.2 Hz, 3 H); 13C NMR (101 MHz, CDCl3) δ = 143.4 (C, Ar), 139.3 (C, Ar), 
129.8 (CH, Ar), 128.5 (CH, Ar), 128.1 (CH, Ar), 127.5 (CH, Ar), 126.7 (CH, Ar), 126.0 (CH, 
Ar), 88.7 (C, Cp ring), 85.2 (CH, OCH), 68.4 (CH, unsubstituted Cp ring), 67.6 (CH, Cp ring), 
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67.0 (CH, Cp ring), 66.4 (CH, Cp ring), 61.7 (CH, CpCH), 40.9 (CH2, CpCHCH2), 38.8 (CH2, 
OCHCH2), 19.4 (CH2, OCHCH2CH2), 14.3 (CH3); IR (neat) ν (cm-1) = 3248, 3086, 3026, 2952, 
2930, 2882, 2863, 1600, 1494, 1454, 1408, 1106, 821, 769, 750, 698. Data in agreement with 
that previously reported.123 
 
N-(1R)-(1’S)-1-Ferrocenyl-1-t-butyl-N-(1-phenylbutoxy)-1-ethylamine 
29b: Obtained from the oxime (394 mg, 1.1 mmol), BF3.OEt2 (0.41 mL, 
3.3 mmol) and t-BuLi (1.9 mL, 3.3 mmol) as an orange yellow solid (274 
mg, yield 60%). 1H NMR (CDCl3, 300 MHz)  δ = 7.47-7.36 (m, 4 H), 7.34-7.27 (m, 1 H),  6.03 
(s, 1 H), 4.68 (t, J = 7.1 Hz, 1 H), 4.15-3.90 (m, 8 H), 3.74 (s, 1 H), 3.29 (s, 1 H), 1.95-1.80 (m, 
1 H), 1.68-1.55 (m, 1 H), 1.53-1.39 (m, 1H), 1.34-1.21 (m, 1 H), 0.93 (t, J = 7.4 Hz, 3 H), 0.86 
(s, 9 H); 13C NMR (101 MHz, CDCl3) δ = 143.2 (C,P h ypsos), 128.6 (CH, Ph ), 127.7 (CH, 
Ph, ), 127.3 (CH, Ph ), 89.8 (C, Cp ring), 84.7 (CH, CHO), 70.5 (CH, Cp ring), 68.5 (H, 
unsubstituted Cp ring), 68.1 (CH, Cp ring), 67.3 (CH, CpCH), 66.2 (CH, Cp ring), 66.1 (CH, 
Cp ring) , 38.5 (CH2, CH3CH2CH), 34.7 (C, t-Bu), 27.7 (CH3, t-Bu), 19.5 (CH2, CH3CH), 14.3 
(CH3, CH2CH); IR (neat) ν (cm
-1) = 3210, 3086, 3025, 2954, 2869, 1454, 1427, 1361, 1105, 
973, 823, 695. Data in agreement with that previously reported.123 
 
 (R)-1-Ferrocenyl-2-phenyl-1-ethylamine 30a: N-(1R)-(1’S)-1-ferrocenyl-2-
phenyl-N-(1-phenylbutoxy)-1-ethylamine 29a (218 mg, 0.5 mmol) was added to 
acetic acid (10 mL), water (10 mL) and THF (3 mL). Zinc powder (1.25 g, 19 
mmol) was added and the reaction mixture was heated at 40 °C for 21 h. After cooling down 
to room temperature, Et2O (20 mL) was added and the solution was filtered and extracted with 
Et2O. The aqueous phase was back extracted with CH2Cl2. The organic phases were washed 
with sodium hydroxide 1 M (pH=12), dried over sodium sulfate, filtered and evaporated under 
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reduced pressure. The crude amine was purified by silica gel column chromatography 
(EtOAc:MeOH:NEt3 1:0:0 then 90:5:5) to yield an orange solid (83 mg, yield 56%). 1H NMR 
(300 MHz, CDCl3) δ = 7.30-7.05 (m, 5 H), 4.16-4.13 (m, 1 H), 4.07 (s, 5 H), 4.06-4.02 (m, 2 
H), 4.00-3.98 (m, 1 H), 3.80 (dd, J = 8.9, 4.6 Hz, 1 H), 2.89 (dd, J = 13.2, 4.5 Hz, 1 H), 2.60 
(dd, J = 13.2, 8.9 Hz, 1 H), 1.86 (s, 2 H); 13C NMR (101 MHz, CDCl3) δ = 139.3 (C, Ph ypsos), 
129.5 (CH, Ph ortho), 128.5 (CH, Ph meta), 126.4 (CH, Ph para), 94.5 (C, Cp ring), 68.4 (CH, 
unsubstituted Cp ring), 67.6 (CH, Cp ring), 67.5 (CH, Cp ring), 52.4 (CH, CpCH), 46.2 (CH2); 
IR (neat) ʋ (cm-1) = 3357, 3282, 3102, 2963, 2866, 1595, 1479, 1386, 1360, 1234, 1104, 917, 
811; m/z = 305.1 [M]+ (10%), 288.1 [M-NH2]+ (100%); HR-MS: calc. for C18H19NFe: 
305.0867, found 305.0869; mp = 51-53 °C. Data in agreement with that previously reported.123 
 
(R)-2,2-Dimethyl-1-ferrocenylpropan-1-amine 30b: A stirred mixture of 
hydroxylamine (255 mg, 0.6 mmol), THF (10 mL), HCl 1 M (50 mL) and zinc 
powder (3.18 g, 48 mmol) was heated at 80 °C for 16 h. After cooling to room 
temperature, the solution was extracted with dichloromethane, and the organic phase was 
washed with NaOH(aq) (pH=12), dried over sodium sulfate, filtered and evaporated under 
reduced pressure. The crude amine was purified by silica gel column chromatography 
(Hexane:EtOAc:NEt3 75:15:5) to yield a yellow solid (53 mg, yield 32%). 1H-NMR (300 MHz, 
CDCl3) δ = 4.21 (1H, dd, J = 3.5, 1.7 Hz), 4.15 (5H, s), 4.12 – 4.08 (3H, m), 3.37 (1H, s), 1.68 
(2H, s), 0.81 (9H, s); 13C-NMR (101 MHz, CDCl3) δ  = 92.7, 69.7, 68.3, 67.0, 66.7, 66.0, 60.1, 
34.7; IR (neat) ν (cm-1) = 3357, 3282, 3102, 2963, 2866, 2825, 1595, 1479, 1386, 1360, 1234, 
1104, 917, 811; m/z = 271.2 [M+] (47%), 255.1 [M+-NH2] (100%), 214.1 [M
+-tBu] (38%); HR-
MS: calc. for C15H21NFe: 271.1023, found 271.1024. Data in agreement with that previously 
reported.123 
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(E)-O-(methoxy)ferrocene carboxaldoximine 31: O-methoxyamine hydrogen 
chloride (390 mg, 4.7 mmol) and sodium acetate (573 mg, 7.0 mmol) were added 
to a solution of ferrocene carboxaldehyde (498 mg, 2.3 mmol) in ethanol (10 mL). After 40 
minutes at reflux, the reaction mixture was allowed to cool down and was concentrated under 
reduced pressure. The residue was dissolved in chloroform, filtered and dried over sodium 
sulfate. The solvent was removed under reduced pressure and the residue was purified by silica 
gel column chromatography (EtOAc:Hexane 1:9) to yield oxime 78 (ratio E:Z = 3:1) (545 mg, 
yield 96%). 1H-NMR (300 MHz, CDCl3) δ = 7.89 (s, 1 H), 4.53 (s, 2 H), 4.35 (s, 2 H), 4.22 (s, 
5 H), 3.88 (s, 3 H); m/z = 244.1 [M+H+] (100%), 266.1 [M+Na+] (83%).  
 
(Z)-O-(methoxy)ferrocene carboxaldoximine 31: 1H-NMR (300 MHz, CDCl3) δ = 
7.13 (s, 1 H), 4.73 (s, 2 H), 4.35 (s, 2 H), 4.19 (s, 5 H), 3.96 (s, 3 H); m/z = 244.1 
[M+H+] (100%), 266.1 [M+Na+] (83%).  
 
1-Ferrocenyl-2-phenyl-N-(methoxy)-1-ethylamine 32: Oxime 31 (200 mg, 0.82 
mmol) was dissolved in toluene (5 mL), cooled to -78 °C and BF3.OEt2 (310 µL, 
2.47 mmol) was added. After 15 minutes, BnMgCl (2.47 mL, 2.47 mmol) was added 
drop-wise and the mixture was stirred for 2 hours. Saturated ammonium chloride (4 mL) was 
then added drop-wise to quench the solution which was extracted with CH2Cl2. The organic 
phase was dried over sodium sulfate, filtered and evaporated under reduced pressure. The 
residue was purified by silica gel column chromatography (Hexane:EtOAc 9:1) to yield the 
title compound (151 mg, yield 55%). 1H-NMR (300 MHz, CDCl3) δ = 7.33-7.22 (m, 3 H), 
7.20-7.16 (m, 2 H), 5.91 (br s, 1 H), 4.24-4.22 (m, 1 H), 4.16 (s, 5 H), 4.15-4.13 (m, 1 H), 4.11-
4.09 (m, 1 H), 3.92 (dd, J = 7.7, 6.2 Hz, 1 H), 3.46 (s, 3 H), 3.08 (qd, J = 13.5, 6.9 Hz, 2 H). 
 
CHAPTER 4 : EXPERIMENTAL SECTION 
117 
 
4.2.2.4. Precursors for planar chiral ferrocene (thio)urea 
 (2S,4S)-4-(hydroxymethyl)-2-ferrocenyl-1,3-dioxolane 34: Ferrocene 
carboxaldehyde (4 g, 18.6 mmol) was dissolved in HC(OMe)3 (40 mL) and 
PTSA (177 mg, 0.9 mmol) was added. After stirring for 23 hours at 80 °C, 
cooling to room temperature, potassium carbonate (200 mg, 1.4 mmol) was added and the 
mixture was filtered through Celite (CH2Cl2). The solvents were removed under reduced 
pressure and the residue was dried under high vacuum for 8 hours. The crude acetal (4.8 g) was 
then dissolved in CHCl3 (7 mL) and injected to a mixture of (S)-1,2,4-butantriol (1.95 g, 18.4 
mmol), Camphorsulfonic acid (213 mg, 0.9 mmol), and activated 4 Å molecular sieves (10 g) 
in CHCl3 (23 mL). The reaction mixture was stirred at room temperature for 19 hours and 
potassium carbonate (200 mg, 1.4 mmol) was added. After filtration over Celite (CH2Cl2), the 
solvents were removed under reduced pressure and the residue was purified by silica gel 
column chromatography (Hexane:EtOAc 3:2) to yield orange yellow crystals (2.39 g, yield 
43%). 1H NMR (CDCl3, 300 MHz) δ = 5.39 (s, 1 H), 4.35 (d, J = 3.9 Hz, 2 H), 4.27- 4.12 (m, 
9 H), 3.97- 3.85 (m, 2 H), 3.71- 3.55 (m, 2 H), 2.23 (t, J = 5.7 Hz, 1 H), 1.83 (ddd, J = 24.4, 
12.6, 5.1 Hz, 1 H), 1.39 (ddd, J = 13.2, 4.0, 2.5 Hz, 1 H); 13C NMR (CDCl3, 100 MHz) δ = 
100.3 (CH, CpCH), 85.9 (C, Cp ring), 77.3 (CH, OCHCH2OCH3), 69.0 (CH, unsubstituted Cp 
ring), 68.2 (CH, Cp ring),, 66.8 (CH, Cp ring), 66.6 (CH, Cp ring), 66.6 (CH2, CH2CH2O), 65.8 
(CH2, CH2OH), 27.0 (CH2, OCH2CH2CHO). Data in agreement with that previously 
reported.100 
 
 (2S,4S)-4-(methoxymethyl)-2-ferrocenyl-1,3-dioxolane 35: (2S,4S)-4-
(hydroxymethyl)-2-ferrocenyl-1,3-dioxolane 34 (1.59 g, 5.3 mmol) in dry 
THF (12 mL) was added to a solution of NaH (190 mg, 7.9 mmol) in dry THF 
(3 mL), followed by MeI (0.48 mL, 7.9 mmol). The mixture was stirred at room temperature 
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for 40 min and MeOH (1 mL) was slowly injected. Evaporation of the solvents under reduced 
pressure and purification by silica gel column chromatography (Hexane:EtOAc 7:3) yielded a 
dark orange oil (1.58 g, 95%). 1H NMR (CDCl3, 300 MHz) δ = 5.37 (s, 1H), 4.35 (ddd, J = 4.8, 
3.1, 1.8 Hz, 2H), 4.23 (ddd, J = 11.4, 5.1, 1.6 Hz, 1H), 4.18 (s, 5H), 4.12 (t, J = 1.8 Hz, 2H), 
3.99 (dddd, J = 11.4, 6.3, 4.5, 2.5 Hz, 1H), 3.90 (ddd, J = 12.3, 11.4, 2.7 Hz, 1H), 3.53 (dd, J 
= 10.3, 6.1 Hz, 1H), 3.42 (s, 3H), 3.40 (dd, J = 10.3, 4.5 Hz, 1H), 1.77 (qd, J = 12.4, 5.1 Hz, 
1H), 1.48 (dtd, J = 13.2, 2.5, 1.4 Hz, 1H); 13C NMR (CDCl3, 100 MHz) δ = 100.0 (CH, CpCH), 
86.0 (C, Cp ring), 76.0 (CH, OCHCH2OCH3), 75.6 (CH2, CH2CH2O), 68.9 (CH, unsubstituted 
Cp ring), 67.9 (CH, Cp ring), 66.7 (CH, Cp ring), 66.7 (CH2, CH2OCH3), 59.4 (CH3), 28.0 
(CH2, OCH2CH2CHO). Data in agreement with that previously reported.
100 
 
 (Rp)-1-Carboxaldehyde-2-methylferrocene 37: (2S,4S)-4-(methoxymethyl)-2-
ferrocenyl-1,3-dioxalane 35 (239 mg, 0.75 mmol) was dissolved in dry Et2O (5 
mL) and cooled to -78 °C. A solution of t-BuLi (0.49 mL, 0.83 mmol) was added drop-wise 
and the solution was stirred 10 minutes at this temperature before removal of the cooling bath. 
After 1 hour, MeI (0.2 mL, 3 mmol) was injected at -10 °C and the mixture was slowly allowed 
to warm up to room temperature and stirred for 19 hours. After quenching with MeOH the 
solvents were removed under reduced pressure. The crude alkylated ferrocene 36 was reacted 
with PTSA (200 mg, 1 mmol) in CH2Cl2 (7 mL) and water (3 mL) for 20 min. The solution 
was then extracted with CH2Cl2, dried over sodium sulfate, filtered and evaporated under 
reduced pressure. Purification by silica gel column chromatography (Hexane:EtOAc 9:1) 
yielded compound 37 as an orange solid (135 mg, yield 66%). 1H NMR (CDCl3, 300 MHz) δ 
= 10.10 (s, 1 H), 4.69 (dd, J = 2.7, 1.5 Hz, 1 H), 4.49 (m, 1H), 4.46 (t, J = 2.6 Hz, 1 H), 4.20 
(s, 5 H), 2.25 (s, 3 H); 13C NMR (CDCl3, 100 MHz) δ = 194.0 (CH, CHO), 87.2 (C, CpCH3), 
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75.2 (CH, Cp ring), 71.2 (CH, Cp ring), 70.3 (CH, unsubstituted Cp ring), 69.6 (CH, Cp ring), 
13.7 (CH3). Data in agreement with that previously reported.100 
 
Rac-1-Carboxaldehyde-2-methylferrocene 37: 1H NMR (CDCl3, 300 MHz) δ 
= 10.09 (s, 1 H), 4.68 (s, 1 H), 4.48 (s, 1 H), 4.45 (s, 1 H), 4.19 (s, 5 H), 2.24 (s, 
3 H). 
 
 (Rp)-1-Carboxaldoxime-2-methylferrocene 38: Hydroxylamine hydrogen 
chloride (82 mg, 1.2 mmol) in water (1.5 mL) was added to a solution of (Rp)-
1-carboxaldehyde-2-methylferrocene 37 (135 mg, 0.6 mmol) and NaOAc (145 
mg, 1.8 mmol) in EtOH (8 mL). The mixture was stirred at 80 °C for 5 hours, after which it 
was concentrated under reduced pressure. The residue was taken in CHCl3 and filtered, yielding 
38 an orange oil which was pure enough to be used without purification (134 mg, 93%). 1H 
NMR (CDCl3, 300 MHz) δ = 8.06 (s, 1 H), 4.49 (dd, J = 2.4, 1.5 Hz, 1 H), 4.22 (m, 1 H), 4.18 
(t, J = 2.5 Hz, 1 H), 4.11 (s, 5 H), 2.10 (s, 3 H). 
 
Rac-1-Carboxaldoxime-2-methylferrocene 38: 1H NMR (CDCl3, 300 MHz) 
δ = 8.11 (s, 1 H), 4.52 (dd, J = 2.3, 1.4 Hz, 1 H), 4.28 (t, J = 1.4 Hz, 1 H), 4.24 
(t, J = 2.5 Hz, 1 H), 4.14 (s, 5 H), 2.10 (s, 3 H). Data in agreement with that 
previously reported.123 
 
2-Ferrocenyl-4,4-dimethyl-1,3-dioxolane 40: Ferrocene carboxaldehyde 
(600 mg, 2.8 mmol) was dissolved in toluene (10 mL) and 2,2-
dimethylpropanediol (732 mg, 7 mmol) and PTSA (27 mg, 0.1 mmol) were 
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added. After refluxing for 9 hours, the solution was cooled down to room temperature and 
evaporated under reduced pressure. The residue was purified by silica gel column 
chromatography (Hexane:EtOAc 4:1) to yield orange yellow crystals (724 mg, yield 86%). 1H 
NMR (300 MHz, CDCl3) δ = 5.25 (s, 1 H), 4.33 (t, J = 1.9 Hz, 2 H), 4.20 (s, 5 H), 4.14 (t, J = 
1.9 Hz, 2 H), 3.71 (d, J = 11.2 Hz, 2 H), 3.58 (d, J = 10.8 Hz, 2 H), 1.26 (s, 3 H), 0.77 (s, 3 H); 
13C NMR (101 MHz, CDCl3) δ = 100.6 (CH, CpCH), 86.4 (C, Cp ring), 77.7 (2 CH2), 69.2 
(CH, unsubstituted Cp ring), 68.3 (CH, Cp ring), 66.8 (CH, Cp ring), 30.3 (C, CH3C), 23.2 
(CH3), 22.1 (CH3); IR (neat) ʋ (cm-1) = 3103, 2947, 2861, 2810, 1491, 1384, 1099, 1013, 807.      
 
4.2.2.5. Precursors for the bi-functional ferrocene-thiourea 
(S)-1-Hydroxy-1-ferrocenylethane 43: In dry THF (10 mL) at 0 °C was added 
(R)-CBS (364 mg, 1.32 mmol) and 20% of the total BH3SMe2 (0.44 mL, 0.88 
mmol). After 5 minutes, acetylferrocene (1 g, 4.38 mmol) in dry THF (10 mL) and the rest of 
BH3SMe2 (1.75 mL, 3.5 mmol) were added simultaneously to the reaction mixture, which was 
left at room temperature for 15 minutes. MeOH was added until no bubbling occurred, the 
resulting solution was poured in NH4Cl(sat) and extracted with Et2O. The etheral phase was 
washed with water and brine, dried over sodium sulfate, filtered and evaporated under reduced 
pressure. The residue was purified by silica gel column chromatography (Hexane:EtOAc 7:3) 
to yield the title compound as a yellow powder (998 mg, yield 99%). 1H NMR (CDCl3, 300 
MHz) δ = 4.59-4.51 (m, 1 H), 4.24-4.14 (m, 9 H), 1.89 (d, J = 4.7 Hz, 1 H), 1.44 (d, J = 6.4 
Hz, 3 H); 13C NMR (CDCl3, 100 MHz) δ = 95.4 (C, Cp ring), 68.8 (CH, unsubstituted Cp ring), 
68.4 (CH, Cp ring), 66.7 (CH, Cp ring), 66.6 (CH, Cp ring), 65.7 (CH, CpCH), 23.8 (CH3). 
Data in agreement with that previously reported.101 
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(S)-1-Acetoxy-1-ferrocenylethane 44: A solution of (S)-1-hydroxy-1-
ferrocenylethane 43 (786 mg, 3.43 mmol), acetic anhydride (0.69 mL, 7.35 mmol), 
triethylamine (1.02 mL, 7.35 mmol) and DMAP (26 mg, 0.2 mmol) in dry CH2Cl2 (15 mL) was 
stirred at room temperature for 16 hours. The resulting mixture was washed with NaHCO3 
(3x20 mL), dried over sodium sulfate, filtered and evaporated under reduced pressure to yield 
the title compound as an orange solid (902 mg, yield 97%). 1H NMR (CDCl3, 300 MHz) δ = 
5.83 (q, J = 6.5 Hz, 1 H), 4.28-4.27 (m, 1 H), 4.23-4.21 (m, 1 H), 4.18-4.15 (m, 2 H), 4.14 (s, 
5 H), 2.03 (s, 3 H), 1.56 (d, J = 6.4 Hz, 3 H) ; 13C NMR (CDCl3, 100 MHz) δ = 170.6 (C, CO), 
88.1 (C, Cp ring), 69.2 (CH, Cp ring), 68.9 (CH, unsubstituted Cp ring), 68.5 (2 CH, Cp ring), 
68.1 (CH, Cp ring), 66.1 (CH, CpCH), 21.5 (CH3, acetyl), 21.1 (CH3, CpCHCH). Data in 
agreement with that previously reported.101 
 
 (S)-1-N-Dimethylamine-1-ferrocenylethane 45: (S)-1-acetoxy-1-
ferrocenylethane 44 (2.75 g, 10.1 mmol) and dimethylamine (10 mL, 40% in 
H2O) in MeOH (40 mL) were stirred for 24 hours at room temperature. Water (30 mL) was 
then added (a yellow precipitate appeared) and the solution was extracted with CH2Cl2. The 
organic phase was washed twice with water, dried over Na2SO4, filtered and evaporated under 
reduced pressure. The residue was purified by silica gel column chromatography 
(Hexane:EtOAc 2:3 then EtOAc:MeOH 9:1) to yield the title compound as an orange oil (2.47 
mg, yield 95%). 1H NMR (CDCl3, 300 MHz) δ = 4.15- 4.06 (m, 9 H), 3.58 (q, J = 6.9 Hz, 1 
H), 2.06 (s, 6 H), 1.43 (d, J = 6.9 Hz, 3 H); 13C NMR (CDCl3, 100 MHz) δ = 86.9 (C, Cp ring), 
69.4 (CH, Cp ring), 68.6 (CH, unsubstituted Cp ring), 67.4 (CH, Cp ring), 67.3 (CH, Cp ring), 
66.9 (CH, Cp ring), 58.7 (CH, CpCHCH3), 40.6 (CH3, NCH), 16.1 (CH3, CpCHCH);  IR (neat) 
ν (cm-1) = 3093, 2971, 2934, 2818, 2776, 1641, 1454, 1366, 1105, 1038, 1000, 814. Data in 
agreement with that previously reported.101 
CHAPTER 4 : EXPERIMENTAL SECTION 
122 
 
 
 (S,Rp)-1-Carboxaldehyde- 2-((α-N-dimethylamine)ethyl)ferrocene 46: (S)-
(α-N-dimethylamine)ethylferrocene 45 (502 mg, 1.95 mmol) was dissolved in 
dry Et2O (8 mL) and cooled to -78 °C. t-BuLi (1.8 mL, 2.15 mmol) was added 
drop-wise and the mixture was stirred for 10 minutes. The cooling bath was then removed and 
the solution allowed warming up to room temperature. An orange precipitate formed as the 
temperature rose. After 1 hour, DMF was added drop-wise and the precipitate disappeared 
within seconds. Quenching with MeOH (4 mL) after 45 minutes yielded a red solution that was 
dry loaded on silica. Purification by silica gel column chromatography (Et2O:NEt3 95:5) gave 
the aldehyde as a red-orange oil (494 mg, yield 88%).  1H NMR (CDCl3, 300 MHz) δ = 10.11 
(s, 1 H), 4.80 (dd, J = 2.7, 1.5 Hz, 1 H), 4.58 (t, J = 2.7 Hz, 1 H), 4.55 (dd, J = 2.7, 1.5 Hz, 1 
H), 4.22 (s, 5 H), 4.15 (q, J = 6.9 Hz, 1 H), 2.08 (s, 6 H), 1.48 (d, J = 6.9 Hz, 3 H); 13C NMR 
(CDCl3, 100 MHz) δ = 193.4 (C, CHO), 91.6 (C, Cp ring), 72.6 (CH, Cp ring), 71.4 (CH, Cp 
ring), 70.5 (CH, unsubstituted Cp ring), 69.6 (CH, Cp ring), 55.7 (CH, CpCHCH3), 40.5 (CH3, 
NCH), 14.8 (CH3, CpCHCH); m/z = 308.1 [M+Na
+] (35%), 286.1 [M+H+] (84%), 241.0 [M+-
NMe2] (100%); HR-MS: calc. for C15H20NOFe: 286.0894, found 286.0897. 
 
(R,Sp)-1-Carboxaldehyde- 2-((α-N-dimethylamine)ethyl)ferrocene 46: 
1H 
NMR (CDCl3, 300 MHz)δ = 10.10 (s, 1 H), 4.79 (dd, J = 2.6, 1.4 Hz, 1 H), 
4.57 (t, J = 2.6 Hz, 1 H), 4.53 (dd, J = 2.6, 1.4 Hz, 1 H), 4.21 (s, 5 H), 4.12 (q, 
J = 6.8 Hz, 1 H), 2.08 (s, 6 H), 1.46 (d, J = 6.9 Hz, 3 H). 
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(S,Rp)-1-Carboxaldoxime-2-(α-N-dimethylamine)ethylferrocene 47: (S, Rp)-
1-carboxaldehyde-2-(α-N-dimethylamine)ethylferrocene 46 (83 mg, 0.29 mmol) 
was dissolved in absolute ethanol (4 mL), and hydroxylamine hydrochloride (40 
mg, 0.58 mmol) in water (0.75 mL) was then added, followed by sodium acetate 
(71 mg, 0.87 mmol). The mixture was refluxed for 3 hours. After cooling down to room 
temperature, ethanol was removed under reduced pressure and the residue was stirred with 
chloroform (3 mL) for 5 min. The organic phase was separated, dried over sodium sulfate and 
filtered. Purification by silica gel column chromatography (EtOAC:MeOH:NEt3 94:3:3) gave 
the titled compound as an orange solid (80 mg, yield 91%).  1H NMR (CDCl3, 300 MHz) δ = 
8.00 (s, 1 H), 4.69 (q, J = 7.0 Hz, 1 H), 4.45 (app t, J = 2.0 Hz, 1 H), 4.33-4.29 (m, 2 H), 4.16 
(s, 5 H), 2.11 (s, 6 H), 1.63 (d, J = 7.0 Hz, 3 H); 13C NMR (CDCl3, 100 MHz) δ = 148.7 (CH, 
aldoxime), 85.7 (C, Cp ring), 76.6 (C, Cp ring), 70.0 (CH, unsubstituted Cp ring), 69.5 (CH, 
Cp ring), 68.4 (CH, Cp ring), 68.3 (CH, Cp ring), 55.3 (CH, CpCHCH3), 39.9 (2 CH3, NCH3), 
17.1 (CH3, CpCHCH3); IR (neat) ν (cm-1) = 3080, 2954, 2869, 2558 (br), 1637, 1445, 1376, 
1240, 1199, 964, 819; m/z (TOF-AP+) = 301.1 [M+H+] (5%), 283.1 [M+-OH] (58%), 256.0 
[M+-NMe2] (88%), 239.0 [M+-NMe2-OH] (100%); HR-MS: calc. for C15H21N2OFe: 301.1003, 
found 301.0997; mp = 141-143 ˚C. 
 
(R,Sp)-1-Carboxaldoxime-2-(α-N-dimethylamine)ethylferrocene 47: 1H 
NMR (CDCl3, 300 MHz) δ = 8.00 (s, 1 H), 4.70 (q, J = 6.9 Hz, 1 H), 4.45 (dd, 
J = 2.3, 1.6 Hz, 1 H), 4.33-4.30 (m, 2 H), 4.16 (s, 5 H), ), 2.11 (s, 6 H), 1.63 (d, 
J = 7.0 Hz, 3 H). 
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(S,Sp)-1-(α-N-dimethylamine)ethyl-2-methylamineferrocene 48: to a 
solution of (S, Rp)-1-(α-N-dimethylamine)ethyl-2-methyloximeferrocene 47 
(372 mg, 1.24 mmol) in THF (40 mL) was added LiAlH4 (470 mg, 12.4 mmol). 
The mixture was heated at 80 °C for 2 hours. After cooling down with an ice 
bath, ice was carefully dropped in the reaction mixture, followed by water. The compound was 
extracted with diethyl ether to quantitatively yield the title compound as an orange oil (353 mg, 
yield 99%). 1H NMR (CDCl3, 300 MHz) δ = 4.10-4.05 (m, 2 H), 4.02-3.96 (m, 6 H), 3.88 (q, 
J = 6.7 Hz, 1 H), 3.65 (d, J = 13.8 Hz, 1 H), 3.36 (d, J = 13.7 Hz, 1 H), 2.12 (br s, 2 H), 2.08 
(s, 6 H), 1.22 (d, J = 6.7 Hz, 3 H); 13C NMR (CDCl3, 100 MHz) δ = 89.7, 89.5, 69.0, 68.6, 
67.3, 65.3, 56.9, 41.1, 39.5, 8.2; IR (neat) ν (cm-1) = 3091, 2970, 2932, 2857, 2819, 2776, 1639, 
1569, 1451, 1365, 1104, 1071, 999, 933, 808, 748; m/z (TOF-AP+) = 287.1 [M+H+] (100%); 
HR-MS: calc. for C15H23N2Fe: 287.1211, found 287.1206. 
 
(R,Rp)-1-(α-N-dimethylamine)ethyl-2-methylamineferrocene 42: 1H NMR 
(CDCl3, 300 MHz) δ = 4.09-4.05 (m, 2 H), 3.98 (s, 5 H), 3.99-3.96 (m, 1 H), 
3.87 (q, J = 6.7 Hz, 1 H), 3.64 (d, J = 13.8 Hz, 1 H), 3.35 (d, J = 13.8 Hz, 1 H), 
2.33 (br s, 2 H), 2.07 (s, 6 H), 1.21 (d, J = 6.7 Hz, 3 H). 
 
4.2.2.6. Ferrocene Boronate-Urea 
Ø Racemic synthesis of 1-urea-2-boronate ferrocene 
N-Ferrocenyl-O-tert-butylcarbamate 63: ferrocene amine 24 (175 mg, 
0.87 mmol) and water (1 mL) were introduced in a vial and di-(tert-
butyl)carbamate anhydride (208 mg, 0.96 mmol) was added. The heterogeneous mixture was 
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vigorously shacked for 20 minutes and extracted with EtOAc. The organic phase was dried 
over sodium sulfate, filtered and evaporated under reduced pressure to offer the title compound 
as an orange solid (260 mg, yield 99%). 1H NMR (300 MHz, CDCl3) δ = 5.68 (s, 1 H), 4.43 (s, 
2 H), 4.16 (s, 5 H), 3.98 (t, J = 1.9 Hz, 2 H), 1.50 (s, 9 H); 13C NMR (101 MHz, CDCl3) δ = 
97.0 (C, Cp ring), 69.2 (CH, unsubstituted Cp ring), 64.4 (CH, Cp ring), 61.0 (CH, Cp ring), 
28.5 (CH3); IR (neat) ʋ (cm-1) =  3319, 3081, 2976, 2931, 1810, 1693, 1547, 1366, 1250, 1156, 
1070, 814, 667; m/z = 301.1 [M+] (90%), 245.0 [M-tBu+H+] (100%), 201.0 [FcNH+H+] (20%); 
HR-MS: calc. for C15H19FeNO2: 301.0765, found 301.0769; mp = 179-181 °C. 
 
1-(N-Boc)-2-boronpinacol ferrocene 64:  N-ferrocenyl-O-tert-
butylcarbamate 63 (50 mg, 0.17 mmol) was dissolved in dry THF (1 mL) 
and cooled to -78 °C. t-BuLi (0.23 mL, 0.4 mmol) was then added drop-
wise and the mixture was warm up to -20 °C for 2.5 hours, after which B(Oi-Pr)3 (48 µL, 0.21 
mmol) was injected and left at this temperature for 10 minutes. The cooling bath was removed 
and the mixture stirred for 1.3 hours. Pinacol (29 mg, 0.25 mmol) was added and the reaction 
stirred for 18 hours at room temperature. The mixture was then diluted with Et2O (3 mL) and 
water (1 mL) was added. Extraction with Et2O followed by drying over sodium sulfate, 
filtration and evaporation under reduced pressure left a residue that was purified by silica gel 
column chromatography (Hexane:EtOAc 9:1) to give the title compound as orange dot-like 
crystals (13 mg, yield 18%). 1H NMR (300 MHz, CDCl3) δ = 6.13 (s, 1 H), 4.40 (s, 5 H), 4.36 
(s, 1 H), 3.97 (t, J = 1.9 Hz, 2 H), 1.48 (s, 9 H), 1.36 (s, 12 H); 13C NMR (101 MHz, CDCl3) δ 
= 83.5 (C, CpN), 74.9 (CH, NCCH), 73.3 (CH, CHCHCH), 65.6 (CH, unsubstituted Cp ring), 
63.7 (CH, BCCH), 28.8 (CH3, t-Bu), 25.0 (CH3, pinacol); 11B NMR (128 MHz, CDCl3) δ 
=15.1; m/z = 427.2 [M+] (17%), 345.1 [boronic acid+] (100%) ; HR-MS: calc. for 
C21H3011BFeNO4: 427.1617, found 427.1619. 
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1-N-((N’-3,5-bis(trifluoromethyl)phenyl)urea-1’-
pinacolatoboronylferrocene 66: The protected amine 64 (13 mg, 
0.03 mmol) was dissolved in CH2Cl2 (2 mL) at 0 °C and 
trifluoroacetic acid (0.5 mL, 6.5 mmol) was added. The cooling bath removed and the solution 
was stirred for 10 minutes. Saturated sodium hydrogenocarbonate (5 mL) was added and the 
mixture was extracted with EtOAc. The organic phase was dried over sodium sulfate, filtered 
and evaporated under reduced pressure. The residue was taken in dry CH2Cl2 (0.5 mL) and 3,5-
bis(trifluoromethl)phenyl isocyanate (5 μL, 0.03 mmol) was added. After 3.5 h stirring at room 
temperature, the solvent was removed under reduced pressure and the crude oil was purified 
by silica gel column chromatography (Hexane:EtOAc 4:1) to yield a yellow orange solid (11 
mg, yield 63%). 1H NMR (300 MHz, Acetone d6) δ = 8.65 (s, 0.5 H), 8.20 (s, 2 H), 7.67 (s, 0.5 
H), 7.58 (s, 1 H), 4.58 (t, J = 1.9 Hz, 2 H), 4.39 (t, J = 1.7 Hz, 2 H), 4.32 (t, J = 1.7 Hz, 2 H), 
3.96 (t, J = 1.9 Hz, 2 H), 1.31 (s, 12 H); 13C NMR (101 MHz, Acetone d6) δ = 153.4 (C, CO), 
143.2 (C, Ph ipsos), 132.5 (C, q, J = 33.0 Hz, Ph meta), 124.6 (C, q, J = 272.4 Hz, CF3), 118.9 
(CH, Ph ortho), 115.3 (CH, Ph para), 97.4 (C, CpN), 83.9 (C, CpB), 75.5 (CH, Cp ring), 74.2 
(CH, Cp ring), 65.7 (CH, Cp ring), 62.6 (CH, Cp ring), 25.4 (CH3); 
11B NMR ( MHz, Acetone) 
δ =14.9; IR (neat) ʋ (cm-1) = 3334, 3102, 2981, 2931, 1666, 1564, 1471, 1383, 1276, 1175, 
1125, 735; m/z = 582.1  [M]+ (100%); HR-MS: calc. for C25H25
11BF6FeN2O3: 582.1240, found 
582.1246. 
 
Ø Asymmetric synthesis of 1-urea-2-boronate ferrocene 
(S)-Tetrahydro-1H-pyrrolo[1,2-c]imidazole-1,3(2H)-dione 67: L-Proline (4.0 
g, 34 mmol) and potassium isocyanate (3.7 g, 45 mmol) was stirred for 45 minutes 
in water (20 mL) at 70 ˚C, then HCl 6 N (20 mL) was added to the mixture which 
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was heated up to reflux for 30 minutes. After allowing cooling down to room temperature, the 
solution was further cooled down with an ice-bath, upon which crystals started to appear. The 
solid liquid mixture was put at 5 ˚C for 16 hours and then filtered to give the title compound as 
white crystals (4.7 g, yield 98%). 1H NMR (300 MHz, CDCl3) δ = 8.93 (s, 1 H), 4.12 (t, J = 
8.2 Hz, 1 H), 3.67 (dt, J = 10.6, 7.6 Hz, 1 H), 3.27 – 3.02 (m, 1 H), 2.28-2.16 (m, 1 H), 2.15-
1.98 (m, 2 H), 1.83-1.69 (m, 1 H); 13C NMR (101 MHz, CDCl3) δ = 174.8, 160.7, 64.8, 45.3, 
27.5, 27.2. Data in agreement with that previously reported.111 
 
(–)-2-Ferrocenyl-7aS-tetrahydropyrrolo[1,2-c]imidazole-1,3-dione 68: A 
solution of iodoferrocene (2.18 g, 6.98 mmol), hydantoine 67 (1.46 g, 10.48 
mmol) and copper(I) oxide (800 mg, 5.59 mmol) in DMSO (7 mL) was stirred 
at 120 °C for 44 hours. After cooling down to room temperature, the mixture was extracted 
with Et2O until not coloured. The organic phase was washed twice with water, brine, and was 
dried over sodium sulfate, filtered and evaporated under reduced pressure. The residue was 
purified by silica gel column chromatography (Hexane:EtOAc 4:1 then 7:3) to yield an orange 
solid (1.28 g, 56%). 1H NMR (300 MHz, CDCl3) δ = 4.95 (s, 1 H), 4.92 (s, 1 H), 4.20 (s, 5 H), 
4.14 -4.08 (m, 3 H), 3.80 -3.71 (m, 1 H), 3.35 -3.27 (m, 1 H), 2.35 -2.25 (m, 1 H), 2.17 -2.02 
(m, 2 H), 1.80 -1.67 (m, 1 H); 13C NMR (101 MHz, CDCl3) δ = 172.3, 159.3, 89.1, 69.6, 65.4, 
62.7, 62.8, 62.6, 46.0, 28.0, 26.9. Data in agreement with that previously reported.111 
 
(+)-2-Ferrocenyl-1R-triethylsilyloxy-7aS-hexahydropyrrolo[1,2-c]imidazol-
3-one 69: Amide 68 (1.13 g, 3.5 mmol) and Cp2Zr(H)Cl (1.17 g, 4.5 mmol) 
were stirred in dry THF (10 mL) until the solution became clear. Tri-
ethylchlorosilane (0.76 mL, 4.5 mmol), imidazole (545 mg, 8.0 mmol) and DMAP (38 mg, 0.3 
mmol) were then added to the solution and stirred at room temperature for 6 h. Et2O (15 mL) 
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and water (5 mL) were then added. The organic phase was washed with saturated copper sulfate 
10% (2x15 mL), sodium hydrogenocarbonate and water. After filtration over Celite (EtOAc), 
the organic phase was dried over sodium sulfate, filtered and evaporated under reduced 
pressure. The residue was purified by silica gel column chromatography (Hexane:EtOAc 4:1) 
to yield an orange solid (1.19 g, yield 78%). 1H NMR (300 MHz, CDCl3) δ = 5.42 (d, J = 5.9 
Hz, 1 H), 4.80 (s, 1 H), 4.30 (s, 1 H), 4.18 (s, 5 H), 4.04 (s, 1 H), 3.95 -3.89 (m, 2 H), 3.64 -
3.56 (m, 1 H), 3.13 -3.06 (m, 1 H), 1.95 -1.85 (m, 3 H), 1.75 -1.67 (m, 1 H), 0.88 (t, J = 7.9 
Hz, 9 H), 0.58 -0.50 (m, 6 H); 13C NMR (101 MHz, CDCl3) δ = 159.2, 96.7, 82.7, 69.2, 65.2, 
63.7, 62.0, 61.7, 61.6, 45.8, 26.5, 25.3, 6.9, 5.1. Data in agreement with that previously 
reported.111 
 
(+)-(2Sp-((1R,7aS)-3-Oxo-1-((triethylsilyl)oxy)tetrahydro-1H-pyrrolo[1,2-
c]imidazol-2(3H)-yl)ferrocenyl)boronic pinacol ester 71: Hydantoine 69 
(711 mg, 1.6 mmol) was dissolved in dry THF (20 mL) at -78 °C and t-BuLi 
(2.1 mL, 3.6 mmol) was added drop-wise. After 45 minutes, boron tri-
isopropoxide (0.9 mL, 4.1 mmol) was injected and the mixture was stirred for another hour. 
Pinacol (955 mg, 8.1 mmol) was then added, the cooling bath removed. The solution stirred 
for 15 min and wet Et2O (20 mL) was added. After evaporation of the solvents under reduced 
pressure, the residue was purified by silica gel column chromatography (Hexane:EtOAc 7:3) 
to offer the title compound as an orange solid (759 mg, yield 82%). 1H NMR (300 MHz, CDCl3) 
δ = 5.40 (d, J = 6.4 Hz, 1 H), 4.30 (dd, J = 2.6, 1.3 Hz, 1 H), 4.25 -4.23 (m, 6 H), 4.14 (t, J = 
2.5 Hz, 1 H), 3.91 (q, J = 6.8 Hz, 1 H), 3.59 (dt, J = 10.6, 6.8 Hz, 1 H), 3.06 (ddd, J = 10.6, 
7.3, 5.3 Hz, 1 H), 2.02 -1.78 (m, 3 H), 1,75 -1.62 (m, 1 H), 1.28 (s, 6 H), 1.27 (s, 6 H), 0.87 (t, 
J = 7.9 Hz, 9 H), 0.50 (ddd, J = 11.6, 7.9, 2.9 Hz, 6 H); 13C NMR (101 MHz, CDCl3) δ =159.8, 
98.5, 84.6, 82.8, 71.3, 69.8, 67.3, 67.0, 62.0, 46.4, 26.5, 25.6, 25.2, 24.9, 6.9, 5.0; IR (neat) ʋ 
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(cm-1) = 3094, 2955, 2877, 1712, 1461, 1377, 1311, 1138, 1117, 1107, 728; m/z = 566.2 [M]+ 
(55%), 512.2 [M-CH2CH2CH2CH]+ rearrangement (100%); HR-MS: calc. for 
C28H43BFeN2O4Si: 566.2435, found 566.2430; mp = 98-100 °C. 
 
Ø Racemic synthesis of 1-methyleneurea-2-boronate ferrocene  
2-(2-boronic acid)ferrocenyl-4,4-dimethyl-1,3-dioxolane 72a: Dioxolane 
40 (300 mg, 1.0 mmol) was dissolved in dry Et2O (8 mL) and the solution 
was cooled down to -20 ˚C before t-BuLi (0.70 mL, 1.2 mmol) was added 
drop-wise. After 1 hour, boron tri-isopropyl (0.35 mL, 1.5 mmol) was added and the solution 
was stirred at -20 ˚C for 3.5 hours. Water (8 mL) was then added and the mixture was extracted 
with Et2O. The organic phase was washed with brine, dried over sodium sulfate, filtered and 
evaporated under reduced pressure. The residue was purified by silica gel column 
chromatography (Hexane:EtOAc 9:1). Order of elution was the recovered starting dioxolane 
40, then the ortho-substituted product 72a (41 mg, 12%). 1H NMR (300 MHz, CDCl3) δ =5.69 
(s, 1 H), 4.68 (dd, J  = 2.3, 1.4 Hz, 1 H), 4.41 (dd, J = 2.4, 1.4 Hz, 1 H), 4.37 (t, J = 2.4 Hz, 1 
H),  4.16 (s, 5 H), 3.84-3.72 (m, 4 H), 1.33 (s, 3 H), 0.81 (s, 3 H); 11B NMR (128 MHz, CDCl3) 
δ = 11.3. 
 
2-(3-boronic acid)ferrocenyl-4,4-dimethyl-1,3-dioxolane 72b: meta-
substituted product 72b (60 mg, 17%) came at later elution. 1H NMR 
(300 MHz, CDCl3) δ = 5.45 (s, 1 H), 4.66 (app s, 1 H), 4.59 (app s, 1 H), 
4.40 (app s, 1 H), 4.27 (s, 5 H), 3.74 (dt, J = 11.1, 2.5 Hz, 2 H), 3.63 (dd, J = 11.2, 5.8 Hz, 2 
H), 1.29 (s, 3 H), 0.77 (s, 3 H); 11B NMR (128 MHz, CDCl3) δ = 11.4. 
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1-Carboxaldehyde-2-pinacolatoboronylferrocene 73: Boronic acid 72a (41 
mg, 0.16 mmol ) was dissolved in THF (2 mL) and pinacol (19 mg, 0.16 mmol) 
was added. After one hour, the solvent was removed under reduced pressure and 
the residue was treated with PTSA (38 mg, 0.2 mmol) in CH2Cl2 (5 mL) at room temperature 
for 20 minutes. Water (5 mL) was added and the solution was extracted with CH2Cl2, dried 
over sodium sulfate, filtered and evaporated under reduced pressure. Purification by silica gel 
column chromatography (Hexane:EtOAc 9:1) yielded compound 72 as an orange solid (11 mg, 
yield 21%). 1H NMR (300 MHz, CDCl3) δ = 10.41 (s, 1 H), 5.10 (dd, J = 2.3, 1.5 Hz, 1 H), 
4.79 (dd, J = 2.6, 1.5 Hz, 1 H), 4.78 (td, J = 2.6, 0.8 Hz, 1 H), 4.25 (s, 5 H), 1.37 (s, 6 H), 1.36 
(s, 6 H). 
 
Ø Asymmetric synthesis of 1-methaneurea-2-boronate ferrocene 
(2S,4S,SFc)-4-(Methoxymethyl)-2-[α-pinacolboronoferrocenyl)-1,3-
dioxolane 76: (2S,4S)-4-(methoxymethyl)-2-ferrocenyl-1,3-dioxalane 35 
(386 mg, 1.22 mmol) was dissolved in dry Et2O (6 mL) and cooled to -78 
°C. A solution of t-BuLi (0.71 mL, 1.34 mmol) was added drop-wise and the solution was 
stirred 10 minutes at this temperature before removal of the cooling bath. After 1 hour, the 
temperature was set at -78 °C and B(Oi-Pr)3 (0.42 mL, 1.83 mmol) was injected and the mixture 
was left at this temperature for 2 hours. Water (3 mL) was then added and the solution allowed 
warming up to room temperature. The phases were separated and the aqueous phase was 
saturated in sodium chloride. After extraction with EtOAc, the organic phases were gathered, 
dried over sodium sulfate, filtered and evaporated under reduced pressure. The residue was 
reacted with pinacol (164 mg, 1.39 mmol) in toluene (10 mL) at 90 ˚C for 1 hour. Evaporation 
of the solvent and purification by silica gel column chromatography (Hexane:EtOAc 7:3) 
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yielded the title compound as an orange yellow  solid (384 mg, yield 72%). 1H NMR (300 
MHz, CDCl3) δ = 5.71 (s, 1 H), 4.63 (s, 1 H), 4.33 (d, J = 7.7 Hz, 2 H), 4.28 (dd, J = 12.1, 5.2 
Hz, 1 H), 4.13 (s, 5 H), 3.99 (t, J = 10.7 Hz, 1 H), 3.45 (dd, J = 10.4, 5.8 Hz, 1 H), 3.35-3.29 
(m, 4 H), 1.77 (ddd, J = 17.1, 12.4, 5.2 Hz, 1 H), 1.50 (d, J = 13.2 Hz, 1 H), 1.34 (s, 6 H), 1.33 
(s, 6 H); 13C NMR (101 MHz, CDCl3) δ = 100.6 (CH, CpCH), 91.3 (C, CpCHO), 83.0 (C, 
CpB), 76.2 (CH, OCHCH2OCH3), 75.7 (CH2, CH2OCH3), 74.5 (CH, Cp ring), 71.4 (CH, Cp 
ring), 70.2 (CH, Cp ring), 69.5 (CH, unsubstituted Cp ring), 67.1 (CH2, OCHCH2), 59.4 (CH3, 
OCH3), 28.6 (CH2, OCH2CHCHCH2OCH3), 25.3 (CH3, pinacol), 24.9 (CH3, pinacol); IR 
(neat) ʋ (cm-1) = 3092, 2976, 2951, 2915, 2874, 2805, 1667, 1462, 1320, 1139, 1001, 822, 750; 
m/z = 466.1 [M(11B)+Na+] (45%), 465.1 [M(10B)+Na+] (86%), 442.1 [(11B)M+] (100%), 441.1 
[M(10B)]+ (48%); HR-MS: calc. for C22H31 11BFeO5: 442.1614, found 442.1623; mp = 89-91 
°C. 
 
(Rp)-1-Carboxaldehyde-2-pinacolatoboronylferrocene 73: (2S,4S,SFc)-4-
(Methoxymethyl)-2-[α-pinacolboronoferrocenyl)-1,3-dioxolane 76 (117 mg, 
0.26 mmol) was dissolved in CH2Cl2 (3 mL) and put at 0 °C. 2,4,6-collidine (141 
µL, 0.78 mmol) was added, followed by TMSOTf (70 µL, 0.53 mmol). After completion (TLC 
monitoring, typically 3 h) the reaction mixture was quenched with water (2.5 mL) and the ice-
bath removed. The solution was stirred 10 more minutes and then extracted with CH2Cl2. The 
organic phases were dried over sodium sulfate, filtered and evaporated under reduced pressure. 
The residue was purified by silica gel column chromatography (EtOAc:Hexane 1:4) to yield 
the title compound as orange-red crystals (79 mg, yield 89%). 1H NMR (300 MHz, CDCl3) δ 
= 10.43 (s, 1 H), 5.11 (dd, J = 2.3, 1.5 Hz, 1 H), 4.80 (dd, J = 2.6, 1.5 Hz, 1 H), 4.79 (td, J = 
2.6, 0.8 Hz, 1 H), 4.25 (s, 5 H), 1.37 (s, 6 H), 1.36 (s, 6 H); 13C NMR (101 MHz, CDCl3) δ = 
196.8, 84.4, 83.7, 79.7, 77.4, 76.2, 71.4, 70.3, 25.1; 11B NMR (128 MHz, CDCl3) δ =14.5; IR 
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(neat) ʋ (cm-1) = 3098, 2976, 2922, 2852, 1663, 1462, 1319, 1141; m/z = 363.1 [M(11B)+Na+] 
(100%), 340.1 [M(11B) +] (6%), 339.1 [M(10B) +] (18%); HR-MS: calc. for C17H2110BFeO3: 
339.0969, found 339.0964; mp = 118-120 °C. 
 
(Rp)-1-Carboxaldoxime-2-pinacolatoboronylferrocene 74: (Rp)-1-
carboxaldehyde-2-pinacolatoboronylferrocene 73 (759 mg, 2.23 mmol) was 
dissolved in EtOH (10 mL) at 0 °C and 2,4,6-collidine (1.21 mL, 6.69 mmol) 
was added, followed by hydroxylamine hydrochloride (310 mg, 4.46 mmol). The mixture was 
stirred for 10 minutes at 0 °C and then concentrated under reduced pressure. The residue was 
purified by neutralised silica gel column chromatography (Hexane:EtOAC:NEt3  87:8:5) to 
yield an orange solid (500 mg, yield 63%). 1H NMR (300 MHz, CDCl3) δ = 8.47 (s, 1H), 4.94 
(s, 1 H), 4.60 (d, J = 2.4 Hz, 1 H), 4.56 (t, J = 2.2 Hz, 1 H), 4.20 (s, 5 H), 1.35 (s, 12 H); 13C 
NMR (101 MHz, CDCl3) δ = 151.5, 83.5, 81.5, 76.2, 73.7, 69.9, 69.2, 25.1 25.0; IR (neat) ʋ 
(cm-1) = 3400-3180, 3096, 2977, 1622, 1458, 1313, 1139, 995, 950, 854, 812, 695; m/z = 355.1 
[M]+ (100%), 338.3 [M-OH]+ (65%), 273.0 [boronic acid]+ (77%); HR-MS: calc. for C17H22 
11BFeNO3: 355.1042, found 355.1049; mp = 57-59 °C. 
 
Ø Synthesis of 1-methyleneurea-1’-boronate ferrocene  
N-Methylferrocene-O-tert-butylcarbamate 77: aminomethylferrocene 
26 (509 mg, 2.36 mmol) and water (2.4 mL) were introduced in a vial and 
di-(tert-butyl)carbamate anhydride (568 mg, 2.60 mmol) was added. The 
heterogeneous mixture was vigorously shacked for 20 minutes and extracted with EtOAc. The 
organic phase was dried over sodium sulfate, filtered and evaporated under reduced pressure. 
The residue was purified by silica gel column chromatography (Hexane:EtOAc 9:1) to offer 
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the title compound as an orange solid (598 mg, yield 80%). 1H NMR (300 MHz, CDCl3) δ = 
4.75 (s, 1 H), 4.16 (s, 2H), 4.15 (s, 5 H), 4.11 (s, 2 H), 4.00 (d, J = 5.5 Hz, 2 H), 1.45 (s, 9 H); 
13C NMR (101 MHz, CDCl3) δ = 155.7 (C, carbamate), 85.8 (C, t-Bu), 79.3 (C, Cp ring), 68.6 
(CH, unsubstituted Cp ring), 68.1 (2 C, Cp ring), 39.9 (CH2), 28.5 (CH3); IR (neat) ʋ (cm-1) = 
3323, 3096, 2973, 2924, 1701, 1683, 1523, 1363, 1274, 1247, 1156, 815; m/z = 338.1 [M+Na+] 
(86%), 315.1 [M+] (100%), 259.0 [M-tBu+H+] (16%), 199.0 [M+-NHBoc]; mp = 178-180 °C. 
 
 1-(O-tert-butylcarbamate)methyl-1'-(pinacol)boronylferrocene 78: N-
methylferrocene-O-tert-butylcarbamate 77 (150 mg, 0.48 mmol) was 
dissolved in THF (1.2 mL) and cooled to -78 °C. t-BuLi (0.67 mL, 1.14 
mmol) was then added drop-wise, stirred for 15 minutes. The mixture was warm up to -15 °C 
for 2.5 hours, and cooled again to -78 °C and boron tri-isopropoxide (48 µL, 0.21 mmol) in dry 
THF (0.4 mL) was injected. The cooling bath was removed and the mixture stirred for 1.5 hour. 
Pinacol (100 mg, 0.80 mmol) was added and the reaction stirred for 1 hour at room temperature. 
The mixture was then diluted with Et2O (3 mL) and water (1 mL) was added. After extraction 
with Et2O, the organic phase was washed twice with brine, dried over sodium sulfate, filtered 
and evaporated under reduced pressure. The residue was purified by silica gel column 
chromatography (Hexane:EtOAc 9:1) to give the title compound as orange oil (144 mg, yield 
72%). 1H NMR (300 MHz, CDCl3) δ = 6.13 (s, 1 H), 4.41 (t, J = 1.8 Hz, 2 H), 4.31 (t, J = 1.8 
Hz, 2 H), 4.17 (t, J = 1.8 Hz, 2 H), 4.07 (t, J = 1.8 Hz, 2 H), 4.00 (d, J = 6.1 Hz, 2 H), 1.42 (s, 
9 H), 1.34 (s, 12 H); 13C NMR (101 MHz, CDCl3) δ = 155.9 (C, CO), 86.3 (C, t-Bu), 83.5 (C, 
CpB), 79.4 (C, CpCH2), 74.4 (CH, Cp ring), 72.5 (CH, Cp ring), 68.4 (CH, Cp ring), 68.1 (CH, 
Cp ring), 39.9 (CH2), 28.7 (CH3, t-Bu), 25.1 (CH3, pinacol); m/z = 441.2 [M
+] (100%), 385.1 
[M-tBu+H+] (11%), 325.1 [M+-NHBoc] (52%); HR-MS: calc. for C22H32
11BNO4Fe: 441.1774, 
found 441.1779. 
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4.3. Electrochemistry 
Electrochemical studies were performed on a BAS 100W electrochemical analyser, with BAS 
100W software. All measurements were carried out at 298 K in dry CH2Cl2, in which 
tetrabutylammomiun hexafluorophosphate (TBAPF6) was dissolved as a supporting electrolyte 
(0.1 M). A conventional 3-electrode system was employed. The working electrode (WE) was 
a platinum disc electrode (diameter: 1.6 mm). Silver/silver chloride (Ag|AgCl) was used as an 
external reference electrode and a platinum wire was used as auxiliary electrode. 
Decamethylferrocene, dmfc (in a concentration comparable to the concentration of the analyte) 
was used as an internal reference. The concentration of the studied compounds was set at 0.3 
mM. All cyclic voltammograms were carried out at a scan rate of 100 mV.s-1 unless otherwise 
stated. The cells and the volumetric flasks used were cleaned using a 1:1 solution of ammonia 
and hydrogen peroxide, rinsed 10 times using MilliQ® water, purified with a Millipore Elix-
Gradient A10 system (18 MΩ cm, toc ≤ 5 ppb, Millipore, France), and dried in the oven 
overnight. Prior to use, the platinum electrode was polished by hand using an eight pattern on 
aqueous slurries of 0.05 μm alumina powder pads and then thoroughly rinsed in deionised 
water followed by MeOH and drying in a directed stream of nitrogen. To check the 
electrochemical reversibility, voltammetric cycles were performed at different scan rates (0.1 
to 1.1 V.s-1) between -250 and 900 mV (vs. Ag/AgCl) with plots of anodic peak current versus 
the square root of the scan rate, giving a straight line.  
 
4.4. 1H-NMR binding studies 
Measurements were performed at 300 MHz on a Bruker AVIII300 NMR spectrometer at 294 
K. Each ferrocenyl receptor was dissolved in deuterated acetonitrile (5 mM) and introduced in 
an NMR tube. The carboxylate guests were prepared as a 0.2 M stock solution (in deuterated 
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acetonitrile) to avoid dilution effect. Spectrum were recorded after each addition of the guest 
into the NMR tube and the urea signal was used to produce the different binding plots. When 
possible, the binding constant K was determined using the program WinEqNMR.106 
 
4.5. Procedures for Organocatalysis 
4.5.1. General procedure for the Henry Reaction 
1-Phenyl-2-nitroethan-1-ol 52: Nitromethane (540 μL, 10 mmol), benzaldehyde 
(102 μL, 1 mmol), DABCO (22 mg, 0.2 mmol) and the appropriate catalyst (0.2 
mmol) in dry THF (1 mL) were stirred at room temperature for the time indicated. The mixture 
was directly purified by silica gel column chromatography (Hexane:EtOAc 9:1) to yield 
compound 52.  1H NMR (300 MHz, CDCl3) δ = 7.43-7.33 (m, 5 H), 5.40 (dd, J = 9.4, 3.4 Hz, 
1 H), 4.56 (dd, J = 13.2, 9.5 Hz, 1 H), 4.46 (dd, J = 13.2, 3.3 Hz, 1H), 3.24 (d, J = 3.8 Hz, 1 
H); m/z (TOF-ES) = 166.2 [M-H+]. Data in agreement with that previously reported.124 
 
4.5.2. General procedure for the Morita-Baylis-Hillman 
2-(hydroxy(phenyl)methyl)cyclohex-2-enone 53: 2-cyclohexenone (150 μL, 
1.55 mmol), benzaldehyde (79 μL, 0.77 mmol), DABCO (21.6 mg, 0.155 mmol) 
and the appropriate catalyst (0.155 mmol) were stirred at room temperature for 24 
hours. Work-up: addition of saturated ammonium chloride (1 mL) and extraction with EtOAc 
(2x3 mL). The organic phase was dried over sodium sulfate, filtered and evaporated under 
reduced pressure. Purification by silica gel column chromatography (Hexane:EtOAc 9:1)  
yielded compound 53 as a colourless oil. 1H NMR (300 MHz, CDCl3) δ = 7.36-7.20 (m, 5 H), 
6.75 (t, J = 4.0 Hz, 1 H), 5.53 (s, 1 H), 3.57 (br s, 1 H), 2.44-2.34 (m, 4 H), 1.97 (dt, J = 12.5, 
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6.1 Hz, 2 H); m/z (TOF-ES-) = 201.2 [M-H+]. Data in agreement with that previously 
reported.125 
 
4.5.3. General procedure for the HBD/Enamine catalysis 
5-Nitro-4-phenylpentan-2-one 54: to a solution of catalyst 21 (11.1 mg, 0.02 
mmol) in DMSO (1 mL) was added L-proline (2.3 mg, 0.02 mmol). Acetone 
(50 µL, 0.7 mmol) and trans-β-nitrostyrene (14.9 mg, 0.1 mmol) were then introduced in the 
reaction mixture. The reaction was stirred for 2 days at room temperature. Addition of brine 
and extraction with CH2Cl2 gave the crude product which was purified by silica gel column 
chromatography (Hexane:EtOAc 9:1) to yield compound 54 (10 mg, 48%). 1H NMR (300 
MHz, CDCl3) δ =  7.36-7.20 (m, 5 H), 4.70 (dd, J = 12.3, 6.9 Hz, 1 H), 4.60 (dd, J = 12.3, 7.7 
Hz, 1 H), 4.01 (p, J = 7.1 Hz, 1 H), 2.92 (d, J = 7.0 Hz, 1 H), 2.12 (s, 3 H); 13C NMR (101 
MHz, CDCl3) δ = 205.5, 138.9, 129.2, 128.1, 127.5, 79.6, 46.3, 39.2, 30.6. Data in agreement 
with that previously reported.126 
 
4.5.4. General procedure for the formation of tetrasubstituted cyclopentane 
3-Nitropropanaldehyde 55: freshly distilled acroleine (0.66 mL, 10.0 mmol) 
was added to a mixture of sodium nitrite (863 mg, 12.5 mmol) in THF (4 mL) 
and water (2.5 mL) at 0 ̊C. Acetic acid (0.63 mL, 11 mmol) was added drop-wise over a period 
of 40 minutes and the reaction mixture was stirred at 0 ̊C for 3 hours. EtOAc (5 mL) was then 
added, followed by saturated sodium carbonate (5 mL). After extraction with EtOAc, the 
organic phase was washed 3 times with brine, dried over sodium sulfate, filtered, evaporated 
under reduced pressure and further dried under high vacuum. A yellow oil was obtained (607 
mg, yield 59%).  1H NMR (300 MHz, CDCl3) δ = 9.79 (s, 1 H), 4.67 (t, J = 6.0 Hz, 2 H), 3.17 
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(t, J = 6.0 Hz, 2 H); 13C NMR (101 MHz, CDCl3) δ = 196.8 (CH, CHO), 67.7 (CH2, CH2CHO), 
39.6 (CH2, CH2NO2). Data in agreement with that previously reported.
127 
 
Methyl-(E)-5-nitropent-2-enoate 56: methyl-2-
(triphenylphosphanylidene)acetate (1.304 g, 3.9 mmol) and 3-
nitropropanaldehyde (607 mg, 5.9 mmol) were stirred in dry CH2Cl2 (15 mL) at room 
temperature for 29 hours. Saturated ammonium chloride (10 mL) and water (30 mL) were then 
added and the mixture was extracted with CH2Cl2. The organic phase was dried over sodium 
sulfate, filtered and evaporated under reduced pressure. The residue was purified by silica gel 
column chromatography (Hexane:EtOAc 6:4) to yield the title compound as a colourless oil 
(361 mg, yield 58%).  1H NMR (300 MHz, CDCl3) δ = 6.77 (dt, J = 15.7, 6.9 Hz, 1 H), 5.84 
(ddd, J = 15.4, 5.5, 4.0 Hz, 1 H), 4.45 (t, J = 6.8 Hz, 2 H), 3.62 (s, 3 H), 2.80 (qd, J = 6.8, 1.5 
Hz, 2 H);  13C NMR (101 MHz, CDCl3) δ = 165.9 (C, COO), 141.7 (CH, CHCOO), 124.1 (CH, 
CHCH2), 73.2 (CH2, CH2NO2), 51.5 (CH3, OCH3), 29.2 (CH2, CH2CH2NO2). Data in 
agreement with that previously reported.127  
 
Catalysis: methyl-(E)-5-nitropent-2-enoate 56 (253 mg, 1.59 mmol) and β-trans-nitrostyrene 
(261 mg, 1.75 mmol) were mixed in dry CH2Cl2 (7.9 mL) at room temperature. Catalyst 21 (88 
mg, 0.16 mmol) was then added and the solution was stirred for 7 days. Water (5 mL) was then 
added and the mixture was extracted with CH2Cl2.  . The organic phase was dried over sodium 
sulfate, filtered and evaporated under reduced pressure. The residue was purified by silica gel 
column chromatography (Hexane:EtOAc 9:1 then 8:2) to yield a fraction containing 2 products 
along with some remaining starting methyl-(E)-5-nitropent-2-enoate. This fraction was 
evaporated under reduced pressure and the resulting oil was taken in a minimum amount of 
CH2Cl2 and Et2O until, upon slow mixing, a thin white precipitate appears. The solid was 
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filtered and washed with a small amount of cold Et2O to obtain an off-white powder (19 mg, 
yield 4%): 
 
Methyl 2-(2,4-dinitro-3-phenylcyclopentyl)acetate 57a: 1H NMR 
(300 MHz, CDCl3) δ = 7.43-7.31 (m, 3 H, Ar), 7.25-7.17 (m, 2 H, Ar), 
5.18 (dd, J = 7.7, 4.5 Hz, 1 H, Hg), 5.01 (dt, J = 9.7, 7.6 Hz, 1 H, He), 
4.69 (dd, J = 7.8, 4.5 Hz, 1 H, Hf), 3.72 (s, 3 H, Ha), 3.19-3.10 (m,  1 H, Hc), 2.84-2.77 (m, 1 
H, Hd’), 2.57 (app dt, J =12.7, 9.8 Hz, 1 H, Hd), 2.53 (d, J = 7.3 Hz, 2 H, Hb) ;  
13C NMR (101 
MHz, CDCl3) δ = 171.2 (C, CO), 137.3 (C, Ph ypsos), 129.7 (CH, Ph), 128.8 (CH, Ph para), 
127.3 (CH, Ph), 93.6 (CH, O2NCHCHCH2), 89.6 (CH, O2NCHCH2), 53.9 (CH, CHPh), 52.4 
(CH3), 38.6 (CH, CH2CHCH2), 35.7 (CH2, cyclopentane), 33.7 (CH2, CHCOOCH3); m/z = 
331.1 [M+Na+]; HR-MS: calc for C14H16N2O6Na: 331.0906, found 331.0910. 
 
The filtrate still contained the sus-described product along with some starting methyl-(E)-5-
nitropent-2-enoate and the other diastereoisomer: 
Methyl 2-(2,4-dinitro-3-phenylcyclopentyl)acetate 57b: 1H NMR 
(300 MHz, CDCl3) δ = 7.43-7.31 (m, 3 H, Ar), 7.25-7.17 (m, 2 H, Ar), 
5.71 (app q, J = 9.0 Hz, 1 H, He), 5.18 (dd, J = 3.6, 7.7 Hz, 1 H, Hg), 4.35 
(dd, J = 10.4, 8.2 Hz, 1 H, Hf), 3.74 (s, 3 H, Ha), 3.32-3.25 (m, 1 H, Hc), 3.07 (dt, J = 13.4, 8.2 
Hz, 1 H, Hd’), 2.73 (d, J = 7.0 Hz, 2 H, Hb), 2.20 (dt, J = 13.4, 8.9 Hz, 1 H, Hd);
 13C NMR (101 
MHz, CDCl3) δ = 171.0 (C, CO), 129.2 (CH, Ph), 128.7 (CH, Ph para), 127.5 (CH, Ph), 93.4 
(CH, O2NCHCHCH2), 86.2 (CH, O2NCHCH2), 53.7 (CH, CHPh), 52.3 (CH3), 38.4 (CH, 
CH2CHCH2), 37.6 (CH2, CHCOOCH3), 36.2 (CH2, cyclopentane); m/z (TOF-AP+) = 309.1 
[M+H+]; HR-MS: calc for C14H17N2O6: 309.1087, found 309.1082. 
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Appendix  
Ø Crystal data and structure refinement (by Dr. Mateusz B. Pitak) 
Fc-oxazole 1a: 
 
 
Table 1. Crystal data and structure refinement details. 
  
Identification code  2012ncs0119 (MFB 150 F2) 
Empirical formula  C31H23FeN3O5S 
Formula weight  605.43 
Temperature  100(2) K 
Wavelength  0.71075 Å 
Crystal system  Triclinic 
Space group  P-1  
Unit cell dimensions a = 7.4138(15) Å a = 106.851(14)° 
 b = 11.173(2) Å b = 97.751(15)° 
 c = 16.823(3) Å g  = 101.490(14)° 
Volume 1279.1(4) Å3 
Z 2 
Density (calculated) 1.572 Mg / m3 
Absorption coefficient 0.721 mm-1 
F(000) 624 
Crystal Block; Red 
Crystal size 0.17 ´ 0.15 ´ 0.06 mm3 
q range for data collection 3.04 - 25.00° 
Index ranges -8 £ h £ 8, -13 £ k £ 13, -20 £ l £ 16 
Reflections collected 13812 
Independent reflections 4457 [Rint = 0.0242] 
Completeness to q = 25.00° 98.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9580 and 0.8872 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4457 / 0 / 370 
Goodness-of-fit on F2 1.045 
Final R indices [F2 > 2s(F2)] R1 = 0.0267, wR2 = 0.0670 
R indices (all data) R1 = 0.0285, wR2 = 0.0680 
Largest diff. peak and hole 0.333 and -0.304 e Å-3 
 
 
  
Diffractometer: AFC12 (Right): Kappa 3 circle with Rigaku Saturn724+ (2x2 bin mode) 
detector (profile data from \w-scans Cell determination: CrystalClear-SM Expert 2.0 r7 
(Rigaku, 2011) Data collection: CrystalClear-SM Expert 2.0 r7 (Rigaku, 2011) Data 
reduction and cell refinement: CrystalClear-SM Expert 2.0 r7 (Rigaku, 2011) Absorption 
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correction: CrystalClear-SM Expert 2.0 r7 (Rigaku, 2011) Structure solution: SHELXS97 
(Sheldrick, G.M. (2008). Acta Cryst. A64, 112-122.) Structure refinement: SHELXL97 (G 
Sheldrick, G.M. (2008). Acta Cryst. A64, 112-122.). 
 
 
Table 2. Atomic coordinates [´ 104], equivalent isotropic displacement parameters [Å2 ´ 103] 
and site occupancy factors. Ueq is defined as one third of the trace of the orthogonalized Uij 
tensor. 
 
Atom  x y z Ueq S.o.f. 
 
C1 5033(2) 10882(2) 3443(1) 14(1) 1 
C2 5059(2) 11398(2) 2790(1) 14(1) 1 
C3 5764(2) 10793(2) 2097(1) 14(1) 1 
C4 6411(2) 9707(2) 2088(1) 13(1) 1 
C5 6330(2) 9188(2) 2746(1) 15(1) 1 
C6 5634(2) 9786(2) 3439(1) 15(1) 1 
C7 10585(2) 10933(2) 1801(1) 12(1) 1 
C8 10625(2) 11802(2) 2586(1) 15(1) 1 
C9 11454(2) 13103(2) 2760(1) 19(1) 1 
C10 12240(2) 13528(2) 2155(1) 20(1) 1 
C11 12176(2) 12648(2) 1368(1) 20(1) 1 
C12 11341(2) 11346(2) 1187(1) 16(1) 1 
C13 10623(2) 8884(2) 2093(1) 12(1) 1 
C14 11440(2) 7908(2) 1803(1) 13(1) 1 
C15 11941(2) 7249(2) 1010(1) 14(1) 1 
C16 12162(3) 7844(2) 394(1) 20(1) 1 
C17 12664(3) 7205(2) -347(1) 24(1) 1 
C18 12960(3) 5988(2) -481(1) 22(1) 1 
C19 12721(3) 5384(2) 122(1) 22(1) 1 
C20 12211(2) 6009(2) 864(1) 19(1) 1 
C21 11194(2) 8187(2) 3119(1) 13(1) 1 
C22 11212(2) 7776(2) 3861(1) 14(1) 1 
C23 10266(2) 8209(2) 4539(1) 18(1) 1 
C24 10383(3) 7409(2) 5055(1) 21(1) 1 
C25 11372(2) 6486(2) 4702(1) 20(1) 1 
C26 11887(2) 6704(2) 3964(1) 16(1) 1 
C27 7162(2) 5908(2) 2721(1) 16(1) 1 
C28 6292(2) 6249(2) 3428(1) 19(1) 1 
C29 6424(2) 5360(2) 3876(1) 21(1) 1 
C30 7397(2) 4477(2) 3453(1) 18(1) 1 
C31 7852(2) 4815(2) 2738(1) 17(1) 1 
Fe1 9039(1) 6327(1) 3836(1) 12(1) 1 
N1 4324(2) 11541(1) 4189(1) 17(1) 1 
N2 9783(2) 9554(1) 1608(1) 12(1) 1 
N3 10498(2) 9075(1) 2938(1) 13(1) 1 
O1 4102(2) 12626(1) 4258(1) 24(1) 1 
O2 4005(2) 10976(1) 4699(1) 26(1) 1 
O3 7034(2) 9544(1) 584(1) 18(1) 1 
O4 7056(2) 7643(1) 1082(1) 19(1) 1 
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O5 11831(2) 7448(1) 2469(1) 13(1) 1 
S1 7467(1) 9007(1) 1240(1) 13(1) 1 
  
 
 
Table 3. Bond lengths [Å] and angles [°]. 
  
C1-C2 1.381(2) 
C1-C6 1.382(2) 
C1-N1 1.481(2) 
C2-C3 1.391(2) 
C2-H2 0.9500 
C3-C4 1.387(2) 
C3-H3 0.9500 
C4-C5 1.393(2) 
C4-S1 1.7777(16) 
C5-C6 1.385(2) 
C5-H5 0.9500 
C6-H6 0.9500 
C7-C12 1.387(2) 
C7-C8 1.387(2) 
C7-N2 1.457(2) 
C8-C9 1.388(2) 
C8-H8 0.9500 
C9-C10 1.389(2) 
C9-H9 0.9500 
C10-C11 1.389(3) 
C10-H10 0.9500 
C11-C12 1.388(2) 
C11-H11 0.9500 
C12-H12 0.9500 
C13-C14 1.351(2) 
C13-N3 1.393(2) 
C13-N2 1.421(2) 
C14-O5 1.3828(19) 
C14-C15 1.461(2) 
C15-C16 1.394(2) 
C15-C20 1.395(2) 
C16-C17 1.385(2) 
C16-H16 0.9500 
C17-C18 1.380(3) 
C17-H17 0.9500 
C18-C19 1.383(3) 
C18-H18 0.9500 
C19-C20 1.384(2) 
C19-H19 0.9500 
C20-H20 0.9500 
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C21-N3 1.297(2) 
C21-O5 1.3668(19) 
C21-C22 1.450(2) 
C22-C26 1.432(2) 
C22-C23 1.434(2) 
C22-Fe1 2.0297(16) 
C23-C24 1.420(3) 
C23-Fe1 2.0374(17) 
C23-H23 0.9500 
C24-C25 1.420(3) 
C24-Fe1 2.0465(18) 
C24-H24 0.9500 
C25-C26 1.419(2) 
C25-Fe1 2.0474(18) 
C25-H25 0.9500 
C26-Fe1 2.0375(17) 
C26-H26 0.9500 
C27-C31 1.421(2) 
C27-C28 1.421(2) 
C27-Fe1 2.0500(17) 
C27-H27 0.9500 
C28-C29 1.420(3) 
C28-Fe1 2.0360(18) 
C28-H28 0.9500 
C29-C30 1.419(3) 
C29-Fe1 2.0428(17) 
C29-H29 0.9500 
C30-C31 1.423(2) 
C30-Fe1 2.0456(17) 
C30-H30 0.9500 
C31-Fe1 2.0497(17) 
C31-H31 0.9500 
N1-O2 1.2233(19) 
N1-O1 1.2304(19) 
N2-S1 1.6672(14) 
O3-S1 1.4292(12) 
O4-S1 1.4302(12) 
 
C2-C1-C6 123.66(15) 
C2-C1-N1 118.15(15) 
C6-C1-N1 118.19(14) 
C1-C2-C3 118.04(16) 
C1-C2-H2 121.0 
C3-C2-H2 121.0 
C4-C3-C2 119.24(15) 
C4-C3-H3 120.4 
C2-C3-H3 120.4 
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C3-C4-C5 121.64(15) 
C3-C4-S1 119.11(12) 
C5-C4-S1 119.19(13) 
C6-C5-C4 119.44(16) 
C6-C5-H5 120.3 
C4-C5-H5 120.3 
C1-C6-C5 117.94(15) 
C1-C6-H6 121.0 
C5-C6-H6 121.0 
C12-C7-C8 121.04(15) 
C12-C7-N2 118.31(14) 
C8-C7-N2 120.63(14) 
C7-C8-C9 119.19(15) 
C7-C8-H8 120.4 
C9-C8-H8 120.4 
C8-C9-C10 120.33(16) 
C8-C9-H9 119.8 
C10-C9-H9 119.8 
C9-C10-C11 119.89(16) 
C9-C10-H10 120.1 
C11-C10-H10 120.1 
C12-C11-C10 120.19(16) 
C12-C11-H11 119.9 
C10-C11-H11 119.9 
C7-C12-C11 119.34(16) 
C7-C12-H12 120.3 
C11-C12-H12 120.3 
C14-C13-N3 110.92(14) 
C14-C13-N2 126.69(14) 
N3-C13-N2 122.01(14) 
C13-C14-O5 106.25(14) 
C13-C14-C15 137.52(15) 
O5-C14-C15 116.22(14) 
C16-C15-C20 119.24(15) 
C16-C15-C14 120.89(15) 
C20-C15-C14 119.87(15) 
C17-C16-C15 119.76(17) 
C17-C16-H16 120.1 
C15-C16-H16 120.1 
C18-C17-C16 120.66(17) 
C18-C17-H17 119.7 
C16-C17-H17 119.7 
C17-C18-C19 119.95(16) 
C17-C18-H18 120.0 
C19-C18-H18 120.0 
C18-C19-C20 119.98(17) 
C18-C19-H19 120.0 
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C20-C19-H19 120.0 
C19-C20-C15 120.39(16) 
C19-C20-H20 119.8 
C15-C20-H20 119.8 
N3-C21-O5 114.13(14) 
N3-C21-C22 129.83(15) 
O5-C21-C22 115.66(14) 
C26-C22-C23 108.07(15) 
C26-C22-C21 125.08(15) 
C23-C22-C21 125.96(16) 
C26-C22-Fe1 69.68(9) 
C23-C22-Fe1 69.65(9) 
C21-C22-Fe1 117.93(11) 
C24-C23-C22 107.31(16) 
C24-C23-Fe1 69.99(10) 
C22-C23-Fe1 69.07(9) 
C24-C23-H23 126.3 
C22-C23-H23 126.3 
Fe1-C23-H23 126.2 
C25-C24-C23 108.66(15) 
C25-C24-Fe1 69.75(10) 
C23-C24-Fe1 69.30(10) 
C25-C24-H24 125.7 
C23-C24-H24 125.7 
Fe1-C24-H24 126.9 
C26-C25-C24 108.28(16) 
C26-C25-Fe1 69.30(10) 
C24-C25-Fe1 69.67(10) 
C26-C25-H25 125.9 
C24-C25-H25 125.9 
Fe1-C25-H25 126.7 
C25-C26-C22 107.67(15) 
C25-C26-Fe1 70.05(10) 
C22-C26-Fe1 69.10(9) 
C25-C26-H26 126.2 
C22-C26-H26 126.2 
Fe1-C26-H26 126.3 
C31-C27-C28 107.83(15) 
C31-C27-Fe1 69.71(10) 
C28-C27-Fe1 69.12(10) 
C31-C27-H27 126.1 
C28-C27-H27 126.1 
Fe1-C27-H27 126.7 
C29-C28-C27 108.14(15) 
C29-C28-Fe1 69.89(10) 
C27-C28-Fe1 70.18(10) 
C29-C28-H28 125.9 
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C27-C28-H28 125.9 
Fe1-C28-H28 125.6 
C30-C29-C28 108.03(15) 
C30-C29-Fe1 69.79(10) 
C28-C29-Fe1 69.37(10) 
C30-C29-H29 126.0 
C28-C29-H29 126.0 
Fe1-C29-H29 126.4 
C29-C30-C31 107.93(15) 
C29-C30-Fe1 69.58(9) 
C31-C30-Fe1 69.83(9) 
C29-C30-H30 126.0 
C31-C30-H30 126.0 
Fe1-C30-H30 126.1 
C27-C31-C30 108.06(15) 
C27-C31-Fe1 69.73(9) 
C30-C31-Fe1 69.52(9) 
C27-C31-H31 126.0 
C30-C31-H31 126.0 
Fe1-C31-H31 126.4 
C22-Fe1-C28 123.53(7) 
C22-Fe1-C23 41.28(7) 
C28-Fe1-C23 105.70(7) 
C22-Fe1-C26 41.22(7) 
C28-Fe1-C26 161.48(7) 
C23-Fe1-C26 69.38(7) 
C22-Fe1-C29 160.93(7) 
C28-Fe1-C29 40.74(7) 
C23-Fe1-C29 123.84(7) 
C26-Fe1-C29 156.62(7) 
C22-Fe1-C30 156.38(7) 
C28-Fe1-C30 68.50(7) 
C23-Fe1-C30 161.67(7) 
C26-Fe1-C30 121.57(7) 
C29-Fe1-C30 40.63(7) 
C22-Fe1-C24 68.66(7) 
C28-Fe1-C24 120.05(8) 
C23-Fe1-C24 40.71(7) 
C26-Fe1-C24 68.56(7) 
C29-Fe1-C24 107.75(7) 
C30-Fe1-C24 125.87(7) 
C22-Fe1-C25 68.73(7) 
C28-Fe1-C25 155.83(7) 
C23-Fe1-C25 68.78(8) 
C26-Fe1-C25 40.65(7) 
C29-Fe1-C25 121.55(7) 
C30-Fe1-C25 108.97(7) 
 147 
 
C24-Fe1-C25 40.58(8) 
C22-Fe1-C31 120.50(7) 
C28-Fe1-C31 68.41(7) 
C23-Fe1-C31 155.17(7) 
C26-Fe1-C31 108.14(7) 
C29-Fe1-C31 68.33(7) 
C30-Fe1-C31 40.66(7) 
C24-Fe1-C31 163.19(7) 
C25-Fe1-C31 126.35(7) 
C22-Fe1-C27 106.45(7) 
C28-Fe1-C27 40.70(7) 
C23-Fe1-C27 119.32(7) 
C26-Fe1-C27 124.94(7) 
C29-Fe1-C27 68.39(7) 
C30-Fe1-C27 68.38(7) 
C24-Fe1-C27 154.86(8) 
C25-Fe1-C27 162.67(7) 
C31-Fe1-C27 40.56(7) 
O2-N1-O1 124.29(14) 
O2-N1-C1 118.05(14) 
O1-N1-C1 117.65(14) 
C13-N2-C7 119.11(13) 
C13-N2-S1 116.20(10) 
C7-N2-S1 117.05(11) 
C21-N3-C13 103.63(13) 
C21-O5-C14 105.03(12) 
O3-S1-O4 121.92(7) 
O3-S1-N2 106.17(7) 
O4-S1-N2 105.92(7) 
O3-S1-C4 107.45(8) 
O4-S1-C4 108.41(7) 
N2-S1-C4 105.94(7) 
  
Symmetry transformations used to generate equivalent atoms:  
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Table 4. Anisotropic displacement parameters [Å2´ 103]. The anisotropic displacement 
factor exponent takes the form: -2p 2[h2a*2U11 + ... + 2 h k a* b* U12 ]. 
 
Atom U11 U22 U33 U23 U13 U12 
 
C1 11(1)  16(1) 12(1)  1(1) 3(1)  2(1) 
C2 11(1)  13(1) 19(1)  6(1) 3(1)  3(1) 
C3 13(1)  16(1) 15(1)  7(1) 4(1)  3(1) 
C4 10(1)  14(1) 13(1)  3(1) 2(1)  1(1) 
C5 14(1)  13(1) 20(1)  6(1) 4(1)  4(1) 
C6 15(1)  17(1) 15(1)  8(1) 3(1)  3(1) 
C7 10(1)  12(1) 16(1)  6(1) 2(1)  5(1) 
C8 14(1)  17(1) 16(1)  6(1) 4(1)  6(1) 
C9 19(1)  16(1) 19(1)  1(1) 1(1)  8(1) 
C10 21(1)  12(1) 26(1)  8(1) 0(1)  4(1) 
C11 22(1)  21(1) 22(1)  14(1) 5(1)  5(1) 
C12 18(1)  18(1) 14(1)  6(1) 3(1)  6(1) 
C13 11(1)  12(1) 13(1)  5(1) 3(1)  1(1) 
C14 12(1)  14(1) 14(1)  8(1) 2(1)  1(1) 
C15 12(1)  14(1) 14(1)  3(1) 2(1)  4(1) 
C16 26(1)  20(1) 19(1)  8(1) 8(1)  10(1) 
C17 32(1)  30(1) 18(1)  12(1) 10(1)  13(1) 
C18 23(1)  28(1) 13(1)  0(1) 4(1)  10(1) 
C19 26(1)  18(1) 21(1)  3(1) 5(1)  12(1) 
C20 25(1)  18(1) 18(1)  8(1) 6(1)  9(1) 
C21 10(1)  14(1) 14(1)  2(1) 4(1)  -1(1) 
C22 11(1)  14(1) 14(1)  4(1) 1(1)  -2(1) 
C23 20(1)  14(1) 14(1)  0(1) 3(1)  -2(1) 
C24 26(1)  22(1) 9(1)  2(1) 2(1)  -4(1) 
C25 20(1)  22(1) 16(1)  10(1) -2(1)  -1(1) 
C26 12(1)  21(1) 15(1)  7(1) 1(1)  2(1) 
C27 14(1)  15(1) 15(1)  4(1) -1(1)  1(1) 
C28 13(1)  16(1) 26(1)  4(1) 5(1)  4(1) 
C29 15(1)  21(1) 22(1)  6(1) 6(1)  -4(1) 
C30 21(1)  13(1) 17(1)  5(1) -1(1)  -1(1) 
C31 19(1)  14(1) 13(1)  0(1) -1(1)  2(1) 
Fe1 13(1)  12(1) 11(1)  3(1) 3(1)  2(1) 
N1 14(1)  21(1) 14(1)  3(1) 3(1)  5(1) 
N2 11(1)  12(1) 13(1)  4(1) 2(1)  3(1) 
N3 12(1)  13(1) 12(1)  4(1) 3(1)  2(1) 
O1 31(1)  21(1) 22(1)  4(1) 9(1)  14(1) 
O2 35(1)  32(1) 18(1)  11(1) 13(1)  12(1) 
O3 17(1)  26(1) 12(1)  6(1) 3(1)  7(1) 
O4 17(1)  14(1) 21(1)  1(1) 4(1)  2(1) 
O5 14(1)  14(1) 13(1)  5(1) 5(1)  5(1) 
S1 12(1)  14(1) 12(1)  2(1) 3(1)  4(1) 
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Table 5. Hydrogen coordinates [´ 104] and isotropic displacement parameters [Å2 ´ 103]. 
 
Atom  x y z Ueq S.o.f. 
 
H2 4609 12143 2813 17 1 
H3 5801 11119 1636 17 1 
H5 6749 8430 2720 18 1 
H6 5572 9453 3897 18 1 
H8 10093 11510 3000 18 1 
H9 11483 13707 3295 22 1 
H10 12819 14418 2279 24 1 
H11 12706 12939 953 24 1 
H12 11289 10744 648 20 1 
H16 11969 8684 483 24 1 
H17 12807 7610 -768 29 1 
H18 13327 5565 -987 27 1 
H19 12906 4541 27 26 1 
H20 12044 5591 1276 23 1 
H23 9672 8901 4627 22 1 
H24 9883 7480 5553 26 1 
H25 11642 5835 4923 24 1 
H26 12559 6225 3603 19 1 
H27 7264 6334 2310 19 1 
H28 5720 6950 3576 22 1 
H29 5945 5357 4372 25 1 
H30 7691 3783 3618 22 1 
H31 8503 4385 2342 20 1 
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Fc-oxazole 1c: 
Table 1. Crystal data and structure refinement details. 
  
Identification code  2012ncs0117 (MFB 125 F2) 
Empirical formula  C29H27FeN3O5S 
Formula weight  585.45 
Temperature  100(2) K 
Wavelength  0.71075 Å 
Crystal system  Triclinic 
Space group  P-1  
Unit cell dimensions a = 7.5361(2) Å a = 101.502(7)° 
 b = 11.3993(3) Å b = 98.011(7)° 
 c = 15.8905(11) Å g  = 101.244(7)° 
Volume 1289.24(10) Å3 
Z 2 
Density (calculated) 1.508 Mg / m3 
Absorption coefficient 0.713 mm-1 
F(000) 608 
Crystal Block; Red 
Crystal size 0.15 ´ 0.15 ´ 0.09 mm3 
q range for data collection 3.31 - 27.48° 
Index ranges -7 £ h £ 9, -14 £ k £ 14, -20 £ l £ 20 
Reflections collected 17297 
Independent reflections 5850 [Rint = 0.0345] 
Completeness to q = 27.48° 98.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9386 and 0.9006 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5850 / 0 / 353 
Goodness-of-fit on F2 1.088 
Final R indices [F2 > 2s(F2)] R1 = 0.0289, wR2 = 0.0789 
R indices (all data) R1 = 0.0319, wR2 = 0.0806 
Largest diff. peak and hole 0.377 and -0.349 e Å-3 
 
 
  
Diffractometer: AFC12 (Right): Kappa 3 circle with Rigaku Saturn724+ (2x2 bin mode) 
detector (profile data from \w-scans Cell determination: CrystalClear-SM Expert 2.0 r7 
(Rigaku, 2011) Data collection: CrystalClear-SM Expert 2.0 r7 (Rigaku, 2011) Data 
reduction and cell refinement: CrystalClear-SM Expert 2.0 r7 (Rigaku, 2011) Absorption 
correction: CrystalClear-SM Expert 2.0 r7 (Rigaku, 2011) Structure solution: SHELXS97 
(Sheldrick, G.M. (2008). Acta Cryst. A64, 112-122.) Structure refinement: SHELXL97 (G 
Sheldrick, G.M. (2008). Acta Cryst. A64, 112-122.). 
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Table 2. Atomic coordinates [´ 104], equivalent isotropic displacement parameters [Å2 ´ 103] 
and site occupancy factors. Ueq is defined as one third of the trace of the orthogonalized Uij 
tensor. 
 
Atom  x y z Ueq S.o.f. 
 
C1 4826(2) 3727(1) 1471(1) 14(1) 1 
C2 4715(2) 3138(1) 2152(1) 15(1) 1 
C3 3930(2) 3634(1) 2838(1) 15(1) 1 
C4 3285(2) 4690(1) 2822(1) 13(1) 1 
C5 3431(2) 5278(1) 2135(1) 16(1) 1 
C6 4211(2) 4789(1) 1447(1) 16(1) 1 
C7 -890(2) 3531(1) 3193(1) 13(1) 1 
C8 -873(2) 2682(1) 2437(1) 17(1) 1 
C9 -1736(2) 1457(1) 2334(1) 23(1) 1 
C10 -2611(2) 1089(1) 2979(1) 26(1) 1 
C11 -2620(2) 1947(2) 3735(1) 24(1) 1 
C12 -1751(2) 3170(1) 3846(1) 18(1) 1 
C13 -873(2) 5537(1) 2811(1) 13(1) 1 
C14 -1818(2) 6366(1) 3112(1) 13(1) 1 
C15 -2352(2) 6824(1) 3956(1) 16(1) 1 
C16 -1054(2) 8047(1) 4459(1) 19(1) 1 
C17 -1626(2) 8599(1) 5308(1) 19(1) 1 
C18 -3300(2) 9140(2) 5150(1) 30(1) 1 
C19 -1417(2) 6419(1) 1789(1) 13(1) 1 
C20 -1347(2) 7014(1) 1066(1) 15(1) 1 
C21 -292(2) 6792(1) 392(1) 19(1) 1 
C22 -347(2) 7721(1) -84(1) 22(1) 1 
C23 -1415(2) 8513(2) 286(1) 21(1) 1 
C24 -2034(2) 8087(1) 999(1) 17(1) 1 
C25 2471(2) 8662(1) 2368(1) 18(1) 1 
C26 3449(2) 8518(1) 1666(1) 20(1) 1 
C27 3356(2) 9500(1) 1245(1) 22(1) 1 
C28 2298(2) 10248(1) 1682(1) 20(1) 1 
C29 1759(2) 9731(1) 2378(1) 19(1) 1 
Fe1 772(1) 8489(1) 1200(1) 12(1) 1 
N1 5628(2) 3186(1) 734(1) 18(1) 1 
N2 -44(2) 4818(1) 3308(1) 13(1) 1 
N3 -655(2) 5549(1) 1955(1) 14(1) 1 
O1 5994(2) 3802(1) 204(1) 26(1) 1 
O2 5886(2) 2149(1) 691(1) 27(1) 1 
O3 2599(1) 4688(1) 4371(1) 18(1) 1 
O4 2632(1) 6592(1) 3826(1) 18(1) 1 
O5 -2195(1) 6950(1) 2450(1) 14(1) 1 
S1 2200(1) 5280(1) 3679(1) 13(1) 1 
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Table 3. Bond lengths [Å] and angles [°]. 
  
C1-C6 1.384(2) 
C1-C2 1.385(2) 
C1-N1 1.4734(17) 
C2-C3 1.3871(19) 
C2-H2 0.9500 
C3-C4 1.3863(19) 
C3-H3 0.9500 
C4-C5 1.3957(19) 
C4-S1 1.7710(14) 
C5-C6 1.3835(19) 
C5-H5 0.9500 
C6-H6 0.9500 
C7-C12 1.3854(19) 
C7-C8 1.3872(19) 
C7-N2 1.4453(17) 
C8-C9 1.388(2) 
C8-H8 0.9500 
C9-C10 1.383(2) 
C9-H9 0.9500 
C10-C11 1.391(2) 
C10-H10 0.9500 
C11-C12 1.385(2) 
C11-H11 0.9500 
C12-H12 0.9500 
C13-C14 1.3443(19) 
C13-N3 1.3947(17) 
C13-N2 1.4157(17) 
C14-O5 1.3790(16) 
C14-C15 1.4781(18) 
C15-C16 1.531(2) 
C15-H15A 0.9900 
C15-H15B 0.9900 
C16-C17 1.5273(19) 
C16-H16A 0.9900 
C16-H16B 0.9900 
C17-C18 1.521(2) 
C17-H17A 0.9900 
C17-H17B 0.9900 
C18-H18A 0.9800 
C18-H18B 0.9800 
C18-H18C 0.9800 
C19-N3 1.2916(18) 
C19-O5 1.3676(16) 
C19-C20 1.4481(19) 
C20-C21 1.4329(19) 
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C20-C24 1.435(2) 
C20-Fe1 2.0339(14) 
C21-C22 1.422(2) 
C21-Fe1 2.0377(14) 
C21-H21 0.9500 
C22-C23 1.419(2) 
C22-Fe1 2.0409(14) 
C22-H22 0.9500 
C23-C24 1.420(2) 
C23-Fe1 2.0482(15) 
C23-H23 0.9500 
C24-Fe1 2.0396(14) 
C24-H24 0.9500 
C25-C26 1.420(2) 
C25-C29 1.422(2) 
C25-Fe1 2.0533(14) 
C25-H25 0.9500 
C26-C27 1.423(2) 
C26-Fe1 2.0416(15) 
C26-H26 0.9500 
C27-C28 1.424(2) 
C27-Fe1 2.0442(15) 
C27-H27 0.9500 
C28-C29 1.425(2) 
C28-Fe1 2.0423(15) 
C28-H28 0.9500 
C29-Fe1 2.0509(14) 
C29-H29 0.9500 
N1-O1 1.2251(17) 
N1-O2 1.2260(17) 
N2-S1 1.6534(12) 
O3-S1 1.4290(10) 
O4-S1 1.4298(11) 
 
C6-C1-C2 123.26(13) 
C6-C1-N1 118.55(12) 
C2-C1-N1 118.19(12) 
C1-C2-C3 118.21(13) 
C1-C2-H2 120.9 
C3-C2-H2 120.9 
C4-C3-C2 119.41(13) 
C4-C3-H3 120.3 
C2-C3-H3 120.3 
C3-C4-C5 121.51(12) 
C3-C4-S1 119.08(10) 
C5-C4-S1 119.39(11) 
C6-C5-C4 119.46(13) 
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C6-C5-H5 120.3 
C4-C5-H5 120.3 
C5-C6-C1 118.13(13) 
C5-C6-H6 120.9 
C1-C6-H6 120.9 
C12-C7-C8 120.90(13) 
C12-C7-N2 118.50(12) 
C8-C7-N2 120.58(12) 
C7-C8-C9 119.40(14) 
C7-C8-H8 120.3 
C9-C8-H8 120.3 
C10-C9-C8 120.16(15) 
C10-C9-H9 119.9 
C8-C9-H9 119.9 
C9-C10-C11 119.98(14) 
C9-C10-H10 120.0 
C11-C10-H10 120.0 
C12-C11-C10 120.26(15) 
C12-C11-H11 119.9 
C10-C11-H11 119.9 
C11-C12-C7 119.29(14) 
C11-C12-H12 120.4 
C7-C12-H12 120.4 
C14-C13-N3 111.05(12) 
C14-C13-N2 125.53(12) 
N3-C13-N2 123.17(12) 
C13-C14-O5 106.40(11) 
C13-C14-C15 135.81(13) 
O5-C14-C15 117.53(11) 
C14-C15-C16 111.31(11) 
C14-C15-H15A 109.4 
C16-C15-H15A 109.4 
C14-C15-H15B 109.4 
C16-C15-H15B 109.4 
H15A-C15-H15B 108.0 
C17-C16-C15 113.17(12) 
C17-C16-H16A 108.9 
C15-C16-H16A 108.9 
C17-C16-H16B 108.9 
C15-C16-H16B 108.9 
H16A-C16-H16B 107.8 
C18-C17-C16 112.51(13) 
C18-C17-H17A 109.1 
C16-C17-H17A 109.1 
C18-C17-H17B 109.1 
C16-C17-H17B 109.1 
H17A-C17-H17B 107.8 
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C17-C18-H18A 109.5 
C17-C18-H18B 109.5 
H18A-C18-H18B 109.5 
C17-C18-H18C 109.5 
H18A-C18-H18C 109.5 
H18B-C18-H18C 109.5 
N3-C19-O5 114.35(12) 
N3-C19-C20 129.35(13) 
O5-C19-C20 115.70(12) 
C21-C20-C24 107.91(12) 
C21-C20-C19 126.04(13) 
C24-C20-C19 125.06(13) 
C21-C20-Fe1 69.54(8) 
C24-C20-Fe1 69.59(8) 
C19-C20-Fe1 117.57(9) 
C22-C21-C20 107.39(13) 
C22-C21-Fe1 69.72(8) 
C20-C21-Fe1 69.25(8) 
C22-C21-H21 126.3 
C20-C21-H21 126.3 
Fe1-C21-H21 126.3 
C23-C22-C21 108.76(13) 
C23-C22-Fe1 69.98(8) 
C21-C22-Fe1 69.48(8) 
C23-C22-H22 125.6 
C21-C22-H22 125.6 
Fe1-C22-H22 126.5 
C22-C23-C24 108.18(13) 
C22-C23-Fe1 69.42(9) 
C24-C23-Fe1 69.35(8) 
C22-C23-H23 125.9 
C24-C23-H23 125.9 
Fe1-C23-H23 126.9 
C23-C24-C20 107.76(13) 
C23-C24-Fe1 70.00(8) 
C20-C24-Fe1 69.16(8) 
C23-C24-H24 126.1 
C20-C24-H24 126.1 
Fe1-C24-H24 126.3 
C26-C25-C29 107.88(13) 
C26-C25-Fe1 69.26(8) 
C29-C25-Fe1 69.64(8) 
C26-C25-H25 126.1 
C29-C25-H25 126.1 
Fe1-C25-H25 126.6 
C25-C26-C27 108.26(13) 
C25-C26-Fe1 70.15(8) 
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C27-C26-Fe1 69.71(9) 
C25-C26-H26 125.9 
C27-C26-H26 125.9 
Fe1-C26-H26 125.8 
C26-C27-C28 107.86(13) 
C26-C27-Fe1 69.52(8) 
C28-C27-Fe1 69.54(8) 
C26-C27-H27 126.1 
C28-C27-H27 126.1 
Fe1-C27-H27 126.4 
C27-C28-C29 107.88(13) 
C27-C28-Fe1 69.68(8) 
C29-C28-Fe1 69.96(8) 
C27-C28-H28 126.1 
C29-C28-H28 126.1 
Fe1-C28-H28 125.9 
C25-C29-C28 108.12(13) 
C25-C29-Fe1 69.82(8) 
C28-C29-Fe1 69.31(8) 
C25-C29-H29 125.9 
C28-C29-H29 125.9 
Fe1-C29-H29 126.5 
C20-Fe1-C21 41.21(6) 
C20-Fe1-C24 41.26(6) 
C21-Fe1-C24 69.32(6) 
C20-Fe1-C22 68.74(6) 
C21-Fe1-C22 40.80(6) 
C24-Fe1-C22 68.59(6) 
C20-Fe1-C26 123.44(6) 
C21-Fe1-C26 105.73(6) 
C24-Fe1-C26 161.41(6) 
C22-Fe1-C26 120.08(7) 
C20-Fe1-C28 156.96(6) 
C21-Fe1-C28 161.03(6) 
C24-Fe1-C28 121.74(6) 
C22-Fe1-C28 125.09(6) 
C26-Fe1-C28 68.59(6) 
C20-Fe1-C27 160.47(6) 
C21-Fe1-C27 123.30(6) 
C24-Fe1-C27 156.78(6) 
C22-Fe1-C27 107.15(6) 
C26-Fe1-C27 40.77(6) 
C28-Fe1-C27 40.78(6) 
C20-Fe1-C23 68.80(6) 
C21-Fe1-C23 68.82(6) 
C24-Fe1-C23 40.66(6) 
C22-Fe1-C23 40.60(6) 
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C26-Fe1-C23 155.89(6) 
C28-Fe1-C23 108.54(6) 
C27-Fe1-C23 121.32(6) 
C20-Fe1-C29 121.11(6) 
C21-Fe1-C29 155.77(6) 
C24-Fe1-C29 108.44(6) 
C22-Fe1-C29 162.63(7) 
C26-Fe1-C29 68.31(6) 
C28-Fe1-C29 40.74(6) 
C27-Fe1-C29 68.43(6) 
C23-Fe1-C29 126.13(6) 
C20-Fe1-C25 106.83(6) 
C21-Fe1-C25 119.74(6) 
C24-Fe1-C25 125.13(6) 
C22-Fe1-C25 155.17(7) 
C26-Fe1-C25 40.59(6) 
C28-Fe1-C25 68.49(6) 
C27-Fe1-C25 68.43(6) 
C23-Fe1-C25 162.60(6) 
C29-Fe1-C25 40.55(6) 
O1-N1-O2 124.22(12) 
O1-N1-C1 117.98(12) 
O2-N1-C1 117.80(12) 
C13-N2-C7 120.03(11) 
C13-N2-S1 117.26(9) 
C7-N2-S1 118.01(9) 
C19-N3-C13 103.33(11) 
C19-O5-C14 104.80(10) 
O3-S1-O4 121.10(6) 
O3-S1-N2 106.56(6) 
O4-S1-N2 106.41(6) 
O3-S1-C4 107.34(6) 
O4-S1-C4 107.97(6) 
N2-S1-C4 106.65(6) 
  
Symmetry transformations used to generate equivalent atoms:  
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Table 4. Anisotropic displacement parameters [Å2´ 103]. The anisotropic displacement 
factor exponent takes the form: -2p 2[h2a*2U11 + ... + 2 h k a* b* U12 ]. 
 
Atom U11 U22 U33 U23 U13 U12 
 
C1 11(1)  18(1) 13(1)  1(1) 2(1)  2(1) 
C2 13(1)  14(1) 18(1)  4(1) 3(1)  3(1) 
C3 13(1)  17(1) 16(1)  7(1) 3(1)  3(1) 
C4 10(1)  15(1) 13(1)  2(1) 2(1)  2(1) 
C5 14(1)  15(1) 19(1)  6(1) 3(1)  4(1) 
C6 15(1)  19(1) 15(1)  7(1) 3(1)  2(1) 
C7 12(1)  13(1) 14(1)  4(1) 2(1)  4(1) 
C8 15(1)  19(1) 18(1)  1(1) 2(1)  6(1) 
C9 20(1)  17(1) 28(1)  -2(1) -2(1)  7(1) 
C10 21(1)  14(1) 37(1)  9(1) -6(1)  0(1) 
C11 21(1)  26(1) 27(1)  15(1) 0(1)  0(1) 
C12 18(1)  22(1) 15(1)  6(1) 3(1)  4(1) 
C13 13(1)  12(1) 12(1)  3(1) 2(1)  1(1) 
C14 14(1)  13(1) 14(1)  4(1) 3(1)  2(1) 
C15 18(1)  16(1) 15(1)  4(1) 7(1)  5(1) 
C16 17(1)  21(1) 17(1)  0(1) 4(1)  2(1) 
C17 21(1)  20(1) 16(1)  0(1) 4(1)  6(1) 
C18 27(1)  32(1) 30(1)  -2(1) 6(1)  12(1) 
C19 11(1)  14(1) 13(1)  1(1) 3(1)  0(1) 
C20 13(1)  16(1) 13(1)  2(1) 0(1)  -1(1) 
C21 22(1)  16(1) 13(1)  -2(1) 3(1)  -1(1) 
C22 27(1)  24(1) 10(1)  3(1) 2(1)  -4(1) 
C23 20(1)  23(1) 18(1)  9(1) -3(1)  -1(1) 
C24 12(1)  22(1) 18(1)  7(1) 0(1)  2(1) 
C25 17(1)  17(1) 18(1)  4(1) -2(1)  1(1) 
C26 13(1)  19(1) 27(1)  3(1) 2(1)  3(1) 
C27 16(1)  22(1) 24(1)  4(1) 5(1)  -3(1) 
C28 23(1)  13(1) 21(1)  2(1) -2(1)  0(1) 
C29 22(1)  19(1) 13(1)  -2(1) -1(1)  5(1) 
Fe1 13(1)  13(1) 10(1)  2(1) 3(1)  1(1) 
N1 15(1)  25(1) 14(1)  2(1) 2(1)  6(1) 
N2 12(1)  12(1) 14(1)  3(1) 2(1)  2(1) 
N3 14(1)  15(1) 13(1)  2(1) 3(1)  1(1) 
O1 31(1)  33(1) 19(1)  10(1) 12(1)  10(1) 
O2 33(1)  27(1) 23(1)  2(1) 8(1)  16(1) 
O3 19(1)  25(1) 12(1)  5(1) 3(1)  7(1) 
O4 16(1)  16(1) 20(1)  0(1) 2(1)  2(1) 
O5 14(1)  15(1) 14(1)  5(1) 4(1)  5(1) 
S1 12(1)  15(1) 12(1)  2(1) 2(1)  3(1) 
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Table 5. Hydrogen coordinates [´ 104] and isotropic displacement parameters [Å2 ´ 103]. 
 
Atom  x y z Ueq S.o.f. 
 
H2 5164 2415 2148 18 1 
H3 3835 3254 3315 18 1 
H5 2997 6007 2140 19 1 
H6 4322 5173 972 19 1 
H8 -277 2938 1993 21 1 
H9 -1724 869 1820 28 1 
H10 -3206 250 2906 31 1 
H11 -3224 1693 4176 29 1 
H12 -1745 3756 4364 22 1 
H15A -2323 6207 4313 19 1 
H15B -3626 6938 3848 19 1 
H16A 205 7915 4596 23 1 
H16B -1017 8641 4081 23 1 
H17A -1906 7952 5634 23 1 
H17B -585 9252 5674 23 1 
H18A -3047 9761 4809 45 1 
H18B -3571 9524 5712 45 1 
H18C -4362 8485 4828 45 1 
H21 331 6144 283 22 1 
H22 235 7798 -570 26 1 
H23 -1672 9208 90 25 1 
H24 -2772 8448 1366 21 1 
H25 2320 8138 2761 22 1 
H26 4061 7876 1506 24 1 
H27 3902 9634 758 26 1 
H28 2004 10964 1535 25 1 
H29 1047 10046 2780 23 1 
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Ylide 2: 
 
 
Table 1. Crystal data and structure refinement details. 
  
Identification code  2012ncs0118 (MFB 127 Ylide)     
Empirical formula  C16H16FeN2O2 
Formula weight  324.16 
Temperature  120(2) K 
Wavelength  0.71075 Å 
Crystal system  Monoclinic 
Space group  P21/c  
Unit cell dimensions a = 13.1358(3) Å a = 90° 
 b = 7.33560(10) Å b = 103.668(7)° 
 c = 15.2031(10) Å g  = 90° 
Volume 1423.47(10) Å3 
Z 4 
Density (calculated) 1.513 Mg / m3 
Absorption coefficient 1.064 mm-1 
F(000) 672 
Crystal Fragment; orange 
Crystal size 0.50 ´ 0.30 ´ 0.10 mm3 
q range for data collection 3.10 - 25.00° 
Index ranges -15 £ h £ 15, -8 £ k £ 8, -18 £ l £ 17 
Reflections collected 6705 
Independent reflections 2463 [Rint = 0.0160] 
Completeness to q = 25.00° 98.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9010 and 0.6181 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2463 / 3 / 196 
Goodness-of-fit on F2 1.091 
Final R indices [F2 > 2s(F2)] R1 = 0.0223, wR2 = 0.0598 
R indices (all data) R1 = 0.0245, wR2 = 0.0610 
Largest diff. peak and hole 0.245 and -0.257 e Å-3 
 
 
  
Diffractometer: Rigaku R-Axis Spider Diffractometer equipped with Rapid image plate  
detector (profile data from \w-scans Cell determination: CrystalClear-SM Expert 2.0 r7 
(Rigaku, 2011) Data collection: CrystalClear-SM Expert 2.0 r7 (Rigaku, 2011) Data 
reduction and cell refinement: CrystalClear-SM Expert 2.0 r7 (Rigaku, 2011) Absorption 
correction: CrystalClear-SM Expert 2.0 r7 (Rigaku, 2011) Structure solution: SHELXS97 
(Sheldrick, G.M. (2008). Acta Cryst. A64, 112-122.) Structure refinement: SHELXL97 (G 
Sheldrick, G.M. (2008). Acta Cryst. A64, 112-122.). 
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Table 2. Atomic coordinates [´ 104], equivalent isotropic displacement parameters [Å2 ´ 103] 
and site occupancy factors. Ueq is defined as one third of the trace of the orthogonalized Uij 
tensor. 
 
Atom  x y z Ueq S.o.f. 
 
C1 1088(1) 4986(2) -2805(1) 21(1) 1 
C2 653(1) 6488(2) -3296(1) 24(1) 1 
C3 927(1) 8219(2) -2963(1) 25(1) 1 
C4 1628(1) 8405(2) -2131(1) 25(1) 1 
C5 2050(1) 6874(2) -1657(1) 23(1) 1 
C6 1973(1) 3268(2) -805(1) 17(1) 1 
C7 2509(1) 1643(2) -327(1) 17(1) 1 
C8 2179(1) 665(2) 368(1) 19(1) 1 
C9 2923(1) -735(2) 692(1) 22(1) 1 
C10 3716(1) -631(2) 192(1) 21(1) 1 
C11 3462(1) 824(2) -438(1) 19(1) 1 
C12 3837(2) 4483(2) 1142(1) 28(1) 1 
C13 3454(2) 3584(3) 1827(1) 29(1) 1 
C14 4184(2) 2224(3) 2212(1) 28(1) 1 
C15 5021(1) 2272(2) 1770(1) 26(1) 1 
C16 4807(1) 3672(2) 1108(1) 26(1) 1 
Fe1 3627(1) 1783(1) 851(1) 15(1) 1 
N1 1778(1) 5203(2) -2003(1) 18(1) 1 
N2 2277(1) 3623(2) -1563(1) 22(1) 1 
O1 1305(1) 4122(2) -494(1) 22(1) 1 
O2 125(1) 2955(2) 727(1) 28(1) 1 
  
 
 
Table 3. Bond lengths [Å] and angles [°]. 
  
C1-N1 1.346(2) 
C1-C2 1.377(2) 
C1-H1 0.9500 
C2-C3 1.382(2) 
C2-H2 0.9500 
C3-C4 1.385(3) 
C3-H3 0.9500 
C4-C5 1.378(2) 
C4-H4 0.9500 
C5-N1 1.349(2) 
C5-H5 0.9500 
C6-O1 1.2578(19) 
C6-N2 1.331(2) 
C6-C7 1.485(2) 
C7-C8 1.426(2) 
C7-C11 1.435(2) 
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C7-Fe1 2.0324(16) 
C8-C9 1.423(2) 
C8-Fe1 2.0422(16) 
C8-H8 0.9500 
C9-C10 1.430(2) 
C9-Fe1 2.0543(16) 
C9-H9 0.9500 
C10-C11 1.420(2) 
C10-Fe1 2.0520(16) 
C10-H10 0.9500 
C11-Fe1 2.0447(16) 
C11-H11 0.9500 
C12-C16 1.418(3) 
C12-C13 1.421(3) 
C12-Fe1 2.0337(17) 
C12-H12 0.9500 
C13-C14 1.412(3) 
C13-Fe1 2.0391(17) 
C13-H13 0.9500 
C14-C15 1.417(3) 
C14-Fe1 2.0514(17) 
C14-H14 0.9500 
C15-C16 1.419(3) 
C15-Fe1 2.0553(17) 
C15-H15 0.9500 
C16-Fe1 2.0464(17) 
C16-H16 0.9500 
N1-N2 1.4189(19) 
O2-H1O 0.839(15) 
O2-H2O 0.816(16) 
 
N1-C1-C2 120.01(16) 
N1-C1-H1 120.0 
C2-C1-H1 120.0 
C1-C2-C3 119.89(16) 
C1-C2-H2 120.1 
C3-C2-H2 120.1 
C2-C3-C4 118.97(16) 
C2-C3-H3 120.5 
C4-C3-H3 120.5 
C5-C4-C3 119.72(16) 
C5-C4-H4 120.1 
C3-C4-H4 120.1 
N1-C5-C4 119.98(16) 
N1-C5-H5 120.0 
C4-C5-H5 120.0 
O1-C6-N2 127.38(15) 
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O1-C6-C7 120.49(14) 
N2-C6-C7 112.12(14) 
C8-C7-C11 107.67(14) 
C8-C7-C6 125.10(14) 
C11-C7-C6 127.17(15) 
C8-C7-Fe1 69.89(9) 
C11-C7-Fe1 69.86(9) 
C6-C7-Fe1 123.44(11) 
C9-C8-C7 108.40(14) 
C9-C8-Fe1 70.13(9) 
C7-C8-Fe1 69.15(9) 
C9-C8-H8 125.8 
C7-C8-H8 125.8 
Fe1-C8-H8 126.5 
C8-C9-C10 107.70(14) 
C8-C9-Fe1 69.21(9) 
C10-C9-Fe1 69.54(9) 
C8-C9-H9 126.2 
C10-C9-H9 126.2 
Fe1-C9-H9 126.7 
C11-C10-C9 108.33(14) 
C11-C10-Fe1 69.44(9) 
C9-C10-Fe1 69.71(9) 
C11-C10-H10 125.8 
C9-C10-H10 125.8 
Fe1-C10-H10 126.6 
C10-C11-C7 107.90(14) 
C10-C11-Fe1 69.99(9) 
C7-C11-Fe1 68.94(9) 
C10-C11-H11 126.0 
C7-C11-H11 126.0 
Fe1-C11-H11 126.6 
C16-C12-C13 107.99(16) 
C16-C12-Fe1 70.15(10) 
C13-C12-Fe1 69.78(10) 
C16-C12-H12 126.0 
C13-C12-H12 126.0 
Fe1-C12-H12 125.7 
C14-C13-C12 107.97(16) 
C14-C13-Fe1 70.28(10) 
C12-C13-Fe1 69.37(10) 
C14-C13-H13 126.0 
C12-C13-H13 126.0 
Fe1-C13-H13 125.9 
C13-C14-C15 108.19(16) 
C13-C14-Fe1 69.34(10) 
C15-C14-Fe1 69.96(10) 
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C13-C14-H14 125.9 
C15-C14-H14 125.9 
Fe1-C14-H14 126.4 
C14-C15-C16 107.99(16) 
C14-C15-Fe1 69.66(10) 
C16-C15-Fe1 69.42(10) 
C14-C15-H15 126.0 
C16-C15-H15 126.0 
Fe1-C15-H15 126.5 
C12-C16-C15 107.86(16) 
C12-C16-Fe1 69.19(10) 
C15-C16-Fe1 70.09(10) 
C12-C16-H16 126.1 
C15-C16-H16 126.1 
Fe1-C16-H16 126.2 
C7-Fe1-C12 105.90(7) 
C7-Fe1-C13 119.49(7) 
C12-Fe1-C13 40.85(8) 
C7-Fe1-C8 40.96(6) 
C12-Fe1-C8 122.45(7) 
C13-Fe1-C8 105.51(7) 
C7-Fe1-C11 41.20(6) 
C12-Fe1-C11 121.45(7) 
C13-Fe1-C11 156.27(7) 
C8-Fe1-C11 68.80(6) 
C7-Fe1-C16 124.04(7) 
C12-Fe1-C16 40.66(8) 
C13-Fe1-C16 68.41(8) 
C8-Fe1-C16 160.00(7) 
C11-Fe1-C16 108.65(7) 
C7-Fe1-C10 68.81(6) 
C12-Fe1-C10 157.86(7) 
C13-Fe1-C10 160.67(8) 
C8-Fe1-C10 68.49(6) 
C11-Fe1-C10 40.56(7) 
C16-Fe1-C10 123.34(7) 
C7-Fe1-C14 155.23(7) 
C12-Fe1-C14 68.25(7) 
C13-Fe1-C14 40.39(8) 
C8-Fe1-C14 120.39(7) 
C11-Fe1-C14 162.34(7) 
C16-Fe1-C14 68.11(7) 
C10-Fe1-C14 125.51(7) 
C7-Fe1-C9 68.86(7) 
C12-Fe1-C9 159.30(7) 
C13-Fe1-C9 122.93(7) 
C8-Fe1-C9 40.66(6) 
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C11-Fe1-C9 68.62(7) 
C16-Fe1-C9 158.54(7) 
C10-Fe1-C9 40.75(7) 
C14-Fe1-C9 107.65(7) 
C7-Fe1-C15 161.84(7) 
C12-Fe1-C15 68.22(7) 
C13-Fe1-C15 68.08(8) 
C8-Fe1-C15 156.76(7) 
C11-Fe1-C15 125.97(7) 
C16-Fe1-C15 40.49(7) 
C10-Fe1-C15 109.78(7) 
C14-Fe1-C15 40.38(8) 
C9-Fe1-C15 122.71(7) 
C1-N1-C5 121.42(15) 
C1-N1-N2 117.91(14) 
C5-N1-N2 120.49(13) 
C6-N2-N1 111.61(13) 
H1O-O2-H2O 106(2) 
  
Symmetry transformations used to generate equivalent atoms:  
  
  
 
 
 
Table 4. Anisotropic displacement parameters [Å2´ 103]. The anisotropic displacement 
factor exponent takes the form: -2p 2[h2a*2U11 + ... + 2 h k a* b* U12 ]. 
 
Atom U11 U22 U33 U23 U13 U12 
 
C1 20(1)  26(1) 18(1)  -3(1) 6(1)  -2(1) 
C2 21(1)  33(1) 17(1)  0(1) 2(1)  2(1) 
C3 25(1)  28(1) 24(1)  6(1) 8(1)  4(1) 
C4 29(1)  23(1) 26(1)  -2(1) 9(1)  -4(1) 
C5 21(1)  29(1) 17(1)  -3(1) 3(1)  -4(1) 
C6 12(1)  20(1) 16(1)  -4(1) 0(1)  -2(1) 
C7 13(1)  19(1) 17(1)  -4(1) 2(1)  2(1) 
C8 16(1)  17(1) 24(1)  -1(1) 6(1)  2(1) 
C9 21(1)  14(1) 29(1)  1(1) 4(1)  1(1) 
C10 17(1)  16(1) 28(1)  -7(1) 3(1)  4(1) 
C11 16(1)  22(1) 19(1)  -8(1) 3(1)  1(1) 
C12 40(1)  14(1) 25(1)  -5(1) -4(1)  4(1) 
C13 31(1)  30(1) 26(1)  -14(1) 7(1)  3(1) 
C14 40(1)  28(1) 15(1)  -2(1) 2(1)  -2(1) 
C15 24(1)  24(1) 26(1)  -4(1) -5(1)  2(1) 
C16 32(1)  24(1) 22(1)  -4(1) 4(1)  -8(1) 
Fe1 17(1)  13(1) 15(1)  -1(1) 2(1)  4(1) 
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N1 16(1)  24(1) 15(1)  1(1) 6(1)  1(1) 
N2 23(1)  24(1) 18(1)  4(1) 6(1)  8(1) 
O1 19(1)  25(1) 24(1)  5(1) 9(1)  9(1) 
O2 29(1)  28(1) 33(1)  12(1) 15(1)  12(1) 
  
 
 
Table 5. Hydrogen coordinates [´ 104] and isotropic displacement parameters [Å2 ´ 103]. 
 
Atom  x y z Ueq S.o.f. 
 
H1 900 3795 -3033 25 1 
H2 166 6336 -3862 29 1 
H3 639 9264 -3300 30 1 
H4 1818 9583 -1887 30 1 
H5 2532 6995 -1086 27 1 
H8 1566 907 578 23 1 
H9 2898 -1585 1158 26 1 
H10 4310 -1404 267 25 1 
H11 3854 1191 -859 23 1 
H12 3503 5456 772 34 1 
H13 2819 3852 1996 35 1 
H14 4125 1415 2686 34 1 
H15 5619 1502 1895 32 1 
H16 5237 4006 712 31 1 
H1O -384(15) 3680(30) 648(16) 42 1 
H2O 481(16) 3290(30) 385(14) 42 1 
  
 
 
 
 
Table 6. Hydrogen bonds [Å and °]. 
 
 D-H···A d(D-H) d(H···A) d(D···A) Ð(DHA) 
 
 O2-H1O...O1i 0.839(15) 1.998(17) 2.8171(16) 165(2) 
 O2-H2O...O1 0.816(16) 2.001(16) 2.8174(16) 178(2)  
 Symmetry transformations used to generate equivalent atoms:  
(i) -x,-y+1,-z   
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Compound 8: 
 
 
Table 1. Crystal data and structure refinement details. 
  
Identification code  2012ncs0120 (MFB 190 F3)     
Empirical formula  C16H14N2O2 
Formula weight  266.29 
Temperature  120(2) K 
Wavelength  0.71075 Å 
Crystal system  Monoclinic 
Space group  P21/n  
Unit cell dimensions a = 10.8895(2) Å a = 90° 
 b = 7.7987(2) Å b = 103.124(7)° 
 c = 16.4558(11) Å g  = 90° 
Volume 1360.99(10) Å3 
Z 4 
Density (calculated) 1.300 Mg / m3 
Absorption coefficient 0.087 mm-1 
F(000) 560 
Crystal Prism; pale yellow 
Crystal size 0.70 ´ 0.60 ´ 0.40 mm3 
q range for data collection 3.24 - 27.48° 
Index ranges -14 £ h £ 14, -10 £ k £ 10, -21 £ l £ 21 
Reflections collected 16991 
Independent reflections 3118 [Rint = 0.0170] 
Completeness to q = 27.48° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9659 and 0.9414 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3118 / 0 / 182 
Goodness-of-fit on F2 1.053 
Final R indices [F2 > 2s(F2)] R1 = 0.0400, wR2 = 0.1064 
R indices (all data) R1 = 0.0424, wR2 = 0.1082 
Largest diff. peak and hole 0.347 and -0.255 e Å-3 
 
  
Diffractometer: Rigaku R-Axis Spider Diffractometer equipped with Rapid image plate 
detector (profile data from \w-scans Cell determination: CrystalClear-SM Expert 2.0 r7 
(Rigaku, 2011) Data collection: CrystalClear-SM Expert 2.0 r7 (Rigaku, 2011) Data 
reduction and cell refinement: CrystalClear-SM Expert 2.0 r7 (Rigaku, 2011) Absorption 
correction: CrystalClear-SM Expert 2.0 r7 (Rigaku, 2011) Structure solution: SHELXS97 
(Sheldrick, G.M. (2008). Acta Cryst. A64, 112-122.) Structure refinement: SHELXL97 (G 
Sheldrick, G.M. (2008). Acta Cryst. A64, 112-122.). 
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Table 2. Atomic coordinates [´ 104], equivalent isotropic displacement parameters [Å2 ´ 103] 
and site occupancy factors. Ueq is defined as one third of the trace of the orthogonalized Uij 
tensor. 
 
Atom  x y z Ueq S.o.f. 
 
C1 1862(1) 1397(2) 375(1) 27(1) 1 
C2 2082(1) 535(2) -315(1) 32(1) 1 
C3 3120(1) -540(2) -224(1) 33(1) 1 
C4 3927(1) -771(2) 551(1) 32(1) 1 
C5 3727(1) 111(2) 1244(1) 25(1) 1 
C6 2693(1) 1207(2) 1155(1) 21(1) 1 
C7 2418(1) 2169(2) 1872(1) 21(1) 1 
C8 3479(1) 2382(1) 2656(1) 18(1) 1 
C9 4042(1) 1884(2) 4152(1) 26(1) 1 
C10 4733(1) 3942(1) 1978(1) 19(1) 1 
C11 6029(1) 3951(1) 1812(1) 17(1) 1 
C12 6219(1) 4822(1) 1108(1) 21(1) 1 
C13 7404(1) 4835(2) 922(1) 24(1) 1 
C14 8405(1) 3990(2) 1442(1) 25(1) 1 
C15 8225(1) 3128(2) 2145(1) 24(1) 1 
C16 7039(1) 3100(1) 2331(1) 20(1) 1 
N1 3188(1) 1779(1) 3337(1) 21(1) 1 
N2 4599(1) 3031(1) 2665(1) 20(1) 1 
O1 1384(1) 2748(1) 1877(1) 31(1) 1 
O2 3876(1) 4766(1) 1514(1) 25(1) 1 
  
 
 
Table 3. Bond lengths [Å] and angles [°]. 
  
C1-C2 1.3865(18) 
C1-C6 1.3995(15) 
C1-H1 0.9500 
C2-C3 1.388(2) 
C2-H2 0.9500 
C3-C4 1.388(2) 
C3-H3 0.9500 
C4-C5 1.3899(17) 
C4-H4 0.9500 
C5-C6 1.3940(16) 
C5-H5 0.9500 
C6-C7 1.4849(16) 
C7-O1 1.2149(14) 
C7-C8 1.5329(15) 
C8-N2 1.3175(14) 
C8-N1 1.3188(14) 
C9-N1 1.4510(14) 
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C9-H9A 0.9800 
C9-H9B 0.9800 
C9-H9C 0.9800 
C10-O2 1.2419(14) 
C10-N2 1.3707(14) 
C10-C11 1.4970(14) 
C11-C12 1.3982(15) 
C11-C16 1.3982(15) 
C12-C13 1.3912(16) 
C12-H12 0.9500 
C13-C14 1.3893(17) 
C13-H13 0.9500 
C14-C15 1.3902(17) 
C14-H14 0.9500 
C15-C16 1.3934(15) 
C15-H15 0.9500 
C16-H16 0.9500 
N1-H1A 0.8800 
 
C2-C1-C6 120.23(12) 
C2-C1-H1 119.9 
C6-C1-H1 119.9 
C1-C2-C3 119.51(12) 
C1-C2-H2 120.2 
C3-C2-H2 120.2 
C2-C3-C4 120.51(12) 
C2-C3-H3 119.7 
C4-C3-H3 119.7 
C3-C4-C5 120.33(12) 
C3-C4-H4 119.8 
C5-C4-H4 119.8 
C4-C5-C6 119.38(11) 
C4-C5-H5 120.3 
C6-C5-H5 120.3 
C5-C6-C1 119.98(11) 
C5-C6-C7 122.01(10) 
C1-C6-C7 118.00(10) 
O1-C7-C6 123.24(10) 
O1-C7-C8 118.40(10) 
C6-C7-C8 118.31(9) 
N2-C8-N1 121.84(10) 
N2-C8-C7 124.74(10) 
N1-C8-C7 113.36(9) 
N1-C9-H9A 109.5 
N1-C9-H9B 109.5 
H9A-C9-H9B 109.5 
N1-C9-H9C 109.5 
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H9A-C9-H9C 109.5 
H9B-C9-H9C 109.5 
O2-C10-N2 124.70(10) 
O2-C10-C11 119.54(10) 
N2-C10-C11 115.74(9) 
C12-C11-C16 119.54(10) 
C12-C11-C10 118.47(10) 
C16-C11-C10 121.98(10) 
C13-C12-C11 120.32(10) 
C13-C12-H12 119.8 
C11-C12-H12 119.8 
C14-C13-C12 119.89(11) 
C14-C13-H13 120.1 
C12-C13-H13 120.1 
C13-C14-C15 120.16(10) 
C13-C14-H14 119.9 
C15-C14-H14 119.9 
C14-C15-C16 120.24(10) 
C14-C15-H15 119.9 
C16-C15-H15 119.9 
C15-C16-C11 119.85(10) 
C15-C16-H16 120.1 
C11-C16-H16 120.1 
C8-N1-C9 122.59(9) 
C8-N1-H1A 118.7 
C9-N1-H1A 118.7 
C8-N2-C10 117.47(9) 
  
Symmetry transformations used to generate equivalent atoms:  
  
  
 
 
 
Table 4. Anisotropic displacement parameters [Å2´ 103]. The anisotropic displacement 
factor exponent takes the form: -2p 2[h2a*2U11 + ... + 2 h k a* b* U12 ]. 
 
Atom U11 U22 U33 U23 U13 U12 
 
C1 27(1)  28(1) 23(1)  2(1) 0(1)  -1(1) 
C2 40(1)  34(1) 20(1)  -2(1) 2(1)  -9(1) 
C3 45(1)  29(1) 28(1)  -10(1) 16(1)  -10(1) 
C4 34(1)  24(1) 38(1)  -6(1) 12(1)  1(1) 
C5 25(1)  23(1) 25(1)  0(1) 4(1)  1(1) 
C6 21(1)  21(1) 20(1)  1(1) 3(1)  -3(1) 
C7 17(1)  23(1) 22(1)  1(1) 3(1)  0(1) 
C8 16(1)  20(1) 20(1)  -2(1) 5(1)  2(1) 
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C9 23(1)  39(1) 18(1)  0(1) 5(1)  -2(1) 
C10 17(1)  19(1) 20(1)  -3(1) 5(1)  0(1) 
C11 16(1)  16(1) 20(1)  -2(1) 5(1)  0(1) 
C12 22(1)  19(1) 22(1)  2(1) 6(1)  3(1) 
C13 29(1)  22(1) 27(1)  3(1) 14(1)  -1(1) 
C14 19(1)  24(1) 36(1)  0(1) 13(1)  -2(1) 
C15 17(1)  23(1) 31(1)  2(1) 3(1)  1(1) 
C16 19(1)  21(1) 21(1)  2(1) 4(1)  -1(1) 
N1 16(1)  27(1) 20(1)  -1(1) 5(1)  -4(1) 
N2 16(1)  24(1) 20(1)  -1(1) 6(1)  -2(1) 
O1 18(1)  44(1) 31(1)  -3(1) 4(1)  6(1) 
O2 19(1)  29(1) 28(1)  5(1) 7(1)  7(1) 
  
 
 
 
 
 
 
Table 5. Hydrogen coordinates [´ 104] and isotropic displacement parameters [Å2 ´ 103]. 
 
Atom  x y z Ueq S.o.f. 
 
H1 1145 2118 319 32 1 
H2 1527 681 -846 39 1 
H3 3278 -1124 -697 39 1 
H4 4621 -1536 609 38 1 
H5 4288 -32 1773 30 1 
H9A 4886 1512 4111 40 1 
H9B 3737 1140 4544 40 1 
H9C 4081 3071 4352 40 1 
H12 5537 5408 755 25 1 
H13 7527 5421 441 29 1 
H14 9214 4002 1316 30 1 
H15 8913 2557 2500 29 1 
H16 6917 2503 2810 24 1 
H1A 2447 1294 3295 25 1 
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Ø HPLC 
Central chiral Thiourea 19a: 
 
Figure 58 : Chiral HPLC of rac-19a. AD column, 5% IPA in hexane, 1 mL.min-1, monitored at 210 nm 
 
Figure 59: Chiral HPLC of (S)-19a. AD column, 5% IPA in hexane, 1 mL.min-1, monitored at 210 nm 
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Central Chiral thiourea 19b: 
 
Figure 60: Chiral HPLC of (R)-19b. OD column, 10% IPA in hexane, 1 mL.min-1, monitored at 254 nm 
 
Figure 61: Chiral HPLC of (S)-19b. OD column, 10% IPA in hexane, 1 mL.min-1, monitored at 230 nm 
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Planar chiral thiourea 20: 
 
Figure 62 : Chiral HPLC of rac-20. Amylose 2 column, 50% MeCN in water, 1 mL.min-1, monitored 
at 210 nm 
 
Figure 63: Chiral HPLC of (R)-20. Amylose 2 column, 50% MeCN in water, 1 mL.min-1, monitored 
at 210 nm 
 175 
 
Bi-functional Thiourea 21: 
 
Figure 64: Chiral HPLC of (R,Rp)-21. OD column, 15% IPA in hexane, 1 mL.min-1, monitored at 230 
nm 
 
Figure 65: Chiral HPLC of (S,Sp)-21. OD column, 15% IPA in hexane, 1 mL.min-1, monitored at 230 
nm 
